{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,19]],"date-time":"2026-11-19T20:08:27Z","timestamp":1795118907203,"version":"4.10.3"},"reference-count":551,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,3,10]],"date-time":"2025-03-10T00:00:00Z","timestamp":1741564800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,3,10]],"date-time":"2025-03-10T00:00:00Z","timestamp":1741564800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sig Transduct Target Ther"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>In the context of global ageing, the prevalence of neurodegenerative diseases and dementia, such as Alzheimer\u2019s disease (AD), is increasing. However, the current symptomatic and disease-modifying therapies have achieved limited benefits for neurodegenerative diseases in clinical settings. Halting the progress of neurodegeneration and cognitive decline or even improving impaired cognition and function are the clinically meaningful goals of treatments for neurodegenerative diseases. Ageing is the primary risk factor for neurodegenerative diseases and their associated comorbidities, such as vascular pathologies, in elderly individuals. Thus, we aim to elucidate the role of ageing in neurodegenerative diseases from the perspective of a complex system, in which the brain is the core and peripheral organs and tissues form a holistic network to support brain functions. During ageing, the progressive deterioration of the structure and function of the entire body hampers its active and adaptive responses to various stimuli, thereby rendering individuals more vulnerable to neurodegenerative diseases. Consequently, we propose that the prevention and treatment of neurodegenerative diseases should be grounded in holistic antiageing and rejuvenation means complemented by interventions targeting disease-specific pathogenic events. This integrated approach is a promising strategy to effectively prevent, pause or slow down the progression of neurodegenerative diseases.<\/jats:p>","DOI":"10.1038\/s41392-025-02145-7","type":"journal-article","created":{"date-parts":[[2025,3,9]],"date-time":"2025-03-09T20:02:03Z","timestamp":1741550523000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":185,"title":["Antiageing strategy for neurodegenerative diseases: from mechanisms to clinical advances"],"prefix":"10.1038","volume":"10","author":[{"given":"Qiu","family":"Jiang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shan","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuan-Yue","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0906-6666","authenticated-orcid":false,"given":"Xiaowei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9289-8177","authenticated-orcid":false,"given":"Guang-Hui","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7657-8154","authenticated-orcid":false,"given":"Keqiang","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9928-889X","authenticated-orcid":false,"given":"Weihong","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Colin L.","family":"Masters","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6227-6112","authenticated-orcid":false,"given":"Yan-Jiang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,3,10]]},"reference":[{"key":"2145_CR1","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.smhs.2019.08.005","volume":"1","author":"JC Drake","year":"2019","unstructured":"Drake, J. C. & Yan, Z. Targeting healthspan to optimally combat non-communicable disease in an aging world. Sports Med Health Sci. 1, 59\u201360 (2019).","journal-title":"Sports Med Health Sci."},{"key":"2145_CR2","doi-asserted-by":"crossref","unstructured":"Global, regional, and national burden of disorders affecting the nervous system, 1990\u20132021: a systematic analysis for the Global Burden of Disease Study 2021. Lancet Neurol. 23, 344\u2013381 (2024).","DOI":"10.1016\/S1474-4422(24)00038-3"},{"key":"2145_CR3","unstructured":"Gauthier, S. Rosa-Neto, P. Morais, J. A. & Webster, C. World Alzheimer Report 2021: Journey through the diagnosis of dementia. Alzheimer's Disease International. https:\/\/www.alzint.org\/resource\/world-alzheimer-report-2021\/ (2021)."},{"key":"2145_CR4","doi-asserted-by":"crossref","first-page":"377","DOI":"10.33588\/rn.6611.2017519","volume":"66","author":"J Garre-Olmo","year":"2018","unstructured":"Garre-Olmo, J. Epidemiology of Alzheimer\u2019s disease and other dementias. Rev. Neurol. 66, 377\u2013386 (2018).","journal-title":"Rev. Neurol."},{"key":"2145_CR5","doi-asserted-by":"crossref","unstructured":"2024 Alzheimer\u2019s disease facts and figures. Alzheimers Dement. 20, 3708\u20133821 (2024).","DOI":"10.1002\/alz.13809"},{"key":"2145_CR6","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1016\/j.jalz.2017.12.006","volume":"14","author":"J Jia","year":"2018","unstructured":"Jia, J. et al. The cost of Alzheimer\u2019s disease in China and re-estimation of costs worldwide. Alzheimers Dement 14, 483\u2013491 (2018).","journal-title":"Alzheimers Dement"},{"key":"2145_CR7","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1038\/s41531-020-0117-1","volume":"6","author":"W Yang","year":"2020","unstructured":"Yang, W. et al. Current and projected future economic burden of Parkinson\u2019s disease in the U.S. NPJ Parkinsons Dis. 6, 15 (2020).","journal-title":"NPJ Parkinsons Dis."},{"key":"2145_CR8","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1111\/ene.15645","volume":"30","author":"I Rodr\u00edguez-Santana","year":"2023","unstructured":"Rodr\u00edguez-Santana, I. et al. Economic burden of Huntington disease in Europe and the USA: Results from the Huntington\u2019s Disease Burden of Illness study. Eur. J. Neurol. 30, 1109\u20131117 (2023).","journal-title":"Eur. J. Neurol."},{"key":"2145_CR9","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1016\/S0140-6736(23)01429-0","volume":"403","author":"T Foltynie","year":"2024","unstructured":"Foltynie, T. et al. Medical, surgical, and physical treatments for Parkinson\u2019s disease. Lancet 403, 305\u2013324 (2024).","journal-title":"Lancet"},{"key":"2145_CR10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/978-3-319-71779-1_1","volume":"1049","author":"R Ghosh","year":"2018","unstructured":"Ghosh, R. & Tabrizi, S. J. Clinical Features of Huntington\u2019s Disease. Adv. Exp. Med. Biol. 1049, 1\u201328 (2018).","journal-title":"Adv. Exp. Med. Biol."},{"key":"2145_CR11","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1007\/s13311-023-01380-6","volume":"20","author":"KD Neylan","year":"2023","unstructured":"Neylan, K. D. & Miller, B. L. New Approaches to the Treatment of Frontotemporal Dementia. Neurotherapeutics 20, 1055\u20131065 (2023).","journal-title":"Neurotherapeutics"},{"key":"2145_CR12","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1007\/s13311-022-01190-2","volume":"19","author":"S Luo","year":"2022","unstructured":"Luo, S., Rabbani, Q. & Crone, N. E. Brain-Computer Interface: Applications to Speech Decoding and Synthesis to Augment Communication. Neurotherapeutics 19, 263\u2013273 (2022).","journal-title":"Neurotherapeutics"},{"key":"2145_CR13","doi-asserted-by":"publisher","first-page":"3183","DOI":"10.1080\/17483107.2024.2316312","volume":"19","author":"A Pirasteh","year":"2024","unstructured":"Pirasteh, A., Shamseini Ghiyasvand, M. & Pouladian, M. EEG-based brain-computer interface methods with the aim of rehabilitating advanced stage ALS patients. Disabil. Rehabil. Assist. Technol. 19, 3183\u20133193 (2024).","journal-title":"Disabil. Rehabil. Assist. Technol."},{"key":"2145_CR14","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1016\/j.neuron.2019.01.039","volume":"101","author":"SJ Tabrizi","year":"2019","unstructured":"Tabrizi, S. J., Ghosh, R. & Leavitt, B. R. Huntingtin Lowering Strategies for Disease Modification in Huntington\u2019s Disease. Neuron 101, 801\u2013819 (2019).","journal-title":"Neuron"},{"key":"2145_CR15","doi-asserted-by":"publisher","first-page":"4260","DOI":"10.1016\/j.cell.2023.08.021","volume":"186","author":"M Jucker","year":"2023","unstructured":"Jucker, M. & Walker, L. C. Alzheimer\u2019s disease: From immunotherapy to immunoprevention. Cell 186, 4260\u20134270 (2023).","journal-title":"Cell"},{"key":"2145_CR16","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1056\/NEJMoa2212948","volume":"388","author":"CH van Dyck","year":"2023","unstructured":"van Dyck, C. H. et al. Lecanemab in Early Alzheimer\u2019s Disease. N. Engl. J. Med. 388, 9\u201321 (2023).","journal-title":"N. Engl. J. Med."},{"key":"2145_CR17","doi-asserted-by":"crossref","unstructured":"Tagliapietra, M. Aducanumab for the treatment of Alzheimer\u2019s disease. Drugs Today 58, 465\u2013477 (2022).","DOI":"10.1358\/dot.2022.58.10.3422314"},{"key":"2145_CR18","doi-asserted-by":"crossref","unstructured":"Rashad, A. et al. Donanemab for Alzheimer\u2019s Disease: A Systematic Review of Clinical Trials. Healthcare. 11, 32 (2022).","DOI":"10.3390\/healthcare11010032"},{"key":"2145_CR19","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1016\/j.cels.2015.09.002","volume":"1","author":"R Zhang","year":"2015","unstructured":"Zhang, R., Chen, H. Z. & Liu, D. P. The Four Layers of Aging. Cell Syst. 1, 180\u2013186 (2015).","journal-title":"Cell Syst."},{"key":"2145_CR20","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1212\/WNL.55.2.198","volume":"55","author":"LX Hy","year":"2000","unstructured":"Hy, L. X. & Keller, D. M. Prevalence of AD among whites: a summary by levels of severity. Neurology 55, 198\u2013204 (2000).","journal-title":"Neurology"},{"key":"2145_CR21","doi-asserted-by":"crossref","unstructured":"2022 Alzheimer\u2019s disease facts and figures. Alzheimers Dement. 18, 700\u2013789, (2022).","DOI":"10.1002\/alz.12638"},{"key":"2145_CR22","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/S0140-6736(23)01419-8","volume":"403","author":"Y Ben-Shlomo","year":"2024","unstructured":"Ben-Shlomo, Y. et al. The epidemiology of Parkinson\u2019s disease. Lancet 403, 283\u2013292 (2024).","journal-title":"Lancet"},{"key":"2145_CR23","doi-asserted-by":"publisher","first-page":"1583","DOI":"10.1002\/mds.25945","volume":"29","author":"T Pringsheim","year":"2014","unstructured":"Pringsheim, T., Jette, N., Frolkis, A. & Steeves, T. D. The prevalence of Parkinson\u2019s disease: a systematic review and meta-analysis. Mov. Disord. 29, 1583\u20131590 (2014).","journal-title":"Mov. Disord."},{"key":"2145_CR24","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1080\/21678421.2021.1949021","volume":"23","author":"P Mehta","year":"2022","unstructured":"Mehta, P. et al. Prevalence of amyotrophic lateral sclerosis (ALS), United States, 2016. Amyotroph. Lateral Scler. Frontotemporal Degener. 23, 220\u2013225 (2022).","journal-title":"Amyotroph. Lateral Scler. Frontotemporal Degener."},{"key":"2145_CR25","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1136\/practneurol-2020-002835","volume":"21","author":"D Wilson","year":"2021","unstructured":"Wilson, D., Le Heron, C. & Anderson, T. Corticobasal syndrome: a practical guide. Pr. Neurol. 21, 276\u2013285 (2021).","journal-title":"Pr. Neurol."},{"key":"2145_CR26","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.aaw6404","volume":"5","author":"S Wegmann","year":"2019","unstructured":"Wegmann, S. et al. Experimental evidence for the age dependence of tau protein spread in the brain. Sci. Adv. 5, eaaw6404 (2019).","journal-title":"Sci. Adv."},{"key":"2145_CR27","doi-asserted-by":"publisher","first-page":"841","DOI":"10.2165\/11640070-000000000-00000","volume":"26","author":"RE Seltman","year":"2012","unstructured":"Seltman, R. E. & Matthews, B. R. Frontotemporal lobar degeneration: epidemiology, pathology, diagnosis and management. CNS Drugs 26, 841\u2013870 (2012).","journal-title":"CNS Drugs"},{"key":"2145_CR28","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1001\/jamaneurol.2022.5128","volume":"80","author":"G Logroscino","year":"2023","unstructured":"Logroscino, G. et al. Incidence of Syndromes Associated With Frontotemporal Lobar Degeneration in 9 European Countries. JAMA Neurol. 80, 279\u2013286 (2023).","journal-title":"JAMA Neurol."},{"key":"2145_CR29","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1111\/cge.12574","volume":"89","author":"F Squitieri","year":"2016","unstructured":"Squitieri, F. et al. Epidemiology of Huntington disease: first post-HTT gene analysis of prevalence in Italy. Clin. Genet 89, 367\u2013370 (2016).","journal-title":"Clin. Genet"},{"key":"2145_CR30","doi-asserted-by":"publisher","first-page":"595","DOI":"10.15252\/emmm.201606210","volume":"8","author":"DJ Selkoe","year":"2016","unstructured":"Selkoe, D. J. & Hardy, J. The amyloid hypothesis of Alzheimer\u2019s disease at 25 years. EMBO Mol. Med 8, 595\u2013608 (2016).","journal-title":"EMBO Mol. Med"},{"key":"2145_CR31","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1002\/alz.12192","volume":"17","author":"AFT Arnsten","year":"2021","unstructured":"Arnsten, A. F. T., Datta, D., Del Tredici, K. & Braak, H. Hypothesis: Tau pathology is an initiating factor in sporadic Alzheimer\u2019s disease. Alzheimers Dement 17, 115\u2013124 (2021).","journal-title":"Alzheimers Dement"},{"key":"2145_CR32","doi-asserted-by":"publisher","first-page":"129","DOI":"10.3233\/ADR-210299","volume":"6","author":"JD Rudge","year":"2022","unstructured":"Rudge, J. D. A New Hypothesis for Alzheimer\u2019s Disease: The Lipid Invasion Model. J. Alzheimers Dis. Rep. 6, 129\u2013161 (2022).","journal-title":"J. Alzheimers Dis. Rep."},{"key":"2145_CR33","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1001\/jama.2019.20939","volume":"323","author":"BM Kuehn","year":"2020","unstructured":"Kuehn, B. M. In Alzheimer Research, Glucose Metabolism Moves to Center Stage. JAMA 323, 297\u2013299 (2020).","journal-title":"JAMA"},{"key":"2145_CR34","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1038\/s41582-020-00435-y","volume":"17","author":"F Leng","year":"2021","unstructured":"Leng, F. & Edison, P. Neuroinflammation and microglial activation in Alzheimer disease: where do we go from here? Nat. Rev. Neurol. 17, 157\u2013172 (2021).","journal-title":"Nat. Rev. Neurol."},{"key":"2145_CR35","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/S0891-5849(96)00629-6","volume":"23","author":"WR Markesbery","year":"1997","unstructured":"Markesbery, W. R. Oxidative stress hypothesis in Alzheimer\u2019s disease. Free Radic. Biol. Med. 23, 134\u2013147 (1997).","journal-title":"Free Radic. Biol. Med."},{"key":"2145_CR36","doi-asserted-by":"publisher","first-page":"1397","DOI":"10.1016\/j.neubiorev.2011.03.001","volume":"35","author":"LA Craig","year":"2011","unstructured":"Craig, L. A., Hong, N. S. & McDonald, R. J. Revisiting the cholinergic hypothesis in the development of Alzheimer\u2019s disease. Neurosci. Biobehav. Rev. 35, 1397\u20131409 (2011).","journal-title":"Neurosci. Biobehav. Rev."},{"key":"2145_CR37","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1038\/s41392-023-01502-8","volume":"8","author":"X Li","year":"2023","unstructured":"Li, X. et al. Inflammation and aging: signaling pathways and intervention therapies. Signal Transduct. Target Ther. 8, 239 (2023).","journal-title":"Signal Transduct. Target Ther."},{"key":"2145_CR38","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1016\/j.bbr.2010.11.058","volume":"221","author":"R Schliebs","year":"2011","unstructured":"Schliebs, R. & Arendt, T. The cholinergic system in aging and neuronal degeneration. Behav. Brain Res. 221, 555\u2013563 (2011).","journal-title":"Behav. Brain Res."},{"key":"2145_CR39","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1111\/j.1753-4887.1975.tb05227.x","volume":"33","author":"CM McCay","year":"1975","unstructured":"McCay, C. M., Maynard, L. A., Sperling, G. & Barnes, L. L. The Journal of Nutrition. Volume 18 July\u2013December, 1939. Pages 1\u201313. Retarded growth, life span, ultimate body size and age changes in the albino rat after feeding diets restricted in calories. Nutr. Rev. 33, 241\u2013243 (1975).","journal-title":"Nutr. Rev."},{"key":"2145_CR40","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1126\/science.1173635","volume":"325","author":"RJ Colman","year":"2009","unstructured":"Colman, R. J. et al. Caloric restriction delays disease onset and mortality in rhesus monkeys. Science 325, 201\u2013204 (2009).","journal-title":"Science"},{"key":"2145_CR41","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1054\/mehy.1999.0856","volume":"54","author":"J Bowles","year":"2000","unstructured":"Bowles, J. Shattered: Medawar\u2019s test tubes and their enduring legacy of chaos. Med. Hypotheses 54, 326\u2013339 (2000).","journal-title":"Med. Hypotheses"},{"key":"2145_CR42","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1007\/s10522-009-9234-2","volume":"10","author":"D Harman","year":"2009","unstructured":"Harman, D. Origin and evolution of the free radical theory of aging: a brief personal history, 1954\u20132009. Biogerontology 10, 773\u2013781 (2009).","journal-title":"Biogerontology"},{"key":"2145_CR43","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1749-6632.1994.tb12069.x","volume":"717","author":"D Harman","year":"1994","unstructured":"Harman, D. Free-radical theory of aging. Increasing the functional life span. Ann. N. Y. Acad. Sci. 717, 1\u201315 (1994).","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"2145_CR44","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1038\/287141a0","volume":"287","author":"M Rose","year":"1980","unstructured":"Rose, M. & Charlesworth, B. A test of evolutionary theories of senescence. Nature 287, 141\u2013142 (1980).","journal-title":"Nature"},{"key":"2145_CR45","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1038\/35036093","volume":"1","author":"JW Shay","year":"2000","unstructured":"Shay, J. W. & Wright, W. E. Hayflick, his limit, and cellular ageing. Nat. Rev. Mol. Cell Biol. 1, 72\u201376 (2000).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"2145_CR46","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1093\/geront\/4.4.195","volume":"4","author":"RL Walford","year":"1964","unstructured":"Walford, R. L. The immunologic theory of aging. Gerontologist 4, 195\u2013197 (1964).","journal-title":"Gerontologist"},{"key":"2145_CR47","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/0022-5193(73)90198-7","volume":"41","author":"AM Olovnikov","year":"1973","unstructured":"Olovnikov, A. M. A theory of marginotomy. The incomplete copying of template margin in enzymic synthesis of polynucleotides and biological significance of the phenomenon. J. Theor. Biol. 41, 181\u2013190 (1973).","journal-title":"J. Theor. Biol."},{"key":"2145_CR48","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1111\/j.1749-6632.2000.tb06651.x","volume":"908","author":"C Franceschi","year":"2000","unstructured":"Franceschi, C. et al. Inflamm-aging. An evolutionary perspective on immunosenescence. Ann. N. Y. Acad. Sci. 908, 244\u2013254 (2000).","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"2145_CR49","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/S0047-6374(00)00118-4","volume":"115","author":"HR Warner","year":"2000","unstructured":"Warner, H. R. et al. Program for testing biological interventions to promote healthy aging. Mech. Ageing Dev. 115, 199\u2013207 (2000).","journal-title":"Mech. Ageing Dev."},{"key":"2145_CR50","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/j.cell.2022.12.017","volume":"186","author":"X Liu","year":"2023","unstructured":"Liu, X. et al. Resurrection of endogenous retroviruses during aging reinforces senescence. Cell 186, 287\u2013304.e226 (2023).","journal-title":"Cell"},{"key":"2145_CR51","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1093\/genetics\/118.1.75","volume":"118","author":"DB Friedman","year":"1988","unstructured":"Friedman, D. B. & Johnson, T. E. A mutation in the age-1 gene in Caenorhabditis elegans lengthens life and reduces hermaphrodite fertility. Genetics 118, 75\u201386 (1988).","journal-title":"Genetics"},{"key":"2145_CR52","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1038\/366461a0","volume":"366","author":"C Kenyon","year":"1993","unstructured":"Kenyon, C. et al. A C. elegans mutant that lives twice as long as wild type. Nature 366, 461\u2013464 (1993).","journal-title":"Nature"},{"key":"2145_CR53","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms3192","volume":"4","author":"A Martin-Montalvo","year":"2013","unstructured":"Martin-Montalvo, A. et al. Metformin improves healthspan and lifespan in mice. Nat. Commun. 4, 2192 (2013).","journal-title":"Nat. Commun."},{"key":"2145_CR54","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1016\/0092-8674(95)90499-9","volume":"80","author":"BK Kennedy","year":"1995","unstructured":"Kennedy, B. K., Austriaco, N. R. Jr., Zhang, J. & Guarente, L. Mutation in the silencing gene SIR4 can delay aging in S. cerevisiae. Cell 80, 485\u2013496 (1995).","journal-title":"Cell"},{"key":"2145_CR55","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1146\/annurev.pathol.4.110807.092250","volume":"5","author":"MC Haigis","year":"2010","unstructured":"Haigis, M. C. & Sinclair, D. A. Mammalian sirtuins: biological insights and disease relevance. Annu Rev. Pathol. 5, 253\u2013295 (2010).","journal-title":"Annu Rev. Pathol."},{"key":"2145_CR56","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1038\/nature01960","volume":"425","author":"KT Howitz","year":"2003","unstructured":"Howitz, K. T. et al. Small molecule activators of sirtuins extend Saccharomyces cerevisiae lifespan. Nature 425, 191\u2013196 (2003).","journal-title":"Nature"},{"key":"2145_CR57","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1016\/j.cub.2004.03.059","volume":"14","author":"P Kapahi","year":"2004","unstructured":"Kapahi, P. et al. Regulation of lifespan in Drosophila by modulation of genes in the TOR signaling pathway. Curr. Biol. 14, 885\u2013890 (2004).","journal-title":"Curr. Biol."},{"key":"2145_CR58","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1038\/nature08221","volume":"460","author":"DE Harrison","year":"2009","unstructured":"Harrison, D. E. et al. Rapamycin fed late in life extends lifespan in genetically heterogeneous mice. Nature 460, 392\u2013395 (2009).","journal-title":"Nature"},{"key":"2145_CR59","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1038\/nature02789","volume":"430","author":"JG Wood","year":"2004","unstructured":"Wood, J. G. et al. Sirtuin activators mimic caloric restriction and delay ageing in metazoans. Nature 430, 686\u2013689 (2004).","journal-title":"Nature"},{"key":"2145_CR60","doi-asserted-by":"publisher","first-page":"1224","DOI":"10.1126\/science.abe9985","volume":"372","author":"M Yoshino","year":"2021","unstructured":"Yoshino, M. et al. Nicotinamide mononucleotide increases muscle insulin sensitivity in prediabetic women. Science 372, 1224\u20131229 (2021).","journal-title":"Science"},{"key":"2145_CR61","doi-asserted-by":"publisher","first-page":"6358","DOI":"10.1016\/j.cell.2024.08.021","volume":"187","author":"Y Yang","year":"2024","unstructured":"Yang, Y. et al. Metformin decelerates aging clock in male monkeys. Cell 187, 6358\u20136378.e6329 (2024).","journal-title":"Cell"},{"key":"2145_CR62","doi-asserted-by":"publisher","first-page":"2853","DOI":"10.1371\/journal.pbio.0060301","volume":"6","author":"JP Copp\u00e9","year":"2008","unstructured":"Copp\u00e9, J. P. et al. Senescence-associated secretory phenotypes reveal cell-nonautonomous functions of oncogenic RAS and the p53 tumor suppressor. PLoS Biol. 6, 2853\u20132868 (2008).","journal-title":"PLoS Biol."},{"key":"2145_CR63","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1038\/nature16932","volume":"530","author":"DJ Baker","year":"2016","unstructured":"Baker, D. J. et al. Naturally occurring p16(Ink4a)-positive cells shorten healthy lifespan. Nature 530, 184\u2013189 (2016).","journal-title":"Nature"},{"key":"2145_CR64","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1016\/j.ebiom.2018.12.052","volume":"40","author":"JN Justice","year":"2019","unstructured":"Justice, J. N. et al. Senolytics in idiopathic pulmonary fibrosis: Results from a first-in-human, open-label, pilot study. EBioMedicine 40, 554\u2013563 (2019).","journal-title":"EBioMedicine"},{"key":"2145_CR65","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1016\/0047-6374(77)90034-3","volume":"6","author":"H Tauchi","year":"1977","unstructured":"Tauchi, H. & Hasegawa, K. Change of the hepatic cells in parabiosis between old and young rats. Mech. Ageing Dev. 6, 333\u2013339 (1977).","journal-title":"Mech. Ageing Dev."},{"key":"2145_CR66","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1038\/nature03260","volume":"433","author":"IM Conboy","year":"2005","unstructured":"Conboy, I. M. et al. Rejuvenation of aged progenitor cells by exposure to a young systemic environment. Nature 433, 760\u2013764 (2005).","journal-title":"Nature"},{"key":"2145_CR67","first-page":"1","volume":"68","author":"E Jalavisto","year":"1952","unstructured":"Jalavisto, E. The biologic age and life expectancy. Duodecim. Suppl. 68, 1\u201312 (1952).","journal-title":"Duodecim. Suppl."},{"key":"2145_CR68","doi-asserted-by":"publisher","first-page":"e14821","DOI":"10.1371\/journal.pone.0014821","volume":"6","author":"S Bocklandt","year":"2011","unstructured":"Bocklandt, S. et al. Epigenetic predictor of age. PLoS One 6, e14821 (2011).","journal-title":"PLoS One"},{"key":"2145_CR69","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1093\/ije\/dyt094","volume":"42","author":"C Menni","year":"2013","unstructured":"Menni, C. et al. Metabolomic markers reveal novel pathways of ageing and early development in human populations. Int. J. Epidemiol. 42, 1111\u20131119 (2013).","journal-title":"Int. J. Epidemiol."},{"key":"2145_CR70","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms9570","volume":"6","author":"MJ Peters","year":"2015","unstructured":"Peters, M. J. et al. The transcriptional landscape of age in human peripheral blood. Nat. Commun. 6, 8570 (2015).","journal-title":"Nat. Commun."},{"key":"2145_CR71","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1038\/s41576-018-0004-3","volume":"19","author":"S Horvath","year":"2018","unstructured":"Horvath, S. & Raj, K. DNA methylation-based biomarkers and the epigenetic clock theory of ageing. Nat. Rev. Genet 19, 371\u2013384 (2018).","journal-title":"Nat. Rev. Genet"},{"key":"2145_CR72","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1126\/science.1251141","volume":"344","author":"L Katsimpardi","year":"2014","unstructured":"Katsimpardi, L. et al. Vascular and neurogenic rejuvenation of the aging mouse brain by young systemic factors. Science 344, 630\u2013634 (2014).","journal-title":"Science"},{"key":"2145_CR73","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1001\/jamaneurol.2018.3288","volume":"76","author":"SJ Sha","year":"2019","unstructured":"Sha, S. J. et al. Safety, Tolerability, and Feasibility of Young Plasma Infusion in the Plasma for Alzheimer Symptom Amelioration Study: A Randomized Clinical Trial. JAMA Neurol. 76, 35\u201340 (2019).","journal-title":"JAMA Neurol."},{"key":"2145_CR74","doi-asserted-by":"publisher","first-page":"1905","DOI":"10.1002\/mds.28198","volume":"35","author":"JE Parker","year":"2020","unstructured":"Parker, J. E. et al. Safety of Plasma Infusions in Parkinson\u2019s Disease. Mov. Disord. 35, 1905\u20131913 (2020).","journal-title":"Mov. Disord."},{"key":"2145_CR75","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1038\/s43587-021-00093-9","volume":"1","author":"M Boehme","year":"2021","unstructured":"Boehme, M. et al. Microbiota from young mice counteracts selective age-associated behavioral deficits. Nat. Aging 1, 666\u2013676 (2021).","journal-title":"Nat. Aging"},{"key":"2145_CR76","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2023.1103189","volume":"13","author":"X Chen","year":"2023","unstructured":"Chen, X. et al. Preliminary evidence for developing safe and efficient fecal microbiota transplantation as potential treatment for aged related cognitive impairments. Front. Cell Infect. Microbiol. 13, 1103189 (2023).","journal-title":"Front. Cell Infect. Microbiol."},{"key":"2145_CR77","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000016163","volume":"98","author":"H Huang","year":"2019","unstructured":"Huang, H. et al. Fecal microbiota transplantation to treat Parkinson\u2019s disease with constipation: A case report. Medicine 98, e16163 (2019).","journal-title":"Medicine"},{"key":"2145_CR78","doi-asserted-by":"publisher","DOI":"10.1111\/acel.13296","volume":"20","author":"M Ogrodnik","year":"2021","unstructured":"Ogrodnik, M. et al. Whole-body senescent cell clearance alleviates age-related brain inflammation and cognitive impairment in mice. Aging Cell 20, e13296 (2021).","journal-title":"Aging Cell"},{"key":"2145_CR79","doi-asserted-by":"publisher","first-page":"22","DOI":"10.14283\/jpad.2021.62","volume":"9","author":"MM Gonzales","year":"2022","unstructured":"Gonzales, M. M. et al. Senolytic Therapy to Modulate the Progression of Alzheimer\u2019s Disease (SToMP-AD): A Pilot Clinical Trial. J. Prev. Alzheimers Dis. 9, 22\u201329 (2022).","journal-title":"J. Prev. Alzheimers Dis."},{"key":"2145_CR80","doi-asserted-by":"publisher","first-page":"2481","DOI":"10.1038\/s41591-023-02543-w","volume":"29","author":"MM Gonzales","year":"2023","unstructured":"Gonzales, M. M. et al. Senolytic therapy in mild Alzheimer\u2019s disease: a phase 1 feasibility trial. Nat. Med. 29, 2481\u20132488 (2023).","journal-title":"Nat. Med."},{"key":"2145_CR81","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1038\/s42255-020-0196-7","volume":"2","author":"X He","year":"2020","unstructured":"He, X. et al. Single-cell omics in ageing: a young and growing field. Nat. Metab. 2, 293\u2013302 (2020).","journal-title":"Nat. Metab."},{"key":"2145_CR82","doi-asserted-by":"publisher","first-page":"1276","DOI":"10.1161\/CIRCRESAHA.117.310999","volume":"122","author":"K Trachana","year":"2018","unstructured":"Trachana, K. et al. Taking Systems Medicine to Heart. Circ. Res. 122, 1276\u20131289 (2018).","journal-title":"Circ. Res."},{"key":"2145_CR83","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1038\/s43587-022-00252-6","volume":"2","author":"AA Cohen","year":"2022","unstructured":"Cohen, A. A. et al. A complex systems approach to aging biology. Nat. Aging 2, 580\u2013591 (2022).","journal-title":"Nat. Aging"},{"key":"2145_CR84","doi-asserted-by":"crossref","unstructured":"L\u00f3pez-Ot\u00edn, C. & Kroemer, G. Hallmarks of Health. Cell. 184, 33\u201363 (2021).","DOI":"10.1016\/j.cell.2020.11.034"},{"key":"2145_CR85","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/j.cell.2022.11.001","volume":"186","author":"C L\u00f3pez-Ot\u00edn","year":"2023","unstructured":"L\u00f3pez-Ot\u00edn, C. et al. Hallmarks of aging: An expanding universe. Cell 186, 243\u2013278 (2023).","journal-title":"Cell"},{"key":"2145_CR86","doi-asserted-by":"publisher","first-page":"1619","DOI":"10.1038\/s43587-024-00692-2","volume":"4","author":"X Shen","year":"2024","unstructured":"Shen, X. et al. Nonlinear dynamics of multi-omics profiles during human aging. Nat. Aging 4, 1619\u20131634 (2024).","journal-title":"Nat. Aging"},{"key":"2145_CR87","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1126\/science.1566067","volume":"256","author":"JA Hardy","year":"1992","unstructured":"Hardy, J. A. & Higgins, G. A. Alzheimer\u2019s disease: the amyloid cascade hypothesis. Science 256, 184\u2013185 (1992).","journal-title":"Science"},{"key":"2145_CR88","doi-asserted-by":"publisher","first-page":"3617","DOI":"10.1007\/s12035-022-02809-3","volume":"59","author":"SY Liang","year":"2022","unstructured":"Liang, S. Y., Wang, Z. T., Tan, L. & Yu, J. T. Tau Toxicity in Neurodegeneration. Mol. Neurobiol. 59, 3617\u20133634 (2022).","journal-title":"Mol. Neurobiol."},{"key":"2145_CR89","doi-asserted-by":"publisher","first-page":"613","DOI":"10.14348\/molcells.2017.0096","volume":"40","author":"S Jeong","year":"2017","unstructured":"Jeong, S. Molecular and Cellular Basis of Neurodegeneration in Alzheimer\u2019s Disease. Mol. Cells 40, 613\u2013620 (2017).","journal-title":"Mol. Cells"},{"key":"2145_CR90","doi-asserted-by":"publisher","first-page":"148","DOI":"10.3389\/fnagi.2020.00148","volume":"12","author":"X Han","year":"2020","unstructured":"Han, X. et al. Astrocyte Senescence and Alzheimer\u2019s Disease: A Review. Front. Aging Neurosci. 12, 148 (2020).","journal-title":"Front. Aging Neurosci."},{"key":"2145_CR91","doi-asserted-by":"publisher","first-page":"1577","DOI":"10.1016\/j.neuron.2023.02.033","volume":"111","author":"R Praschberger","year":"2023","unstructured":"Praschberger, R. et al. Neuronal identity defines \u03b1-synuclein and tau toxicity. Neuron 111, 1577\u20131590.e1511 (2023).","journal-title":"Neuron"},{"key":"2145_CR92","doi-asserted-by":"publisher","first-page":"2422","DOI":"10.1016\/j.neuron.2022.05.009","volume":"110","author":"N Panicker","year":"2022","unstructured":"Panicker, N. et al. Neuronal NLRP3 is a parkin substrate that drives neurodegeneration in Parkinson\u2019s disease. Neuron 110, 2422\u20132437.e2429 (2022).","journal-title":"Neuron"},{"key":"2145_CR93","doi-asserted-by":"publisher","first-page":"942","DOI":"10.1016\/S0140-6736(10)61156-7","volume":"377","author":"MC Kiernan","year":"2011","unstructured":"Kiernan, M. C. et al. Amyotrophic lateral sclerosis. Lancet 377, 942\u2013955 (2011).","journal-title":"Lancet"},{"key":"2145_CR94","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1038\/s41572-023-00447-0","volume":"9","author":"M Grossman","year":"2023","unstructured":"Grossman, M. et al. Frontotemporal lobar degeneration. Nat. Rev. Dis. Prim. 9, 40 (2023).","journal-title":"Nat. Rev. Dis. Prim."},{"key":"2145_CR95","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1038\/s41418-018-0060-4","volume":"25","author":"H Chen","year":"2018","unstructured":"Chen, H. et al. Exploring the genetics and non-cell autonomous mechanisms underlying ALS\/FTLD. Cell Death Differ. 25, 648\u2013662 (2018).","journal-title":"Cell Death Differ."},{"key":"2145_CR96","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1016\/S0140-6736(07)60111-1","volume":"369","author":"FO Walker","year":"2007","unstructured":"Walker, F. O. Huntington\u2019s disease. Lancet 369, 218\u2013228 (2007).","journal-title":"Lancet"},{"key":"2145_CR97","doi-asserted-by":"publisher","first-page":"105147","DOI":"10.1016\/j.neuint.2021.105147","volume":"149","author":"I \u0160onsk\u00fd","year":"2021","unstructured":"\u0160onsk\u00fd, I., Vodicka, P., Vodickov\u00e1 Kepkov\u00e1, K. & Hans\u00edkov\u00e1, H. Mitophagy in Huntington\u2019s disease. Neurochem. Int. 149, 105147 (2021).","journal-title":"Neurochem. Int."},{"key":"2145_CR98","doi-asserted-by":"crossref","unstructured":"Jimenez-Sanchez, M., Licitra, F., Underwood, B. R. & Rubinsztein, D. C. Huntington\u2019s Disease: Mechanisms of Pathogenesis and Therapeutic Strategies. Cold Spring Harb. Perspect. Med. 7, a024240 (2017).","DOI":"10.1101\/cshperspect.a024240"},{"key":"2145_CR99","doi-asserted-by":"publisher","first-page":"1176","DOI":"10.1016\/j.cmet.2018.05.011","volume":"27","author":"MP Mattson","year":"2018","unstructured":"Mattson, M. P. & Arumugam, T. V. Hallmarks of Brain Aging: Adaptive and Pathological Modification by Metabolic States. Cell Metab. 27, 1176\u20131199 (2018).","journal-title":"Cell Metab."},{"key":"2145_CR100","doi-asserted-by":"publisher","first-page":"931536","DOI":"10.3389\/fnagi.2022.931536","volume":"14","author":"J Lee","year":"2022","unstructured":"Lee, J. & Kim, H. J. Normal Aging Induces Changes in the Brain and Neurodegeneration Progress: Review of the Structural, Biochemical, Metabolic, Cellular, and Molecular Changes. Front. Aging Neurosci. 14, 931536 (2022).","journal-title":"Front. Aging Neurosci."},{"key":"2145_CR101","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.neurobiolaging.2021.07.014","volume":"107","author":"A Ionescu-Tucker","year":"2021","unstructured":"Ionescu-Tucker, A. & Cotman, C. W. Emerging roles of oxidative stress in brain aging and Alzheimer\u2019s disease. Neurobiol. Aging 107, 86\u201395 (2021).","journal-title":"Neurobiol. Aging"},{"key":"2145_CR102","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1038\/s41586-021-03307-7","volume":"592","author":"B Schumacher","year":"2021","unstructured":"Schumacher, B., Pothof, J., Vijg, J. & Hoeijmakers, J. H. J. The central role of DNA damage in the ageing process. Nature 592, 695\u2013703 (2021).","journal-title":"Nature"},{"key":"2145_CR103","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1016\/j.neubiorev.2021.02.040","volume":"125","author":"ER Bacon","year":"2021","unstructured":"Bacon, E. R. & Brinton, R. D. Epigenetics of the developing and aging brain: Mechanisms that regulate onset and outcomes of brain reorganization. Neurosci. Biobehav. Rev. 125, 503\u2013516 (2021).","journal-title":"Neurosci. Biobehav. Rev."},{"key":"2145_CR104","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-60311-3","volume":"14","author":"AJ Graves","year":"2024","unstructured":"Graves, A. J. et al. Accelerated epigenetic age is associated with whole-brain functional connectivity and impaired cognitive performance in older adults. Sci. Rep. 14, 9646 (2024).","journal-title":"Sci. Rep."},{"key":"2145_CR105","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1038\/s41392-023-01486-5","volume":"8","author":"W Zhang","year":"2023","unstructured":"Zhang, W., Xiao, D., Mao, Q. & Xia, H. Role of neuroinflammation in neurodegeneration development. Signal Transduct. Target Ther. 8, 267 (2023).","journal-title":"Signal Transduct. Target Ther."},{"key":"2145_CR106","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.arr.2014.07.001","volume":"18","author":"A Lauri","year":"2014","unstructured":"Lauri, A., Pompilio, G. & Capogrossi, M. C. The mitochondrial genome in aging and senescence. Ageing Res. Rev. 18, 1\u201315 (2014).","journal-title":"Ageing Res. Rev."},{"key":"2145_CR107","doi-asserted-by":"publisher","first-page":"e466","DOI":"10.1093\/cid\/ciaa984","volume":"73","author":"C Roca-Bayerri","year":"2021","unstructured":"Roca-Bayerri, C. et al. Mitochondrial DNA Damage and Brain Aging in Human Immunodeficiency Virus. Clin. Infect. Dis. 73, e466\u2013e473 (2021).","journal-title":"Clin. Infect. Dis."},{"key":"2145_CR108","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1007\/s00401-014-1349-0","volume":"128","author":"JF Crary","year":"2014","unstructured":"Crary, J. F. et al. Primary age-related tauopathy (PART): a common pathology associated with human aging. Acta Neuropathol. 128, 755\u2013766 (2014).","journal-title":"Acta Neuropathol."},{"key":"2145_CR109","doi-asserted-by":"publisher","first-page":"1503","DOI":"10.1093\/brain\/awz099","volume":"142","author":"PT Nelson","year":"2019","unstructured":"Nelson, P. T. et al. Limbic-predominant age-related TDP-43 encephalopathy (LATE): consensus working group report. Brain 142, 1503\u20131527 (2019).","journal-title":"Brain"},{"key":"2145_CR110","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1098\/rstb.2010.0276","volume":"366","author":"C Kenyon","year":"2011","unstructured":"Kenyon, C. The first long-lived mutants: discovery of the insulin\/IGF-1 pathway for ageing. Philos. Trans. R. Soc. Lond. B Biol. Sci. 366, 9\u201316 (2011).","journal-title":"Philos. Trans. R. Soc. Lond. B Biol. Sci."},{"key":"2145_CR111","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1016\/j.neurobiolaging.2007.01.010","volume":"29","author":"L Puglielli","year":"2008","unstructured":"Puglielli, L. Aging of the brain, neurotrophin signaling, and Alzheimer\u2019s disease: is IGF1-R the common culprit? Neurobiol. Aging 29, 795\u2013811 (2008).","journal-title":"Neurobiol. Aging"},{"key":"2145_CR112","doi-asserted-by":"crossref","unstructured":"Lewitt, M. S. & Boyd, G. W. Role of the Insulin-like Growth Factor System in Neurodegenerative Disease. Int. J. Mol. Sci. 25, 4512 (2024).","DOI":"10.3390\/ijms25084512"},{"key":"2145_CR113","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1016\/j.pneurobio.2009.07.008","volume":"89","author":"A Aleman","year":"2009","unstructured":"Aleman, A. & Torres-Alem\u00e1n, I. Circulating insulin-like growth factor I and cognitive function: neuromodulation throughout the lifespan. Prog. Neurobiol. 89, 256\u2013265 (2009).","journal-title":"Prog. Neurobiol."},{"key":"2145_CR114","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1007\/s12035-019-01821-4","volume":"57","author":"G Pharaoh","year":"2020","unstructured":"Pharaoh, G. et al. Disparate Central and Peripheral Effects of Circulating IGF-1 Deficiency on Tissue Mitochondrial Function. Mol. Neurobiol. 57, 1317\u20131331 (2020).","journal-title":"Mol. Neurobiol."},{"key":"2145_CR115","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2021.682388","volume":"13","author":"JA Zegarra-Valdivia","year":"2021","unstructured":"Zegarra-Valdivia, J. A. et al. Reduced Insulin-Like Growth Factor-I Effects in the Basal Forebrain of Aging Mouse. Front. Aging Neurosci. 13, 682388 (2021).","journal-title":"Front. Aging Neurosci."},{"key":"2145_CR116","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1038\/s41580-019-0199-y","volume":"21","author":"GY Liu","year":"2020","unstructured":"Liu, G. Y. & Sabatini, D. M. mTOR at the nexus of nutrition, growth, ageing and disease. Nat. Rev. Mol. Cell Biol. 21, 183\u2013203 (2020).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"2145_CR117","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1038\/s43587-023-00416-y","volume":"3","author":"JB Mannick","year":"2023","unstructured":"Mannick, J. B. & Lamming, D. W. Targeting the biology of aging with mTOR inhibitors. Nat. Aging 3, 642\u2013660 (2023).","journal-title":"Nat. Aging"},{"key":"2145_CR118","doi-asserted-by":"publisher","first-page":"13107","DOI":"10.1074\/jbc.M110.100420","volume":"285","author":"A Caccamo","year":"2010","unstructured":"Caccamo, A. et al. Molecular interplay between mammalian target of rapamycin (mTOR), amyloid-beta, and Tau: effects on cognitive impairments. J. Biol. Chem. 285, 13107\u201313120 (2010).","journal-title":"J. Biol. Chem."},{"key":"2145_CR119","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1038\/s41392-022-01257-8","volume":"7","author":"QJ Wu","year":"2022","unstructured":"Wu, Q. J. et al. The sirtuin family in health and disease. Signal Transduct. Target Ther. 7, 402 (2022).","journal-title":"Signal Transduct. Target Ther."},{"key":"2145_CR120","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1007\/s00109-022-02187-2","volume":"100","author":"R Wang","year":"2022","unstructured":"Wang, R. et al. Deciphering therapeutic options for neurodegenerative diseases: insights from SIRT1. J. Mol. Med. 100, 537\u2013553 (2022).","journal-title":"J. Mol. Med."},{"key":"2145_CR121","first-page":"8205","volume":"14","author":"LV Basova","year":"2022","unstructured":"Basova, L. V. et al. Age-associated changes in microglia activation and Sirtuin-1- chromatin binding patterns. Aging 14, 8205\u20138220 (2022).","journal-title":"Aging"},{"key":"2145_CR122","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/j.pneurobio.2011.09.001","volume":"95","author":"F Zhang","year":"2011","unstructured":"Zhang, F. et al. Protective effects and mechanisms of sirtuins in the nervous system. Prog. Neurobiol. 95, 373\u2013395 (2011).","journal-title":"Prog. Neurobiol."},{"key":"2145_CR123","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-28822-7","volume":"13","author":"J Garcia Morato","year":"2022","unstructured":"Garcia Morato, J. et al. Sirtuin-1 sensitive lysine-136 acetylation drives phase separation and pathological aggregation of TDP-43. Nat. Commun. 13, 1223 (2022).","journal-title":"Nat. Commun."},{"key":"2145_CR124","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.expneurol.2017.08.013","volume":"298","author":"CA Peixoto","year":"2017","unstructured":"Peixoto, C. A., Oliveira, W. H., Ara\u00fajo, S. & Nunes, A. K. S. AMPK activation: Role in the signaling pathways of neuroinflammation and neurodegeneration. Exp. Neurol. 298, 31\u201341 (2017).","journal-title":"Exp. Neurol."},{"key":"2145_CR125","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1016\/j.cmet.2019.09.001","volume":"30","author":"S Lautrup","year":"2019","unstructured":"Lautrup, S., Sinclair, D. A., Mattson, M. P. & Fang, E. F. NAD(+) in Brain Aging and Neurodegenerative Disorders. Cell Metab. 30, 630\u2013655 (2019).","journal-title":"Cell Metab."},{"key":"2145_CR126","doi-asserted-by":"publisher","first-page":"111215","DOI":"10.1016\/j.mad.2020.111215","volume":"187","author":"C Chen","year":"2020","unstructured":"Chen, C., Zhou, M., Ge, Y. & Wang, X. SIRT1 and aging related signaling pathways. Mech. Ageing Dev. 187, 111215 (2020).","journal-title":"Mech. Ageing Dev."},{"key":"2145_CR127","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.neuroscience.2012.09.077","volume":"251","author":"DL Dickstein","year":"2013","unstructured":"Dickstein, D. L., Weaver, C. M., Luebke, J. I. & Hof, P. R. Dendritic spine changes associated with normal aging. Neuroscience 251, 21\u201332 (2013).","journal-title":"Neuroscience"},{"key":"2145_CR128","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-73576-1","volume":"10","author":"Y Mizoguchi","year":"2020","unstructured":"Mizoguchi, Y. et al. Lower brain-derived neurotrophic factor levels are associated with age-related memory impairment in community-dwelling older adults: the Sefuri study. Sci. Rep. 10, 16442 (2020).","journal-title":"Sci. Rep."},{"key":"2145_CR129","doi-asserted-by":"publisher","first-page":"1474","DOI":"10.15252\/embj.201695810","volume":"36","author":"S Camandola","year":"2017","unstructured":"Camandola, S. & Mattson, M. P. Brain metabolism in health, aging, and neurodegeneration. EMBO J. 36, 1474\u20131492 (2017).","journal-title":"EMBO J."},{"key":"2145_CR130","doi-asserted-by":"publisher","first-page":"1208","DOI":"10.1172\/JCI95145","volume":"128","author":"DJ Baker","year":"2018","unstructured":"Baker, D. J. & Petersen, R. C. Cellular senescence in brain aging and neurodegenerative diseases: evidence and perspectives. J. Clin. Invest 128, 1208\u20131216 (2018).","journal-title":"J. Clin. Invest"},{"key":"2145_CR131","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1089\/rej.2006.9096","volume":"10","author":"BE Flanary","year":"2007","unstructured":"Flanary, B. E. et al. Evidence that aging and amyloid promote microglial cell senescence. Rejuvenation Res. 10, 61\u201374 (2007).","journal-title":"Rejuvenation Res."},{"key":"2145_CR132","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1002\/glia.22287","volume":"60","author":"M Tremblay","year":"2012","unstructured":"Tremblay, M. et al. Effects of aging and sensory loss on glial cells in mouse visual and auditory cortices. Glia 60, 541\u2013558 (2012).","journal-title":"Glia"},{"key":"2145_CR133","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1016\/j.neurobiolaging.2010.09.016","volume":"33","author":"A Schuitemaker","year":"2012","unstructured":"Schuitemaker, A. et al. Microglial activation in healthy aging. Neurobiol. Aging 33, 1067\u20131072 (2012).","journal-title":"Neurobiol. Aging"},{"key":"2145_CR134","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1111\/j.1474-9726.2010.00660.x","volume":"10","author":"MR Damani","year":"2011","unstructured":"Damani, M. R. et al. Age-related alterations in the dynamic behavior of microglia. Aging Cell 10, 263\u2013276 (2011).","journal-title":"Aging Cell"},{"key":"2145_CR135","doi-asserted-by":"crossref","unstructured":"Wendimu, M. Y. & Hooks, S. B. Microglia Phenotypes in Aging and Neurodegenerative Diseases. Cells. 11, 2091 (2022).","DOI":"10.3390\/cells11132091"},{"key":"2145_CR136","doi-asserted-by":"publisher","first-page":"1276","DOI":"10.1016\/j.cell.2017.05.018","volume":"169","author":"H Keren-Shaul","year":"2017","unstructured":"Keren-Shaul, H. et al. A Unique Microglia Type Associated with Restricting Development of Alzheimer\u2019s Disease. Cell 169, 1276\u20131290.e1217 (2017).","journal-title":"Cell"},{"key":"2145_CR137","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1016\/j.immuni.2018.01.011","volume":"48","author":"D Mrdjen","year":"2018","unstructured":"Mrdjen, D. et al. High-Dimensional Single-Cell Mapping of Central Nervous System Immune Cells Reveals Distinct Myeloid Subsets in Health, Aging, and Disease. Immunity 48, 380\u2013395.e386 (2018).","journal-title":"Immunity"},{"key":"2145_CR138","doi-asserted-by":"publisher","first-page":"1162","DOI":"10.1038\/nn.4597","volume":"20","author":"TF Galatro","year":"2017","unstructured":"Galatro, T. F. et al. Transcriptomic analysis of purified human cortical microglia reveals age-associated changes. Nat. Neurosci. 20, 1162\u20131171 (2017).","journal-title":"Nat. Neurosci."},{"key":"2145_CR139","doi-asserted-by":"publisher","DOI":"10.1111\/acel.13182","volume":"19","author":"N Yanguas-Cas\u00e1s","year":"2020","unstructured":"Yanguas-Cas\u00e1s, N., Crespo-Castrillo, A., Arevalo, M. A. & Garcia-Segura, L. M. Aging and sex: Impact on microglia phagocytosis. Aging Cell 19, e13182 (2020).","journal-title":"Aging Cell"},{"key":"2145_CR140","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1016\/j.celrep.2016.12.011","volume":"18","author":"L Soreq","year":"2017","unstructured":"Soreq, L. et al. Major Shifts in Glial Regional Identity Are a Transcriptional Hallmark of Human Brain Aging. Cell Rep. 18, 557\u2013570 (2017).","journal-title":"Cell Rep."},{"key":"2145_CR141","doi-asserted-by":"publisher","first-page":"1467","DOI":"10.1002\/glia.24191","volume":"70","author":"O Lawal","year":"2022","unstructured":"Lawal, O., Ulloa Severino, F. P. & Eroglu, C. The role of astrocyte structural plasticity in regulating neural circuit function and behavior. Glia 70, 1467\u20131483 (2022).","journal-title":"Glia"},{"key":"2145_CR142","doi-asserted-by":"publisher","first-page":"1507","DOI":"10.1111\/ggi.13500","volume":"18","author":"KI Tomita","year":"2018","unstructured":"Tomita, K. I. et al. Changes in telomere length with aging in human neurons and glial cells revealed by quantitative fluorescence in situ hybridization analysis. Geriatr. Gerontol. Int. 18, 1507\u20131512 (2018).","journal-title":"Geriatr. Gerontol. Int."},{"key":"2145_CR143","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1111\/j.1471-4159.2006.04369.x","volume":"101","author":"M Pertusa","year":"2007","unstructured":"Pertusa, M. et al. Astrocytes aged in vitro show a decreased neuroprotective capacity. J. Neurochem. 101, 794\u2013805 (2007).","journal-title":"J. Neurochem."},{"key":"2145_CR144","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1111\/j.1474-9726.2012.00816.x","volume":"11","author":"CJ Miranda","year":"2012","unstructured":"Miranda, C. J. et al. Aging brain microenvironment decreases hippocampal neurogenesis through Wnt-mediated survivin signaling. Aging Cell 11, 542\u2013552 (2012).","journal-title":"Aging Cell"},{"key":"2145_CR145","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1038\/nature21029","volume":"541","author":"SA Liddelow","year":"2017","unstructured":"Liddelow, S. A. et al. Neurotoxic reactive astrocytes are induced by activated microglia. Nature 541, 481\u2013487 (2017).","journal-title":"Nature"},{"key":"2145_CR146","doi-asserted-by":"publisher","first-page":"E1896","DOI":"10.1073\/pnas.1800165115","volume":"115","author":"LE Clarke","year":"2018","unstructured":"Clarke, L. E. et al. Normal aging induces A1-like astrocyte reactivity. Proc. Natl Acad. Sci. USA 115, E1896\u2013e1905 (2018).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"2145_CR147","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.mad.2016.05.006","volume":"161","author":"KH Tse","year":"2017","unstructured":"Tse, K. H. & Herrup, K. DNA damage in the oligodendrocyte lineage and its role in brain aging. Mech. Ageing Dev. 161, 37\u201350 (2017).","journal-title":"Mech. Ageing Dev."},{"key":"2145_CR148","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1038\/s41593-020-0588-8","volume":"23","author":"F Wang","year":"2020","unstructured":"Wang, F. et al. Myelin degeneration and diminished myelin renewal contribute to age-related deficits in memory. Nat. Neurosci. 23, 481\u2013486 (2020).","journal-title":"Nat. Neurosci."},{"key":"2145_CR149","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1111\/bcpt.13403","volume":"127","author":"SI Graves","year":"2020","unstructured":"Graves, S. I. & Baker, D. J. Implicating endothelial cell senescence to dysfunction in the ageing and diseased brain. Basic Clin. Pharm. Toxicol. 127, 102\u2013110 (2020).","journal-title":"Basic Clin. Pharm. Toxicol."},{"key":"2145_CR150","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1111\/jcmm.13980","volume":"23","author":"LC Ceafalan","year":"2019","unstructured":"Ceafalan, L. C. et al. Age-related ultrastructural changes of the basement membrane in the mouse blood-brain barrier. J. Cell Mol. Med. 23, 819\u2013827 (2019).","journal-title":"J. Cell Mol. Med."},{"key":"2145_CR151","doi-asserted-by":"publisher","first-page":"129","DOI":"10.3389\/fnagi.2018.00129","volume":"10","author":"J Geng","year":"2018","unstructured":"Geng, J. et al. Blood-Brain Barrier Disruption Induced Cognitive Impairment Is Associated With Increase of Inflammatory Cytokine. Front. Aging Neurosci. 10, 129 (2018).","journal-title":"Front. Aging Neurosci."},{"key":"2145_CR152","doi-asserted-by":"publisher","first-page":"18520","DOI":"10.1021\/acsnano.1c08432","volume":"15","author":"BA Bony","year":"2021","unstructured":"Bony, B. A. et al. Claudin-1-Targeted Nanoparticles for Delivery to Aging-Induced Alterations in the Blood-Brain Barrier. ACS Nano 15, 18520\u201318531 (2021).","journal-title":"ACS Nano"},{"key":"2145_CR153","doi-asserted-by":"publisher","first-page":"2659","DOI":"10.1038\/s41380-022-01511-z","volume":"27","author":"EG Knox","year":"2022","unstructured":"Knox, E. G. et al. The blood-brain barrier in aging and neurodegeneration. Mol. Psychiatry 27, 2659\u20132673 (2022).","journal-title":"Mol. Psychiatry"},{"key":"2145_CR154","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1016\/j.neuron.2014.12.032","volume":"85","author":"A Montagne","year":"2015","unstructured":"Montagne, A. et al. Blood-brain barrier breakdown in the aging human hippocampus. Neuron 85, 296\u2013302 (2015).","journal-title":"Neuron"},{"key":"2145_CR155","doi-asserted-by":"publisher","first-page":"147ra111","DOI":"10.1126\/scitranslmed.3003748","volume":"4","author":"JJ Iliff","year":"2012","unstructured":"Iliff, J. J. et al. A paravascular pathway facilitates CSF flow through the brain parenchyma and the clearance of interstitial solutes, including amyloid \u03b2. Sci. Transl. Med. 4, 147ra111 (2012).","journal-title":"Sci. Transl. Med."},{"key":"2145_CR156","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1038\/s41586-020-2247-3","volume":"581","author":"A Montagne","year":"2020","unstructured":"Montagne, A. et al. APOE4 leads to blood-brain barrier dysfunction predicting cognitive decline. Nature 581, 71\u201376 (2020).","journal-title":"Nature"},{"key":"2145_CR157","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1002\/ana.24271","volume":"76","author":"BT Kress","year":"2014","unstructured":"Kress, B. T. et al. Impairment of paravascular clearance pathways in the aging brain. Ann. Neurol. 76, 845\u2013861 (2014).","journal-title":"Ann. Neurol."},{"key":"2145_CR158","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1038\/nn.4325","volume":"19","author":"S Safaiyan","year":"2016","unstructured":"Safaiyan, S. et al. Age-related myelin degradation burdens the clearance function of microglia during aging. Nat. Neurosci. 19, 995\u2013998 (2016).","journal-title":"Nat. Neurosci."},{"key":"2145_CR159","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.neurobiolaging.2020.06.019","volume":"95","author":"ME MacDonald","year":"2020","unstructured":"MacDonald, M. E. et al. Age-related differences in cerebral blood flow and cortical thickness with an application to age prediction. Neurobiol. Aging 95, 131\u2013142 (2020).","journal-title":"Neurobiol. Aging"},{"key":"2145_CR160","doi-asserted-by":"publisher","first-page":"1251","DOI":"10.2147\/CIA.S139515","volume":"12","author":"H Guo","year":"2017","unstructured":"Guo, H. et al. MRI assessment of whole-brain structural changes in aging. Clin. Inter. Aging 12, 1251\u20131270 (2017).","journal-title":"Clin. Inter. Aging"},{"key":"2145_CR161","doi-asserted-by":"publisher","first-page":"12068","DOI":"10.1523\/JNEUROSCI.1171-17.2017","volume":"37","author":"HK Chung","year":"2017","unstructured":"Chung, H. K., Tymula, A. & Glimcher, P. The Reduction of Ventrolateral Prefrontal Cortex Gray Matter Volume Correlates with Loss of Economic Rationality in Aging. J. Neurosci. 37, 12068\u201312077 (2017).","journal-title":"J. Neurosci."},{"key":"2145_CR162","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1002\/alz.12178","volume":"17","author":"M Habes","year":"2021","unstructured":"Habes, M. et al. The Brain Chart of Aging: Machine-learning analytics reveals links between brain aging, white matter disease, amyloid burden, and cognition in the iSTAGING consortium of 10,216 harmonized MR scans. Alzheimers Dement 17, 89\u2013102 (2021).","journal-title":"Alzheimers Dement"},{"key":"2145_CR163","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.neurobiolaging.2017.04.013","volume":"56","author":"IJ Bennett","year":"2017","unstructured":"Bennett, I. J. et al. Age-related white matter integrity differences in oldest-old without dementia. Neurobiol. Aging 56, 108\u2013114 (2017).","journal-title":"Neurobiol. Aging"},{"key":"2145_CR164","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1038\/mp.2011.81","volume":"17","author":"D Tomasi","year":"2012","unstructured":"Tomasi, D. & Volkow, N. D. Aging and functional brain networks. Mol. Psychiatry 17, 549\u2013458 (2012).","journal-title":"Mol. Psychiatry"},{"key":"2145_CR165","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-43142-0","volume":"14","author":"HR Chong","year":"2023","unstructured":"Chong, H. R. et al. Functional alterations of the prefrontal circuit underlying cognitive aging in mice. Nat. Commun. 14, 7254 (2023).","journal-title":"Nat. Commun."},{"key":"2145_CR166","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-47922-x","volume":"9","author":"E Bagarinao","year":"2019","unstructured":"Bagarinao, E. et al. Reorganization of brain networks and its association with general cognitive performance over the adult lifespan. Sci. Rep. 9, 11352 (2019).","journal-title":"Sci. Rep."},{"key":"2145_CR167","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.neurobiolaging.2021.03.013","volume":"104","author":"AT Shafer","year":"2021","unstructured":"Shafer, A. T. et al. Default mode network connectivity and cognition in the aging brain: the effects of age, sex, and APOE genotype. Neurobiol. Aging 104, 10\u201323 (2021).","journal-title":"Neurobiol. Aging"},{"key":"2145_CR168","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1037\/pag0000310","volume":"34","author":"E Ankudowich","year":"2019","unstructured":"Ankudowich, E., Pasvanis, S. & Rajah, M. N. Age-related differences in prefrontal-hippocampal connectivity are associated with reduced spatial context memory. Psychol. Aging 34, 251\u2013261 (2019).","journal-title":"Psychol. Aging"},{"key":"2145_CR169","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2021.747359","volume":"13","author":"H Watanabe","year":"2021","unstructured":"Watanabe, H. et al. Characteristics of Neural Network Changes in Normal Aging and Early Dementia. Front Aging Neurosci. 13, 747359 (2021).","journal-title":"Front Aging Neurosci."},{"key":"2145_CR170","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1038\/s41380-021-01265-0","volume":"27","author":"WD Taylor","year":"2022","unstructured":"Taylor, W. D. et al. Influences of dopaminergic system dysfunction on late-life depression. Mol. Psychiatry 27, 180\u2013191 (2022).","journal-title":"Mol. Psychiatry"},{"key":"2145_CR171","doi-asserted-by":"publisher","first-page":"806","DOI":"10.2174\/156720501108140910123112","volume":"11","author":"H Li","year":"2014","unstructured":"Li, H. et al. Trajectories of age-related cognitive decline and potential associated factors of cognitive function in senior citizens of Beijing. Curr. Alzheimer Res. 11, 806\u2013816 (2014).","journal-title":"Curr. Alzheimer Res."},{"key":"2145_CR172","doi-asserted-by":"publisher","first-page":"305","DOI":"10.3389\/fnagi.2016.00305","volume":"8","author":"F Quandt","year":"2016","unstructured":"Quandt, F. et al. Spectral Variability in the Aged Brain during Fine Motor Control. Front. Aging Neurosci. 8, 305 (2016).","journal-title":"Front. Aging Neurosci."},{"key":"2145_CR173","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1016\/j.arr.2012.09.004","volume":"12","author":"J Volkert","year":"2013","unstructured":"Volkert, J. et al. The prevalence of mental disorders in older people in Western countries - a meta-analysis. Ageing Res. Rev. 12, 339\u2013353 (2013).","journal-title":"Ageing Res. Rev."},{"key":"2145_CR174","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.tins.2014.11.001","volume":"38","author":"JA Prenderville","year":"2015","unstructured":"Prenderville, J. A., Kennedy, P. J., Dinan, T. G. & Cryan, J. F. Adding fuel to the fire: the impact of stress on the ageing brain. Trends Neurosci. 38, 13\u201325 (2015).","journal-title":"Trends Neurosci."},{"key":"2145_CR175","doi-asserted-by":"crossref","unstructured":"Aging Biomarker, C. et al. A framework of biomarkers for brain aging: a consensus statement by the Aging Biomarker Consortium. Life Med. 2, lnad017 (2023).","DOI":"10.1093\/lifemedi\/lnad033"},{"key":"2145_CR176","doi-asserted-by":"publisher","first-page":"102524","DOI":"10.1016\/j.conb.2022.102524","volume":"73","author":"T Burrinha","year":"2022","unstructured":"Burrinha, T. & Guimas Almeida, C. Aging impact on amyloid precursor protein neuronal trafficking. Curr. Opin. Neurobiol. 73, 102524 (2022).","journal-title":"Curr. Opin. Neurobiol."},{"key":"2145_CR177","doi-asserted-by":"publisher","first-page":"32","DOI":"10.2174\/1874609809666161111101111","volume":"10","author":"NN Nalivaeva","year":"2017","unstructured":"Nalivaeva, N. N. & Turner, A. J. Role of Ageing and Oxidative Stress in Regulation of Amyloid-Degrading Enzymes and Development of Neurodegeneration. Curr. Aging Sci. 10, 32\u201340 (2017).","journal-title":"Curr. Aging Sci."},{"key":"2145_CR178","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1111\/jnc.14860","volume":"151","author":"DM Angelova","year":"2019","unstructured":"Angelova, D. M. & Brown, D. R. Microglia and the aging brain: are senescent microglia the key to neurodegeneration? J. Neurochem. 151, 676\u2013688 (2019).","journal-title":"J. Neurochem."},{"key":"2145_CR179","doi-asserted-by":"crossref","unstructured":"Preininger, M. K. & Kaufer, D. Blood-Brain Barrier Dysfunction and Astrocyte Senescence as Reciprocal Drivers of Neuropathology in Aging. Int. J. Mol. Sci. 23, 6217 (2022).","DOI":"10.3390\/ijms23116217"},{"key":"2145_CR180","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1038\/s41586-023-06120-6","volume":"618","author":"C Depp","year":"2023","unstructured":"Depp, C. et al. Myelin dysfunction drives amyloid-\u03b2 deposition in models of Alzheimer\u2019s disease. Nature 618, 349\u2013357 (2023).","journal-title":"Nature"},{"key":"2145_CR181","doi-asserted-by":"publisher","first-page":"e12782","DOI":"10.1111\/nan.12782","volume":"48","author":"C Kurz","year":"2022","unstructured":"Kurz, C., Walker, L., Rauchmann, B. S. & Perneczky, R. Dysfunction of the blood-brain barrier in Alzheimer\u2019s disease: Evidence from human studies. Neuropathol. Appl Neurobiol. 48, e12782 (2022).","journal-title":"Neuropathol. Appl Neurobiol."},{"key":"2145_CR182","doi-asserted-by":"publisher","first-page":"7896","DOI":"10.1093\/cercor\/bhad086","volume":"33","author":"Z Dai","year":"2023","unstructured":"Dai, Z. et al. The aging of glymphatic system in human brain and its correlation with brain charts and neuropsychological functioning. Cereb. Cortex 33, 7896\u20137903 (2023).","journal-title":"Cereb. Cortex"},{"key":"2145_CR183","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1007\/s00401-017-1717-7","volume":"134","author":"A Kapasi","year":"2017","unstructured":"Kapasi, A., DeCarli, C. & Schneider, J. A. Impact of multiple pathologies on the threshold for clinically overt dementia. Acta Neuropathol. 134, 171\u2013186 (2017).","journal-title":"Acta Neuropathol."},{"key":"2145_CR184","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1111\/j.1471-4159.1990.tb02325.x","volume":"54","author":"AH Schapira","year":"1990","unstructured":"Schapira, A. H. et al. Mitochondrial complex I deficiency in Parkinson\u2019s disease. J. Neurochem. 54, 823\u2013827 (1990).","journal-title":"J. Neurochem."},{"key":"2145_CR185","doi-asserted-by":"crossref","unstructured":"Cornelissen, T. et al. Deficiency of parkin and PINK1 impairs age-dependent mitophagy in Drosophila. Elife. 7, e35878 (2018).","DOI":"10.7554\/eLife.35878"},{"key":"2145_CR186","doi-asserted-by":"publisher","first-page":"1645","DOI":"10.1093\/hmg\/ddz004","volume":"28","author":"F Bonello","year":"2019","unstructured":"Bonello, F. et al. LRRK2 impairs PINK1\/Parkin-dependent mitophagy via its kinase activity: pathologic insights into Parkinson\u2019s disease. Hum. Mol. Genet. 28, 1645\u20131660 (2019).","journal-title":"Hum. Mol. Genet."},{"key":"2145_CR187","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.neuron.2017.11.036","volume":"97","author":"DG Ordonez","year":"2018","unstructured":"Ordonez, D. G., Lee, M. K. & Feany, M. B. \u03b1-synuclein Induces Mitochondrial Dysfunction through Spectrin and the Actin Cytoskeleton. Neuron 97, 108\u2013124.e106 (2018).","journal-title":"Neuron"},{"key":"2145_CR188","doi-asserted-by":"crossref","unstructured":"Zampese, E. & Surmeier, D. J. Calcium, Bioenergetics, and Parkinson\u2019s Disease. Cells. 9, 2045 (2020).","DOI":"10.3390\/cells9092045"},{"key":"2145_CR189","doi-asserted-by":"crossref","unstructured":"Sanchez-Contreras, M. et al. The multi-tissue landscape of somatic mtDNA mutations indicates tissue-specific accumulation and removal in aging. Elife. 12, e83395 (2023).","DOI":"10.7554\/eLife.83395"},{"key":"2145_CR190","doi-asserted-by":"publisher","first-page":"2047","DOI":"10.1038\/s42255-023-00930-8","volume":"5","author":"A Picca","year":"2023","unstructured":"Picca, A. et al. Mitophagy in human health, ageing and disease. Nat. Metab. 5, 2047\u20132061 (2023).","journal-title":"Nat. Metab."},{"key":"2145_CR191","doi-asserted-by":"publisher","first-page":"e613","DOI":"10.1212\/WNL.0000000000207474","volume":"101","author":"C Wolfson","year":"2023","unstructured":"Wolfson, C., Gauvin, D. E., Ishola, F. & Oskoui, M. Global Prevalence and Incidence of Amyotrophic Lateral Sclerosis: A Systematic Review. Neurology 101, e613\u2013e623 (2023).","journal-title":"Neurology"},{"key":"2145_CR192","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1016\/j.neuron.2020.08.022","volume":"108","author":"G Kim","year":"2020","unstructured":"Kim, G. et al. ALS Genetics: Gains, Losses, and Implications for Future Therapies. Neuron 108, 822\u2013842 (2020).","journal-title":"Neuron"},{"key":"2145_CR193","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1038\/s41580-021-00382-6","volume":"22","author":"I Malik","year":"2021","unstructured":"Malik, I., Kelley, C. P., Wang, E. T. & Todd, P. K. Molecular mechanisms underlying nucleotide repeat expansion disorders. Nat. Rev. Mol. Cell Biol. 22, 589\u2013607 (2021).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"2145_CR194","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1007\/s13311-022-01297-6","volume":"19","author":"MP Coleman","year":"2022","unstructured":"Coleman, M. P. Axon Biology in ALS: Mechanisms of Axon Degeneration and Prospects for Therapy. Neurotherapeutics 19, 1133\u20131144 (2022).","journal-title":"Neurotherapeutics"},{"key":"2145_CR195","doi-asserted-by":"publisher","first-page":"S96","DOI":"10.1017\/cjn.2016.25","volume":"43","author":"DB Hogan","year":"2016","unstructured":"Hogan, D. B. et al. The Prevalence and Incidence of Frontotemporal Dementia: a Systematic Review. Can. J. Neurol. Sci. 43, S96\u2013s109 (2016).","journal-title":"Can. J. Neurol. Sci."},{"key":"2145_CR196","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1007\/s13311-019-00742-3","volume":"16","author":"W Peng","year":"2019","unstructured":"Peng, W., Minakaki, G., Nguyen, M. & Krainc, D. Preserving Lysosomal Function in the Aging Brain: Insights from Neurodegeneration. Neurotherapeutics 16, 611\u2013634 (2019).","journal-title":"Neurotherapeutics"},{"key":"2145_CR197","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1186\/s40478-015-0215-1","volume":"3","author":"A Uchino","year":"2015","unstructured":"Uchino, A. et al. Incidence and extent of TDP-43 accumulation in aging human brain. Acta Neuropathol. Commun. 3, 35 (2015).","journal-title":"Acta Neuropathol. Commun."},{"key":"2145_CR198","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1097\/WCO.0000000000000665","volume":"32","author":"DW Sirkis","year":"2019","unstructured":"Sirkis, D. W., Bonham, L. W., Karch, C. M. & Yokoyama, J. S. Immunological signatures in frontotemporal lobar degeneration. Curr. Opin. Neurol. 32, 272\u2013278 (2019).","journal-title":"Curr. Opin. Neurol."},{"key":"2145_CR199","doi-asserted-by":"publisher","first-page":"2327","DOI":"10.1002\/mds.29228","volume":"37","author":"A Medina","year":"2022","unstructured":"Medina, A., Mahjoub, Y., Shaver, L. & Pringsheim, T. Prevalence and Incidence of Huntington\u2019s Disease: An Updated Systematic Review and Meta-Analysis. Mov. Disord. 37, 2327\u20132335 (2022).","journal-title":"Mov. Disord."},{"key":"2145_CR200","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1016\/j.neuron.2020.06.021","volume":"107","author":"H Lee","year":"2020","unstructured":"Lee, H. et al. Cell Type-Specific Transcriptomics Reveals that Mutant Huntingtin Leads to Mitochondrial RNA Release and Neuronal Innate Immune Activation. Neuron 107, 891\u2013908.e898 (2020).","journal-title":"Neuron"},{"key":"2145_CR201","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1038\/s41593-022-01238-8","volume":"26","author":"G Bieri","year":"2023","unstructured":"Bieri, G., Schroer, A. B. & Villeda, S. A. Blood-to-brain communication in aging and rejuvenation. Nat. Neurosci. 26, 379\u2013393 (2023).","journal-title":"Nat. Neurosci."},{"key":"2145_CR202","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1038\/s41586-020-2499-y","volume":"583","author":"N Schaum","year":"2020","unstructured":"Schaum, N. et al. Ageing hallmarks exhibit organ-specific temporal signatures. Nature 583, 596\u2013602 (2020).","journal-title":"Nature"},{"key":"2145_CR203","doi-asserted-by":"publisher","first-page":"2848","DOI":"10.1177\/0271678X16676826","volume":"37","author":"CY Xing","year":"2017","unstructured":"Xing, C. Y. et al. Distribution of cardiac output to the brain across the adult lifespan. J. Cereb. Blood Flow. Metab. 37, 2848\u20132856 (2017).","journal-title":"J. Cereb. Blood Flow. Metab."},{"key":"2145_CR204","doi-asserted-by":"publisher","first-page":"1952","DOI":"10.1016\/j.jacc.2017.01.064","volume":"69","author":"F Paneni","year":"2017","unstructured":"Paneni, F. et al. The Aging Cardiovascular System: Understanding It at the Cellular and Clinical Levels. J. Am. Coll. Cardiol. 69, 1952\u20131967 (2017).","journal-title":"J. Am. Coll. Cardiol."},{"key":"2145_CR205","doi-asserted-by":"publisher","first-page":"1587","DOI":"10.1016\/j.cjca.2017.07.008","volume":"33","author":"IF van der Velpen","year":"2017","unstructured":"van der Velpen, I. F., Yancy, C. W., Sorond, F. A. & Sabayan, B. Impaired Cardiac Function and Cognitive Brain Aging. Can. J. Cardiol. 33, 1587\u20131596 (2017).","journal-title":"Can. J. Cardiol."},{"key":"2145_CR206","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.arr.2018.09.005","volume":"48","author":"KR Chadda","year":"2018","unstructured":"Chadda, K. R. et al. Ageing, the autonomic nervous system and arrhythmia: From brain to heart. Ageing Res. Rev. 48, 40\u201350 (2018).","journal-title":"Ageing Res. Rev."},{"key":"2145_CR207","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.1038\/s41591-023-02296-6","volume":"29","author":"YE Tian","year":"2023","unstructured":"Tian, Y. E. et al. Heterogeneous aging across multiple organ systems and prediction of chronic disease and mortality. Nat. Med. 29, 1221\u20131231 (2023).","journal-title":"Nat. Med."},{"key":"2145_CR208","doi-asserted-by":"publisher","first-page":"919","DOI":"10.3233\/JAD-170088","volume":"58","author":"WS Jin","year":"2017","unstructured":"Jin, W. S. et al. Reduced Cardiovascular Functions in Patients with Alzheimer\u2019s Disease. J. Alzheimers Dis. 58, 919\u2013925 (2017).","journal-title":"J. Alzheimers Dis."},{"key":"2145_CR209","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.jns.2009.02.343","volume":"283","author":"A Stefani","year":"2009","unstructured":"Stefani, A. et al. CSF biomarkers, impairment of cerebral hemodynamics and degree of cognitive decline in Alzheimer\u2019s and mixed dementia. J. Neurol. Sci. 283, 109\u2013115 (2009).","journal-title":"J. Neurol. Sci."},{"key":"2145_CR210","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1007\/s10571-014-0127-9","volume":"35","author":"Y Zhao","year":"2015","unstructured":"Zhao, Y. & Gong, C. X. From chronic cerebral hypoperfusion to Alzheimer-like brain pathology and neurodegeneration. Cell Mol. Neurobiol. 35, 101\u2013110 (2015).","journal-title":"Cell Mol. Neurobiol."},{"key":"2145_CR211","doi-asserted-by":"publisher","first-page":"3446","DOI":"10.1007\/s11064-017-2391-9","volume":"42","author":"Z Cai","year":"2017","unstructured":"Cai, Z. et al. Chronic Cerebral Hypoperfusion Promotes Amyloid-Beta Pathogenesis via Activating \u03b2\/\u03b3-Secretases. Neurochem. Res. 42, 3446\u20133455 (2017).","journal-title":"Neurochem. Res."},{"key":"2145_CR212","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1161\/CIRCRESAHA.118.313563","volume":"124","author":"JM Tublin","year":"2019","unstructured":"Tublin, J. M. et al. Getting to the Heart of Alzheimer Disease. Circ. Res. 124, 142\u2013149 (2019).","journal-title":"Circ. Res."},{"key":"2145_CR213","first-page":"473","volume":"46","author":"JP Bounhoure","year":"1997","unstructured":"Bounhoure, J. P. Cardiac insufficiency with normal systolic function. Physiopathology and therapeutic implications. Ann. Cardiol. Angeiol. 46, 473\u2013478 (1997).","journal-title":"Ann. Cardiol. Angeiol."},{"key":"2145_CR214","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1002\/mds.25431","volume":"28","author":"JA Palma","year":"2013","unstructured":"Palma, J. A. et al. Is cardiac function impaired in premotor Parkinson\u2019s disease? A retrospective cohort study. Mov. Disord. 28, 591\u2013596 (2013).","journal-title":"Mov. Disord."},{"key":"2145_CR215","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1111\/j.1468-1331.2004.00894.x","volume":"11","author":"J Kobal","year":"2004","unstructured":"Kobal, J., Meglic, B., Mesec, A. & Peterlin, B. Early sympathetic hyperactivity in Huntington\u2019s disease. Eur. J. Neurol. 11, 842\u2013848 (2004).","journal-title":"Eur. J. Neurol."},{"key":"2145_CR216","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1113\/JP285126","volume":"602","author":"KG Schwarz","year":"2024","unstructured":"Schwarz, K. G. et al. Autonomic nervous system dysfunction throughout menopausal transition: A potential mechanism underpinning cardiovascular and cognitive alterations during female ageing. J. Physiol. 602, 263\u2013280 (2024).","journal-title":"J. Physiol."},{"key":"2145_CR217","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1177\/1073858421990000","volume":"28","author":"VC Gon\u00e7alves","year":"2022","unstructured":"Gon\u00e7alves, V. C. et al. Heart Matters: Cardiac Dysfunction and Other Autonomic Changes in Parkinson\u2019s Disease. Neuroscientist 28, 530\u2013542 (2022).","journal-title":"Neuroscientist"},{"key":"2145_CR218","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1093\/brain\/aww263","volume":"140","author":"RM Ahmed","year":"2017","unstructured":"Ahmed, R. M. et al. Energy expenditure in frontotemporal dementia: a behavioural and imaging study. Brain 140, 171\u2013183 (2017).","journal-title":"Brain"},{"key":"2145_CR219","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0014254","volume":"5","author":"MH Dong","year":"2010","unstructured":"Dong, M. H., Bettencourt, R., Barrett-Connor, E. & Loomba, R. Alanine aminotransferase decreases with age: the Rancho Bernardo Study. PLoS One 5, e14254 (2010).","journal-title":"PLoS One"},{"key":"2145_CR220","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1038\/s42255-022-00620-x","volume":"4","author":"RK Baboota","year":"2022","unstructured":"Baboota, R. K. et al. BMP4 and Gremlin 1 regulate hepatic cell senescence during clinical progression of NAFLD\/NASH. Nat. Metab. 4, 1007\u20131021 (2022).","journal-title":"Nat. Metab."},{"key":"2145_CR221","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1001\/jamaneurol.2017.3229","volume":"75","author":"G Weinstein","year":"2018","unstructured":"Weinstein, G. et al. Association of Nonalcoholic Fatty Liver Disease With Lower Brain Volume in Healthy Middle-aged Adults in the Framingham Study. JAMA Neurol. 75, 97\u2013104 (2018).","journal-title":"JAMA Neurol."},{"key":"2145_CR222","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/j.pbb.2015.03.020","volume":"133","author":"Y Yu","year":"2015","unstructured":"Yu, Y. et al. Fibroblast growth factor 21 protects mouse brain against D-galactose induced aging via suppression of oxidative stress response and advanced glycation end products formation. Pharm. Biochem. Behav. 133, 122\u2013131 (2015).","journal-title":"Pharm. Biochem. Behav."},{"key":"2145_CR223","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1126\/science.aaw2622","volume":"369","author":"AM Horowitz","year":"2020","unstructured":"Horowitz, A. M. et al. Blood factors transfer beneficial effects of exercise on neurogenesis and cognition to the aged brain. Science 369, 167\u2013173 (2020).","journal-title":"Science"},{"key":"2145_CR224","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-29499-8","volume":"13","author":"CM Hill","year":"2022","unstructured":"Hill, C. M. et al. FGF21 is required for protein restriction to extend lifespan and improve metabolic health in male mice. Nat. Commun. 13, 1897 (2022).","journal-title":"Nat. Commun."},{"key":"2145_CR225","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1016\/j.jceh.2018.06.007","volume":"8","author":"AR Jayakumar","year":"2018","unstructured":"Jayakumar, A. R. & Norenberg, M. D. Hyperammonemia in Hepatic Encephalopathy. J. Clin. Exp. Hepatol. 8, 272\u2013280 (2018).","journal-title":"J. Clin. Exp. Hepatol."},{"key":"2145_CR226","doi-asserted-by":"publisher","first-page":"45897","DOI":"10.1074\/jbc.M407668200","volume":"279","author":"J Ghiso","year":"2004","unstructured":"Ghiso, J. et al. Systemic catabolism of Alzheimer\u2019s Abeta40 and Abeta42. J. Biol. Chem. 279, 45897\u201345908 (2004).","journal-title":"J. Biol. Chem."},{"key":"2145_CR227","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1007\/s00401-023-02559-z","volume":"145","author":"Y Cheng","year":"2023","unstructured":"Cheng, Y. et al. Physiological \u03b2-amyloid clearance by the liver and its therapeutic potential for Alzheimer\u2019s disease. Acta Neuropathol. 145, 717\u2013731 (2023).","journal-title":"Acta Neuropathol."},{"key":"2145_CR228","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3233\/JAD-190848","volume":"75","author":"MF Bassendine","year":"2020","unstructured":"Bassendine, M. F. et al. Is Alzheimer\u2019s Disease a Liver Disease of the Brain? J. Alzheimers Dis. 75, 1\u201314 (2020).","journal-title":"J. Alzheimers Dis."},{"key":"2145_CR229","doi-asserted-by":"publisher","first-page":"1407","DOI":"10.1007\/s11095-006-0208-7","volume":"23","author":"C Tamaki","year":"2006","unstructured":"Tamaki, C. et al. Major involvement of low-density lipoprotein receptor-related protein 1 in the clearance of plasma free amyloid beta-peptide by the liver. Pharm. Res. 23, 1407\u20131416 (2006).","journal-title":"Pharm. Res."},{"key":"2145_CR230","doi-asserted-by":"publisher","first-page":"2847","DOI":"10.1016\/j.neuron.2023.06.002","volume":"111","author":"Y Wu","year":"2023","unstructured":"Wu, Y. et al. Hepatic soluble epoxide hydrolase activity regulates cerebral A\u03b2 metabolism and the pathogenesis of Alzheimer\u2019s disease in mice. Neuron 111, 2847\u20132862.e2810 (2023).","journal-title":"Neuron"},{"key":"2145_CR231","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1186\/s40478-021-01136-3","volume":"9","author":"JF Reyes","year":"2021","unstructured":"Reyes, J. F. et al. Accumulation of alpha-synuclein within the liver, potential role in the clearance of brain pathology associated with Parkinson\u2019s disease. Acta Neuropathol. Commun. 9, 46 (2021).","journal-title":"Acta Neuropathol. Commun."},{"key":"2145_CR232","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1093\/hmg\/ddl481","volume":"16","author":"MC Chiang","year":"2007","unstructured":"Chiang, M. C. et al. Dysregulation of C\/EBPalpha by mutant Huntingtin causes the urea cycle deficiency in Huntington\u2019s disease. Hum. Mol. Genet. 16, 483\u2013498 (2007).","journal-title":"Hum. Mol. Genet."},{"key":"2145_CR233","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1038\/s41583-020-00381-0","volume":"21","author":"BD Needham","year":"2020","unstructured":"Needham, B. D., Kaddurah-Daouk, R. & Mazmanian, S. K. Gut microbial molecules in behavioural and neurodegenerative conditions. Nat. Rev. Neurosci. 21, 717\u2013731 (2020).","journal-title":"Nat. Rev. Neurosci."},{"key":"2145_CR234","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1038\/s41575-022-00605-x","volume":"19","author":"TS Ghosh","year":"2022","unstructured":"Ghosh, T. S., Shanahan, F. & O\u2019Toole, P. W. The gut microbiome as a modulator of healthy ageing. Nat. Rev. Gastroenterol. Hepatol. 19, 565\u2013584 (2022).","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"2145_CR235","doi-asserted-by":"publisher","first-page":"7801","DOI":"10.18632\/aging.103093","volume":"12","author":"Y Li","year":"2020","unstructured":"Li, Y. et al. Age-related shifts in gut microbiota contribute to cognitive decline in aged rats. Aging 12, 7801\u20137817 (2020).","journal-title":"Aging"},{"key":"2145_CR236","doi-asserted-by":"publisher","first-page":"118627","DOI":"10.1016\/j.lfs.2020.118627","volume":"264","author":"P Kesika","year":"2021","unstructured":"Kesika, P., Suganthy, N., Sivamaruthi, B. S. & Chaiyasut, C. Role of gut-brain axis, gut microbial composition, and probiotic intervention in Alzheimer\u2019s disease. Life Sci. 264, 118627 (2021).","journal-title":"Life Sci."},{"key":"2145_CR237","doi-asserted-by":"publisher","first-page":"849","DOI":"10.3233\/JAD-190872","volume":"73","author":"M Sun","year":"2020","unstructured":"Sun, M. et al. A Review of the Brain-Gut-Microbiome Axis and the Potential Role of Microbiota in Alzheimer\u2019s Disease. J. Alzheimers Dis. 73, 849\u2013865 (2020).","journal-title":"J. Alzheimers Dis."},{"key":"2145_CR238","doi-asserted-by":"publisher","DOI":"10.1186\/1742-2094-9-150","volume":"9","author":"MA Erickson","year":"2012","unstructured":"Erickson, M. A. et al. Lipopolysaccharide impairs amyloid \u03b2 efflux from brain: altered vascular sequestration, cerebrospinal fluid reabsorption, peripheral clearance and transporter function at the blood-brain barrier. J. Neuroinflammation 9, 150 (2012).","journal-title":"J. Neuroinflammation"},{"key":"2145_CR239","doi-asserted-by":"publisher","DOI":"10.1038\/srep30891","volume":"6","author":"C Kim","year":"2016","unstructured":"Kim, C. et al. Exposure to bacterial endotoxin generates a distinct strain of \u03b1-synuclein fibril. Sci. Rep. 6, 30891 (2016).","journal-title":"Sci. Rep."},{"key":"2145_CR240","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/S0197-4580(02)00065-9","volume":"24","author":"H Braak","year":"2003","unstructured":"Braak, H. et al. Staging of brain pathology related to sporadic Parkinson\u2019s disease. Neurobiol. Aging 24, 197\u2013211 (2003).","journal-title":"Neurobiol. Aging"},{"key":"2145_CR241","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1016\/j.neuron.2019.05.035","volume":"103","author":"S Kim","year":"2019","unstructured":"Kim, S. et al. Transneuronal Propagation of Pathologic \u03b1-Synuclein from the Gut to the Brain Models Parkinson\u2019s Disease. Neuron 103, 627\u2013641.e627 (2019).","journal-title":"Neuron"},{"key":"2145_CR242","doi-asserted-by":"publisher","first-page":"5","DOI":"10.20517\/and.2023.07","volume":"3","author":"R Ullah","year":"2023","unstructured":"Ullah, R., Dawson, V. L. & Dawson, T. M. A new Perspective on Parkinson\u2019s disease: exploring the involvement of intestine and vagus lysates in \u03b1-synucleinopathy propagation. Ageing Neurodegenerative Dis. 3, 5 (2023).","journal-title":"Ageing Neurodegenerative Dis."},{"key":"2145_CR243","doi-asserted-by":"publisher","first-page":"e0140248","DOI":"10.1371\/journal.pone.0140248","volume":"10","author":"AS Correia","year":"2015","unstructured":"Correia, A. S., Patel, P., Dutta, K. & Julien, J. P. Inflammation Induces TDP-43 Mislocalization and Aggregation. PLoS One 10, e0140248 (2015).","journal-title":"PLoS One"},{"key":"2145_CR244","doi-asserted-by":"publisher","DOI":"10.15252\/embj.2020106320","volume":"40","author":"C Chen","year":"2021","unstructured":"Chen, C. et al. Gut inflammation triggers C\/EBP\u03b2\/\u03b4-secretase-dependent gut-to-brain propagation of A\u03b2 and Tau fibrils in Alzheimer\u2019s disease. EMBO J. 40, e106320 (2021).","journal-title":"EMBO J."},{"key":"2145_CR245","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202103396","volume":"9","author":"G Chen","year":"2022","unstructured":"Chen, G. et al. UNC5C Receptor Proteolytic Cleavage by Active AEP Promotes Dopaminergic Neuronal Degeneration in Parkinson\u2019s Disease. Adv. Sci. 9, e2103396 (2022).","journal-title":"Adv. Sci."},{"key":"2145_CR246","doi-asserted-by":"publisher","first-page":"796288","DOI":"10.3389\/fimmu.2022.796288","volume":"13","author":"Y Mou","year":"2022","unstructured":"Mou, Y. et al. Gut Microbiota Interact With the Brain Through Systemic Chronic Inflammation: Implications on Neuroinflammation, Neurodegeneration, and Aging. Front. Immunol. 13, 796288 (2022).","journal-title":"Front. Immunol."},{"key":"2145_CR247","doi-asserted-by":"publisher","first-page":"1133546","DOI":"10.3389\/fneur.2023.1133546","volume":"14","author":"D Hong","year":"2023","unstructured":"Hong, D. et al. Modulation of the gut-brain axis via the gut microbiota: a new era in treatment of amyotrophic lateral sclerosis. Front. Neurol. 14, 1133546 (2023).","journal-title":"Front. Neurol."},{"key":"2145_CR248","doi-asserted-by":"publisher","first-page":"107988","DOI":"10.1016\/j.pharmthera.2021.107988","volume":"231","author":"SB Chidambaram","year":"2022","unstructured":"Chidambaram, S. B. et al. Gut dysbiosis, defective autophagy and altered immune responses in neurodegenerative diseases: Tales of a vicious cycle. Pharm. Ther. 231, 107988 (2022).","journal-title":"Pharm. Ther."},{"key":"2145_CR249","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1016\/j.kint.2019.10.032","volume":"97","author":"S Tanaka","year":"2020","unstructured":"Tanaka, S. & Okusa, M. D. Crosstalk between the nervous system and the kidney. Kidney Int. 97, 466\u2013476 (2020).","journal-title":"Kidney Int."},{"key":"2145_CR250","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1097\/MNH.0000000000000780","volume":"31","author":"A Denic","year":"2022","unstructured":"Denic, A., Rule, A. D. & Glassock, R. J. Healthy and unhealthy aging on kidney structure and function: human studies. Curr. Opin. Nephrol. Hypertens. 31, 228\u2013234 (2022).","journal-title":"Curr. Opin. Nephrol. Hypertens."},{"key":"2145_CR251","doi-asserted-by":"publisher","first-page":"1360","DOI":"10.1016\/j.celrep.2017.07.024","volume":"20","author":"J Leon","year":"2017","unstructured":"Leon, J. et al. Peripheral Elevation of a Klotho Fragment Enhances Brain Function and Resilience in Young, Aging, and \u03b1-Synuclein Transgenic Mice. Cell Rep. 20, 1360\u20131371 (2017).","journal-title":"Cell Rep."},{"key":"2145_CR252","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1038\/s43587-023-00441-x","volume":"3","author":"SA Castner","year":"2023","unstructured":"Castner, S. A. et al. Longevity factor klotho enhances cognition in aged nonhuman primates. Nat. Aging 3, 931\u2013937 (2023).","journal-title":"Nat. Aging"},{"key":"2145_CR253","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1038\/s41586-023-06802-1","volume":"624","author":"HS Oh","year":"2023","unstructured":"Oh, H. S. et al. Organ aging signatures in the plasma proteome track health and disease. Nature 624, 164\u2013172 (2023).","journal-title":"Nature"},{"key":"2145_CR254","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1007\/s12035-014-8854-y","volume":"52","author":"YH Liu","year":"2015","unstructured":"Liu, Y. H. et al. Association Between Serum Amyloid-Beta and Renal Functions: Implications for Roles of Kidney in Amyloid-Beta Clearance. Mol. Neurobiol. 52, 115\u2013119 (2015).","journal-title":"Mol. Neurobiol."},{"key":"2145_CR255","doi-asserted-by":"publisher","first-page":"6074","DOI":"10.1038\/s41380-021-01073-6","volume":"26","author":"DY Tian","year":"2021","unstructured":"Tian, D. Y. et al. Physiological clearance of amyloid-beta by the kidney and its therapeutic potential for Alzheimer\u2019s disease. Mol. Psychiatry 26, 6074\u20136082 (2021).","journal-title":"Mol. Psychiatry"},{"key":"2145_CR256","doi-asserted-by":"publisher","first-page":"997","DOI":"10.3233\/JAD-151139","volume":"51","author":"K Sakai","year":"2016","unstructured":"Sakai, K. et al. Patients that have Undergone Hemodialysis Exhibit Lower Amyloid Deposition in the Brain: Evidence Supporting a Therapeutic Strategy for Alzheimer\u2019s Disease by Removal of Blood Amyloid. J. Alzheimers Dis. 51, 997\u20131002 (2016).","journal-title":"J. Alzheimers Dis."},{"key":"2145_CR257","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1038\/s41581-020-0266-9","volume":"16","author":"D Viggiano","year":"2020","unstructured":"Viggiano, D. et al. Mechanisms of cognitive dysfunction in CKD. Nat. Rev. Nephrol. 16, 452\u2013469 (2020).","journal-title":"Nat. Rev. Nephrol."},{"key":"2145_CR258","doi-asserted-by":"crossref","unstructured":"Jang, I. A. et al. Effects of Resveratrol on the Renin-Angiotensin System in the Aging Kidney. Nutrients. 10, 1741 (2018).","DOI":"10.3390\/nu10111741"},{"key":"2145_CR259","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11011-020-00623-1","volume":"36","author":"JD Mel\u00e9ndez-Flores","year":"2021","unstructured":"Mel\u00e9ndez-Flores, J. D. & Estrada-Bellmann, I. Linking chronic kidney disease and Parkinson\u2019s disease: a literature review. Metab. Brain Dis. 36, 1\u201312 (2021).","journal-title":"Metab. Brain Dis."},{"key":"2145_CR260","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1183\/09031936.04.00088403","volume":"24","author":"F Garc\u00eda-R\u00edo","year":"2004","unstructured":"Garc\u00eda-R\u00edo, F. et al. Spirometric reference equations for European females and males aged 65-85 yrs. Eur. Respir. J. 24, 397\u2013405 (2004).","journal-title":"Eur. Respir. J."},{"key":"2145_CR261","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1007\/s00441-016-2511-x","volume":"367","author":"C Brandenberger","year":"2017","unstructured":"Brandenberger, C. & M\u00fchlfeld, C. Mechanisms of lung aging. Cell Tissue Res. 367, 469\u2013480 (2017).","journal-title":"Cell Tissue Res."},{"key":"2145_CR262","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.3233\/JAD-220667","volume":"90","author":"S Frenzel","year":"2022","unstructured":"Frenzel, S. et al. Associations of Pulmonary Function with MRI Brain Volumes: A Coordinated Multi-Study Analysis. J. Alzheimers Dis. 90, 1073\u20131083 (2022).","journal-title":"J. Alzheimers Dis."},{"key":"2145_CR263","doi-asserted-by":"publisher","first-page":"2551","DOI":"10.1002\/alz.12625","volume":"18","author":"J Wang","year":"2022","unstructured":"Wang, J. et al. Poor pulmonary function is associated with mild cognitive impairment, its progression to dementia, and brain pathologies: A community-based cohort study. Alzheimers Dement 18, 2551\u20132559 (2022).","journal-title":"Alzheimers Dement"},{"key":"2145_CR264","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1038\/s43587-021-00054-2","volume":"1","author":"R March-Diaz","year":"2021","unstructured":"March-Diaz, R. et al. Hypoxia compromises the mitochondrial metabolism of Alzheimer\u2019s disease microglia via HIF1. Nat. Aging 1, 385\u2013399 (2021).","journal-title":"Nat. Aging"},{"key":"2145_CR265","doi-asserted-by":"crossref","unstructured":"Mitroshina, E. V. & Vedunova, M. V. The Role of Oxygen Homeostasis and the HIF-1 Factor in the Development of Neurodegeneration. Int. J. Mol. Sci. 25, 4581 (2024).","DOI":"10.3390\/ijms25094581"},{"key":"2145_CR266","doi-asserted-by":"publisher","first-page":"e426","DOI":"10.1016\/S2666-7568(21)00118-5","volume":"2","author":"R Muzambi","year":"2021","unstructured":"Muzambi, R. et al. Assessment of common infections and incident dementia using UK primary and secondary care data: a historical cohort study. Lancet Healthy Longev. 2, e426\u2013e435 (2021).","journal-title":"Lancet Healthy Longev."},{"key":"2145_CR267","doi-asserted-by":"publisher","first-page":"1557","DOI":"10.1016\/S1473-3099(21)00144-4","volume":"21","author":"PN Sipil\u00e4","year":"2021","unstructured":"Sipil\u00e4, P. N. et al. Hospital-treated infectious diseases and the risk of dementia: a large, multicohort, observational study with a replication cohort. Lancet Infect. Dis. 21, 1557\u20131567 (2021).","journal-title":"Lancet Infect. Dis."},{"key":"2145_CR268","doi-asserted-by":"publisher","first-page":"138","DOI":"10.3389\/fcimb.2019.00138","volume":"9","author":"KL Patrick","year":"2019","unstructured":"Patrick, K. L., Bell, S. L., Weindel, C. G. & Watson, R. O. Exploring the \u201cMultiple-Hit Hypothesis\u201d of Neurodegenerative Disease: Bacterial Infection Comes Up to Bat. Front. Cell Infect. Microbiol. 9, 138 (2019).","journal-title":"Front. Cell Infect. Microbiol."},{"key":"2145_CR269","doi-asserted-by":"publisher","first-page":"31","DOI":"10.3233\/JPD-202279","volume":"11","author":"RJ Smeyne","year":"2021","unstructured":"Smeyne, R. J. et al. Infection and Risk of Parkinson\u2019s Disease. J. Parkinsons Dis. 11, 31\u201343 (2021).","journal-title":"J. Parkinsons Dis."},{"key":"2145_CR270","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1007\/s13238-020-00778-8","volume":"12","author":"W Tao","year":"2021","unstructured":"Tao, W. et al. Re-detectable positive SARS-CoV-2 RNA tests in patients who recovered from COVID-19 with intestinal infection. Protein Cell 12, 230\u2013235 (2021).","journal-title":"Protein Cell"},{"key":"2145_CR271","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1038\/s41593-020-00758-5","volume":"24","author":"J Meinhardt","year":"2021","unstructured":"Meinhardt, J. et al. Olfactory transmucosal SARS-CoV-2 invasion as a port of central nervous system entry in individuals with COVID-19. Nat. Neurosci. 24, 168\u2013175 (2021).","journal-title":"Nat. Neurosci."},{"key":"2145_CR272","doi-asserted-by":"publisher","first-page":"694446","DOI":"10.3389\/fnins.2021.694446","volume":"15","author":"J Xu","year":"2021","unstructured":"Xu, J. et al. The Role of the Gastrointestinal System in Neuroinvasion by SARS-CoV-2. Front. Neurosci. 15, 694446 (2021).","journal-title":"Front. Neurosci."},{"key":"2145_CR273","doi-asserted-by":"publisher","first-page":"4486","DOI":"10.1007\/s00415-021-10604-8","volume":"268","author":"G Bulfamante","year":"2021","unstructured":"Bulfamante, G. et al. Brainstem neuropathology in two cases of COVID-19: SARS-CoV-2 trafficking between brain and lung. J. Neurol. 268, 4486\u20134491 (2021).","journal-title":"J. Neurol."},{"key":"2145_CR274","doi-asserted-by":"publisher","first-page":"1296","DOI":"10.1002\/jmv.26521","volume":"93","author":"J Dey","year":"2021","unstructured":"Dey, J. et al. Neuroinvasion of SARS-CoV-2 may play a role in the breakdown of the respiratory center of the brain. J. Med. Virol. 93, 1296\u20131303 (2021).","journal-title":"J. Med. Virol."},{"key":"2145_CR275","doi-asserted-by":"crossref","unstructured":"COVID-19 Stats: COVID-19 Incidence,* by Age Group(\u2020) - United States, March 1-November 14, 2020(\u00a7). MMWR Morb. Mortal. Wkly Rep. 69, 1664, (2021).","DOI":"10.15585\/mmwr.mm695152a8"},{"key":"2145_CR276","doi-asserted-by":"publisher","first-page":"101205","DOI":"10.1016\/j.arr.2020.101205","volume":"65","author":"Y Chen","year":"2021","unstructured":"Chen, Y. et al. Aging in COVID-19: Vulnerability, immunity and intervention. Ageing Res. Rev. 65, 101205 (2021).","journal-title":"Ageing Res. Rev."},{"key":"2145_CR277","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1038\/s41577-022-00785-2","volume":"23","author":"CA Schmitt","year":"2023","unstructured":"Schmitt, C. A. et al. COVID-19 and cellular senescence. Nat. Rev. Immunol. 23, 251\u2013263 (2023).","journal-title":"Nat. Rev. Immunol."},{"key":"2145_CR278","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1111\/jnc.15585","volume":"161","author":"OJ Ziff","year":"2022","unstructured":"Ziff, O. J. et al. Amyloid processing in COVID-19-associated neurological syndromes. J. Neurochem. 161, 146\u2013157 (2022).","journal-title":"J. Neurochem."},{"key":"2145_CR279","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.adg2248","volume":"9","author":"R Mart\u00ednez-M\u00e1rmol","year":"2023","unstructured":"Mart\u00ednez-M\u00e1rmol, R. et al. SARS-CoV-2 infection and viral fusogens cause neuronal and glial fusion that compromises neuronal activity. Sci. Adv. 9, eadg2248 (2023).","journal-title":"Sci. Adv."},{"key":"2145_CR280","doi-asserted-by":"publisher","first-page":"73","DOI":"10.31083\/j.jin2102073","volume":"21","author":"T Piekut","year":"2022","unstructured":"Piekut, T. et al. Infectious agents and Alzheimer\u2019s disease. J. Integr. Neurosci. 21, 73 (2022).","journal-title":"J. Integr. Neurosci."},{"key":"2145_CR281","doi-asserted-by":"crossref","unstructured":"Mysiris, D. S. et al. Post-COVID-19 Parkinsonism and Parkinson\u2019s Disease Pathogenesis: The Exosomal Cargo Hypothesis. Int. J. Mol. Sci. 23, 9739 (2022).","DOI":"10.3390\/ijms23179739"},{"key":"2145_CR282","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1001\/jamaneurol.2022.0461","volume":"79","author":"YH Liu","year":"2022","unstructured":"Liu, Y. H. et al. One-Year Trajectory of Cognitive Changes in Older Survivors of COVID-19 in Wuhan, China: A Longitudinal Cohort Study. JAMA Neurol. 79, 509\u2013517 (2022).","journal-title":"JAMA Neurol."},{"key":"2145_CR283","doi-asserted-by":"publisher","first-page":"1186","DOI":"10.1038\/s43587-024-00667-3","volume":"4","author":"YH Liu","year":"2024","unstructured":"Liu, Y. H. et al. Tracking cognitive trajectories in older survivors of COVID-19 up to 2.5 years post-infection. Nat. Aging 4, 1186\u20131193 (2024).","journal-title":"Nat. Aging"},{"key":"2145_CR284","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1056\/NEJMoa2311330","volume":"390","author":"A Hampshire","year":"2024","unstructured":"Hampshire, A. et al. Cognition and Memory after Covid-19 in a Large Community Sample. N. Engl. J. Med. 390, 806\u2013818 (2024).","journal-title":"N. Engl. J. Med."},{"key":"2145_CR285","doi-asserted-by":"publisher","first-page":"1287","DOI":"10.1002\/mds.28170","volume":"35","author":"R Cilia","year":"2020","unstructured":"Cilia, R. et al. Effects of COVID-19 on Parkinson\u2019s Disease Clinical Features: A Community-Based Case-Control Study. Mov. Disord. 35, 1287\u20131292 (2020).","journal-title":"Mov. Disord."},{"key":"2145_CR286","doi-asserted-by":"publisher","first-page":"1365","DOI":"10.3233\/JPD-202249","volume":"10","author":"EG Brown","year":"2020","unstructured":"Brown, E. G. et al. The Effect of the COVID-19 Pandemic on People with Parkinson\u2019s Disease. J. Parkinsons Dis. 10, 1365\u20131377 (2020).","journal-title":"J. Parkinsons Dis."},{"key":"2145_CR287","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1038\/s41591-018-0275-4","volume":"25","author":"MV Lourenco","year":"2019","unstructured":"Lourenco, M. V. et al. Exercise-linked FNDC5\/irisin rescues synaptic plasticity and memory defects in Alzheimer\u2019s models. Nat. Med. 25, 165\u2013175 (2019).","journal-title":"Nat. Med."},{"key":"2145_CR288","doi-asserted-by":"publisher","first-page":"e4","DOI":"10.1017\/erm.2022.41","volume":"25","author":"B S\u00e1nchez","year":"2022","unstructured":"S\u00e1nchez, B., Mu\u00f1oz-Pinto, M. F. & Cano, M. Irisin enhances longevity by boosting SIRT1, AMPK, autophagy and telomerase. Expert Rev. Mol. Med. 25, e4 (2022).","journal-title":"Expert Rev. Mol. Med."},{"key":"2145_CR289","doi-asserted-by":"crossref","unstructured":"Arosio, B. et al. Sarcopenia and Cognitive Decline in Older Adults: Targeting the Muscle-Brain Axis. Nutrients. 15, 1853 (2023).","DOI":"10.3390\/nu15081853"},{"key":"2145_CR290","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1111\/acel.12126","volume":"12","author":"F Demontis","year":"2013","unstructured":"Demontis, F., Piccirillo, R., Goldberg, A. L. & Perrimon, N. The influence of skeletal muscle on systemic aging and lifespan. Aging Cell 12, 943\u2013949 (2013).","journal-title":"Aging Cell"},{"key":"2145_CR291","doi-asserted-by":"publisher","first-page":"1826","DOI":"10.1111\/jgs.17206","volume":"69","author":"MS Beeri","year":"2021","unstructured":"Beeri, M. S. et al. Sarcopenia is associated with incident Alzheimer\u2019s dementia, mild cognitive impairment, and cognitive decline. J. Am. Geriatr. Soc. 69, 1826\u20131835 (2021).","journal-title":"J. Am. Geriatr. Soc."},{"key":"2145_CR292","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1016\/S0002-9440(10)64947-4","volume":"156","author":"YM Kuo","year":"2000","unstructured":"Kuo, Y. M. et al. Elevated abeta42 in skeletal muscle of Alzheimer disease patients suggests peripheral alterations of AbetaPP metabolism. Am. J. Pathol. 156, 797\u2013805 (2000).","journal-title":"Am. J. Pathol."},{"key":"2145_CR293","doi-asserted-by":"crossref","unstructured":"Cappello, V. & Francolini, M. Neuromuscular Junction Dismantling in Amyotrophic Lateral Sclerosis. Int. J. Mol. Sci. 18, 2092 (2017).","DOI":"10.3390\/ijms18102092"},{"key":"2145_CR294","doi-asserted-by":"publisher","first-page":"1715","DOI":"10.1002\/mds.21540","volume":"22","author":"C Turner","year":"2007","unstructured":"Turner, C., Cooper, J. M. & Schapira, A. H. Clinical correlates of mitochondrial function in Huntington\u2019s disease muscle. Mov. Disord. 22, 1715\u20131721 (2007).","journal-title":"Mov. Disord."},{"key":"2145_CR295","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1007\/s11154-023-09812-6","volume":"24","author":"XQ Zheng","year":"2023","unstructured":"Zheng, X. Q. et al. Targeting aging with the healthy skeletal system: The endocrine role of bone. Rev. Endocr. Metab. Disord. 24, 695\u2013711 (2023).","journal-title":"Rev. Endocr. Metab. Disord."},{"key":"2145_CR296","doi-asserted-by":"publisher","first-page":"8217","DOI":"10.18632\/aging.102316","volume":"11","author":"IS Bae","year":"2019","unstructured":"Bae, I. S. et al. Association between bone mineral density and brain parenchymal atrophy and ventricular enlargement in healthy individuals. Aging 11, 8217\u20138238 (2019).","journal-title":"Aging"},{"key":"2145_CR297","doi-asserted-by":"publisher","first-page":"786337","DOI":"10.3389\/fnagi.2021.786337","volume":"13","author":"MJ Kwon","year":"2021","unstructured":"Kwon, M. J. et al. The Occurrence of Alzheimer\u2019s Disease and Parkinson\u2019s Disease in Individuals With Osteoporosis: A Longitudinal Follow-Up Study Using a National Health Screening Database in Korea. Front. Aging Neurosci. 13, 786337 (2021).","journal-title":"Front. Aging Neurosci."},{"key":"2145_CR298","doi-asserted-by":"publisher","first-page":"1606","DOI":"10.1002\/mds.29579","volume":"38","author":"KY Park","year":"2023","unstructured":"Park, K. Y. et al. Bone Mineral Density and the Risk of Parkinson\u2019s Disease in Postmenopausal Women. Mov. Disord. 38, 1606\u20131614 (2023).","journal-title":"Mov. Disord."},{"key":"2145_CR299","doi-asserted-by":"publisher","first-page":"Rrn1214","DOI":"10.1371\/currents.RRN1214","volume":"3","author":"AO Goodman","year":"2011","unstructured":"Goodman, A. O. & Barker, R. A. Body composition in premanifest Huntington\u2019s disease reveals lower bone density compared to controls. PLoS Curr. 3, Rrn1214 (2011).","journal-title":"PLoS Curr."},{"key":"2145_CR300","doi-asserted-by":"publisher","first-page":"32","DOI":"10.4161\/auto.26508","volume":"10","author":"JY Shin","year":"2014","unstructured":"Shin, J. Y. et al. Mesenchymal stem cells enhance autophagy and increase \u03b2-amyloid clearance in Alzheimer disease models. Autophagy 10, 32\u201344 (2014).","journal-title":"Autophagy"},{"key":"2145_CR301","doi-asserted-by":"publisher","first-page":"5720","DOI":"10.1002\/alz.13864","volume":"20","author":"ZT Liu","year":"2024","unstructured":"Liu, Z. T. et al. Crosstalk between bone and brain in Alzheimer\u2019s disease: Mechanisms, applications, and perspectives. Alzheimers Dement 20, 5720\u20135739 (2024).","journal-title":"Alzheimers Dement"},{"key":"2145_CR302","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1038\/s41420-023-01343-y","volume":"9","author":"C Shan","year":"2023","unstructured":"Shan, C. et al. Osteocalcin ameliorates cognitive dysfunctions in a mouse model of Alzheimer\u2019s Disease by reducing amyloid \u03b2 burden and upregulating glycolysis in neuroglia. Cell Death Discov. 9, 46 (2023).","journal-title":"Cell Death Discov."},{"key":"2145_CR303","doi-asserted-by":"publisher","DOI":"10.1186\/s40168-020-00988-6","volume":"9","author":"YF Hou","year":"2021","unstructured":"Hou, Y. F. et al. Gut microbiota-derived propionate mediates the neuroprotective effect of osteocalcin in a mouse model of Parkinson\u2019s disease. Microbiome 9, 34 (2021).","journal-title":"Microbiome"},{"key":"2145_CR304","doi-asserted-by":"publisher","first-page":"1","DOI":"10.7762\/cnr.2018.7.1.1","volume":"7","author":"J Song","year":"2018","unstructured":"Song, J. & Kim, O. Y. Perspectives in Lipocalin-2: Emerging Biomarker for Medical Diagnosis and Prognosis for Alzheimer\u2019s Disease. Clin. Nutr. Res. 7, 1\u201310 (2018).","journal-title":"Clin. Nutr. Res."},{"key":"2145_CR305","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1038\/s42255-024-00989-x","volume":"6","author":"T Shi","year":"2024","unstructured":"Shi, T. et al. Osteocyte-derived sclerostin impairs cognitive function during ageing and Alzheimer\u2019s disease progression. Nat. Metab. 6, 531\u2013549 (2024).","journal-title":"Nat. Metab."},{"key":"2145_CR306","doi-asserted-by":"publisher","first-page":"2280","DOI":"10.1038\/s41418-023-01216-y","volume":"30","author":"SY Jiang","year":"2023","unstructured":"Jiang, S. Y. et al. The cGAS-STING-YY1 axis accelerates progression of neurodegeneration in a mouse model of Parkinson\u2019s disease via LCN2-dependent astrocyte senescence. Cell Death Differ. 30, 2280\u20132292 (2023).","journal-title":"Cell Death Differ."},{"key":"2145_CR307","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1002\/mus.26911","volume":"62","author":"T Petrozziello","year":"2020","unstructured":"Petrozziello, T. et al. Lipocalin-2 is increased in amyotrophic lateral sclerosis. Muscle Nerve 62, 272\u2013283 (2020).","journal-title":"Muscle Nerve"},{"key":"2145_CR308","doi-asserted-by":"publisher","first-page":"1501","DOI":"10.2217\/epi-2019-0215","volume":"12","author":"BW Wu","year":"2020","unstructured":"Wu, B. W. et al. Osteoblast-derived lipocalin-2 regulated by miRNA-96-5p\/Foxo1 advances the progression of Alzheimer\u2019s disease. Epigenomics 12, 1501\u20131513 (2020).","journal-title":"Epigenomics"},{"key":"2145_CR309","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1038\/s41583-019-0255-9","volume":"21","author":"JV Pluvinage","year":"2020","unstructured":"Pluvinage, J. V. & Wyss-Coray, T. Systemic factors as mediators of brain homeostasis, ageing and neurodegeneration. Nat. Rev. Neurosci. 21, 93\u2013102 (2020).","journal-title":"Nat. Rev. Neurosci."},{"key":"2145_CR310","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1038\/nature10357","volume":"477","author":"SA Villeda","year":"2011","unstructured":"Villeda, S. A. et al. The ageing systemic milieu negatively regulates neurogenesis and cognitive function. Nature 477, 90\u201394 (2011).","journal-title":"Nature"},{"key":"2145_CR311","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms13363","volume":"7","author":"J Rebo","year":"2016","unstructured":"Rebo, J. et al. A single heterochronic blood exchange reveals rapid inhibition of multiple tissues by old blood. Nat. Commun. 7, 13363 (2016).","journal-title":"Nat. Commun."},{"key":"2145_CR312","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1038\/nrneurol.2017.111","volume":"13","author":"J Wang","year":"2017","unstructured":"Wang, J., Gu, B. J., Masters, C. L. & Wang, Y. J. A systemic view of Alzheimer disease - insights from amyloid-\u03b2 metabolism beyond the brain. Nat. Rev. Neurol. 13, 612\u2013623 (2017).","journal-title":"Nat. Rev. Neurol."},{"key":"2145_CR313","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1006\/bbrc.1995.2103","volume":"213","author":"M Chen","year":"1995","unstructured":"Chen, M., Inestrosa, N. C., Ross, G. S. & Fernandez, H. L. Platelets are the primary source of amyloid beta-peptide in human blood. Biochem. Biophys. Res. Commun. 213, 96\u2013103 (1995).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"2145_CR314","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1007\/s10555-020-09926-2","volume":"39","author":"AVS Faria","year":"2020","unstructured":"Faria, A. V. S. et al. Platelets in aging and cancer-\u201cdouble-edged sword. Cancer Metastasis Rev. 39, 1205\u20131221 (2020).","journal-title":"Cancer Metastasis Rev."},{"key":"2145_CR315","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1097\/MOH.0000000000000526","volume":"26","author":"E Montenont","year":"2019","unstructured":"Montenont, E., Rondina, M. T. & Campbell, R. A. Altered functions of platelets during aging. Curr. Opin. Hematol. 26, 336\u2013342 (2019).","journal-title":"Curr. Opin. Hematol."},{"key":"2145_CR316","doi-asserted-by":"publisher","first-page":"5568","DOI":"10.1038\/s41380-020-0842-1","volume":"26","author":"HL Sun","year":"2021","unstructured":"Sun, H. L. et al. Blood cell-produced amyloid-\u03b2 induces cerebral Alzheimer-type pathologies and behavioral deficits. Mol. Psychiatry 26, 5568\u20135577 (2021).","journal-title":"Mol. Psychiatry"},{"key":"2145_CR317","doi-asserted-by":"publisher","first-page":"e815","DOI":"10.1212\/WNL.0000000000010005","volume":"95","author":"JW Kim","year":"2020","unstructured":"Kim, J. W. et al. Serum albumin and beta-amyloid deposition in the human brain. Neurology 95, e815\u2013e826 (2020).","journal-title":"Neurology"},{"key":"2145_CR318","doi-asserted-by":"publisher","first-page":"37","DOI":"10.3177\/jnsv.53.37","volume":"53","author":"I Gom","year":"2007","unstructured":"Gom, I. et al. Relationship between serum albumin level and aging in community-dwelling self-supported elderly population. J. Nutr. Sci. Vitaminol. 53, 37\u201342 (2007).","journal-title":"J. Nutr. Sci. Vitaminol."},{"key":"2145_CR319","doi-asserted-by":"publisher","first-page":"32916","DOI":"10.1074\/jbc.271.51.32916","volume":"271","author":"AL Biere","year":"1996","unstructured":"Biere, A. L. et al. Amyloid beta-peptide is transported on lipoproteins and albumin in human plasma. J. Biol. Chem. 271, 32916\u201332922 (1996).","journal-title":"J. Biol. Chem."},{"key":"2145_CR320","doi-asserted-by":"publisher","first-page":"932","DOI":"10.1038\/nm.3898","volume":"21","author":"LK Smith","year":"2015","unstructured":"Smith, L. K. et al. \u03b22-microglobulin is a systemic pro-aging factor that impairs cognitive function and neurogenesis. Nat. Med. 21, 932\u2013937 (2015).","journal-title":"Nat. Med."},{"key":"2145_CR321","doi-asserted-by":"publisher","first-page":"1026","DOI":"10.1016\/j.cell.2023.01.021","volume":"186","author":"Y Gao","year":"2023","unstructured":"Gao, Y. et al. \u03b22-microglobulin functions as an endogenous NMDAR antagonist to impair synaptic function. Cell 186, 1026\u20131038.e1020 (2023).","journal-title":"Cell"},{"key":"2145_CR322","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1038\/nature22067","volume":"544","author":"JM Castellano","year":"2017","unstructured":"Castellano, J. M. et al. Human umbilical cord plasma proteins revitalize hippocampal function in aged mice. Nature 544, 488\u2013492 (2017).","journal-title":"Nature"},{"key":"2145_CR323","doi-asserted-by":"publisher","first-page":"507","DOI":"10.3233\/JAD-2010-091471","volume":"21","author":"TD Boyd","year":"2010","unstructured":"Boyd, T. D. et al. GM-CSF upregulated in rheumatoid arthritis reverses cognitive impairment and amyloidosis in Alzheimer mice. J. Alzheimers Dis. 21, 507\u2013518 (2010).","journal-title":"J. Alzheimers Dis."},{"key":"2145_CR324","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.jneuroim.2018.03.009","volume":"319","author":"T Kiyota","year":"2018","unstructured":"Kiyota, T. et al. Granulocyte-macrophage colony-stimulating factor neuroprotective activities in Alzheimer\u2019s disease mice. J. Neuroimmunol. 319, 80\u201392 (2018).","journal-title":"J. Neuroimmunol."},{"key":"2145_CR325","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.bbrc.2022.07.058","volume":"623","author":"K Zhang","year":"2022","unstructured":"Zhang, K. et al. Neuroprotective effects of TRPV1 by targeting GDF11 in the Mpp+\/MPTP-induced Parkinson\u2019s disease model. Biochem. Biophys. Res. Commun. 623, 104\u2013110 (2022).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"2145_CR326","doi-asserted-by":"publisher","first-page":"1777","DOI":"10.1016\/S0140-6736(00)04904-7","volume":"357","author":"J Parkin","year":"2001","unstructured":"Parkin, J. & Cohen, B. An overview of the immune system. Lancet 357, 1777\u20131789 (2001).","journal-title":"Lancet"},{"key":"2145_CR327","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1007\/s10522-014-9514-3","volume":"16","author":"J Hazeldine","year":"2015","unstructured":"Hazeldine, J. & Lord, J. M. Innate immunesenescence: underlying mechanisms and clinical relevance. Biogerontology 16, 187\u2013201 (2015).","journal-title":"Biogerontology"},{"key":"2145_CR328","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1038\/s41586-021-03547-7","volume":"594","author":"MJ Yousefzadeh","year":"2021","unstructured":"Yousefzadeh, M. J. et al. An aged immune system drives senescence and ageing of solid organs. Nature 594, 100\u2013105 (2021).","journal-title":"Nature"},{"key":"2145_CR329","doi-asserted-by":"publisher","DOI":"10.1038\/s41398-020-01113-9","volume":"10","author":"SH Chen","year":"2020","unstructured":"Chen, S. H. et al. Amyloid-beta uptake by blood monocytes is reduced with ageing and Alzheimer\u2019s disease. Transl. Psychiatry 10, 423 (2020).","journal-title":"Transl. Psychiatry"},{"key":"2145_CR330","doi-asserted-by":"publisher","DOI":"10.15252\/embj.2022111038","volume":"41","author":"L Xu","year":"2022","unstructured":"Xu, L. et al. Erythropoietin signaling in peripheral macrophages is required for systemic \u03b2-amyloid clearance. EMBO J. 41, e111038 (2022).","journal-title":"EMBO J."},{"key":"2145_CR331","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-22479-4","volume":"12","author":"K Kim","year":"2021","unstructured":"Kim, K. et al. Therapeutic B-cell depletion reverses progression of Alzheimer\u2019s disease. Nat. Commun. 12, 2185 (2021).","journal-title":"Nat. Commun."},{"key":"2145_CR332","doi-asserted-by":"publisher","DOI":"10.1111\/acel.13808","volume":"22","author":"R Liu","year":"2023","unstructured":"Liu, R. et al. Mid-life leukocyte telomere length and dementia risk: An observational and mendelian randomization study of 435,046 UK Biobank participants. Aging Cell 22, e13808 (2023).","journal-title":"Aging Cell"},{"key":"2145_CR333","doi-asserted-by":"publisher","first-page":"S93","DOI":"10.3233\/JPD-223228","volume":"12","author":"A Kouli","year":"2022","unstructured":"Kouli, A. & Williams-Gray, C. H. Age-Related Adaptive Immune Changes in Parkinson\u2019s Disease. J. Parkinsons Dis. 12, S93\u2013s104 (2022).","journal-title":"J. Parkinsons Dis."},{"key":"2145_CR334","doi-asserted-by":"crossref","unstructured":"Yildiz, O. et al. Senescent-like Blood Lymphocytes and Disease Progression in Amyotrophic Lateral Sclerosis. Neurol. Neuroimmunol. Neuroinflamm. 10, e200042 (2023).","DOI":"10.1212\/NXI.0000000000200042"},{"key":"2145_CR335","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1016\/j.expneurol.2009.05.012","volume":"219","author":"J Sassone","year":"2009","unstructured":"Sassone, J. et al. Huntington\u2019s disease: the current state of research with peripheral tissues. Exp. Neurol. 219, 385\u2013397 (2009).","journal-title":"Exp. Neurol."},{"key":"2145_CR336","doi-asserted-by":"publisher","first-page":"e28645","DOI":"10.1097\/MD.0000000000028645","volume":"101","author":"RP Sawyer","year":"2022","unstructured":"Sawyer, R. P. et al. Differences in peripheral immune system gene expression in frontotemporal degeneration. Medicine 101, e28645 (2022).","journal-title":"Medicine"},{"key":"2145_CR337","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-023-02746-5","volume":"20","author":"M Chu","year":"2023","unstructured":"Chu, M. et al. Peripheral inflammation in behavioural variant frontotemporal dementia: associations with central degeneration and clinical measures. J. Neuroinflammation 20, 65 (2023).","journal-title":"J. Neuroinflammation"},{"key":"2145_CR338","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1136\/jnnp-2022-330866","volume":"94","author":"BM Asken","year":"2023","unstructured":"Asken, B. M. et al. Plasma inflammation for predicting phenotypic conversion and clinical progression of autosomal dominant frontotemporal lobar degeneration. J. Neurol. Neurosurg. Psychiatry 94, 541\u2013549 (2023).","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"2145_CR339","doi-asserted-by":"crossref","unstructured":"Borsa, L., Dubois, M., Sacco, G. & Lupi, L. Analysis the Link between Periodontal Diseases and Alzheimer\u2019s Disease: A Systematic Review. Int. J. Environ. Res. Public Health. 18, 9312 (2021).","DOI":"10.3390\/ijerph18179312"},{"key":"2145_CR340","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1007\/s00508-020-01638-5","volume":"132","author":"F Leblhuber","year":"2020","unstructured":"Leblhuber, F. et al. Knock-on effect of periodontitis to the pathogenesis of Alzheimer\u2019s disease? Wien. Klin. Wochenschr. 132, 493\u2013498 (2020).","journal-title":"Wien. Klin. Wochenschr."},{"key":"2145_CR341","doi-asserted-by":"publisher","first-page":"97","DOI":"10.3389\/fphar.2014.00097","volume":"5","author":"R Piacentini","year":"2014","unstructured":"Piacentini, R. et al. HSV-1 and Alzheimer\u2019s disease: more than a hypothesis. Front. Pharm. 5, 97 (2014).","journal-title":"Front. Pharm."},{"key":"2145_CR342","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1002\/alz.13490","volume":"20","author":"S Gaikwad","year":"2024","unstructured":"Gaikwad, S., Senapati, S., Haque, M. A. & Kayed, R. Senescence, brain inflammation, and oligomeric tau drive cognitive decline in Alzheimer\u2019s disease: Evidence from clinical and preclinical studies. Alzheimers Dement. 20, 709\u2013727 (2024).","journal-title":"Alzheimers Dement."},{"key":"2145_CR343","doi-asserted-by":"publisher","first-page":"1086","DOI":"10.1016\/j.neuron.2022.12.029","volume":"111","author":"KS Levine","year":"2023","unstructured":"Levine, K. S. et al. Virus exposure and neurodegenerative disease risk across national biobanks. Neuron 111, 1086\u20131093.e1082 (2023).","journal-title":"Neuron"},{"key":"2145_CR344","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1042\/BST20220771","volume":"51","author":"S Hosseini","year":"2023","unstructured":"Hosseini, S. & Korte, M. How viral infections cause neuronal dysfunction: a focus on the role of microglia and astrocytes. Biochem. Soc. Trans. 51, 259\u2013274 (2023).","journal-title":"Biochem. Soc. Trans."},{"key":"2145_CR345","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1007\/s11481-011-9302-7","volume":"7","author":"D Sagar","year":"2012","unstructured":"Sagar, D. et al. Mechanisms of dendritic cell trafficking across the blood-brain barrier. J. Neuroimmune Pharm. 7, 74\u201394 (2012).","journal-title":"J. Neuroimmune Pharm."},{"key":"2145_CR346","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1016\/j.devcel.2020.09.020","volume":"55","author":"J Cui","year":"2020","unstructured":"Cui, J. et al. Inflammation of the Embryonic Choroid Plexus Barrier following Maternal Immune Activation. Dev. Cell 55, 617\u2013628.e616 (2020).","journal-title":"Dev. Cell"},{"key":"2145_CR347","doi-asserted-by":"crossref","unstructured":"Cugurra, A. et al. Skull and vertebral bone marrow are myeloid cell reservoirs for the meninges and CNS parenchyma. Science. 373, eabf7844 (2021).","DOI":"10.1126\/science.abf7844"},{"key":"2145_CR348","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1038\/s41586-019-1895-7","volume":"577","author":"D Gate","year":"2020","unstructured":"Gate, D. et al. Clonally expanded CD8 T cells patrol the cerebrospinal fluid in Alzheimer\u2019s disease. Nature 577, 399\u2013404 (2020).","journal-title":"Nature"},{"key":"2145_CR349","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1016\/S2213-8587(18)30026-3","volume":"6","author":"AW van den Beld","year":"2018","unstructured":"van den Beld, A. W. et al. The physiology of endocrine systems with ageing. Lancet Diab. Endocrinol. 6, 647\u2013658 (2018).","journal-title":"Lancet Diab. Endocrinol."},{"key":"2145_CR350","doi-asserted-by":"publisher","first-page":"238","DOI":"10.12965\/jer.1632584.292","volume":"12","author":"YA Shin","year":"2016","unstructured":"Shin, Y. A. & Lee, K. Y. Low estrogen levels and obesity are associated with shorter telomere lengths in pre- and postmenopausal women. J. Exerc. Rehabil. 12, 238\u2013246 (2016).","journal-title":"J. Exerc. Rehabil."},{"key":"2145_CR351","doi-asserted-by":"publisher","first-page":"90","DOI":"10.3389\/fnagi.2013.00090","volume":"5","author":"K Franke","year":"2013","unstructured":"Franke, K., Gaser, C., Manor, B. & Novak, V. Advanced BrainAGE in older adults with type 2 diabetes mellitus. Front. Aging Neurosci. 5, 90 (2013).","journal-title":"Front. Aging Neurosci."},{"key":"2145_CR352","doi-asserted-by":"publisher","DOI":"10.1038\/s41398-021-01735-7","volume":"11","author":"ZM Harvanek","year":"2021","unstructured":"Harvanek, Z. M., Fogelman, N., Xu, K. & Sinha, R. Psychological and biological resilience modulates the effects of stress on epigenetic aging. Transl. Psychiatry 11, 601 (2021).","journal-title":"Transl. Psychiatry"},{"key":"2145_CR353","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1038\/s41586-022-04463-0","volume":"603","author":"J Xiong","year":"2022","unstructured":"Xiong, J. et al. FSH blockade improves cognition in mice with Alzheimer\u2019s disease. Nature 603, 470\u2013476 (2022).","journal-title":"Nature"},{"key":"2145_CR354","doi-asserted-by":"publisher","first-page":"225","DOI":"10.14283\/jpad.2018.34","volume":"5","author":"O Scheyer","year":"2018","unstructured":"Scheyer, O. et al. Female Sex and Alzheimer\u2019s Risk: The Menopause Connection. J. Prev. Alzheimers Dis. 5, 225\u2013230 (2018).","journal-title":"J. Prev. Alzheimers Dis."},{"key":"2145_CR355","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.neuroscience.2023.05.013","volume":"523","author":"L Zhou","year":"2023","unstructured":"Zhou, L. et al. Disruption of \u03b1-Synuclein Proteostasis in the Striatum and Midbrain of Long-term Ovariectomized Female Mice. Neuroscience 523, 80\u201390 (2023).","journal-title":"Neuroscience"},{"key":"2145_CR356","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1016\/S1474-4422(20)30231-3","volume":"19","author":"D Kellar","year":"2020","unstructured":"Kellar, D. & Craft, S. Brain insulin resistance in Alzheimer\u2019s disease and related disorders: mechanisms and therapeutic approaches. Lancet Neurol. 19, 758\u2013766 (2020).","journal-title":"Lancet Neurol."},{"key":"2145_CR357","doi-asserted-by":"crossref","unstructured":"Hong, C. T. et al. Insulin Resistance Promotes Parkinson\u2019s Disease through Aberrant Expression of \u03b1-Synuclein, Mitochondrial Dysfunction, and Deregulation of the Polo-Like Kinase 2 Signaling. Cells. 9, 740 (2020).","DOI":"10.3390\/cells9030740"},{"key":"2145_CR358","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/s40035-022-00288-z","volume":"11","author":"YQ Lv","year":"2022","unstructured":"Lv, Y. Q. et al. Long-term hyperglycemia aggravates \u03b1-synuclein aggregation and dopaminergic neuronal loss in a Parkinson\u2019s disease mouse model. Transl. Neurodegener. 11, 14 (2022).","journal-title":"Transl. Neurodegener."},{"key":"2145_CR359","doi-asserted-by":"publisher","first-page":"1812","DOI":"10.1212\/WNL.0000000000000993","volume":"83","author":"RM Ahmed","year":"2014","unstructured":"Ahmed, R. M. et al. Systemic metabolism in frontotemporal dementia. Neurology 83, 1812\u20131818 (2014).","journal-title":"Neurology"},{"key":"2145_CR360","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1007\/s43440-022-00377-w","volume":"74","author":"N Sawicka-Gutaj","year":"2022","unstructured":"Sawicka-Gutaj, N., Zawalna, N., Gut, P. & Ruchala, M. Relationship between thyroid hormones and central nervous system metabolism in physiological and pathological conditions. Pharm. Rep. 74, 847\u2013858 (2022).","journal-title":"Pharm. Rep."},{"key":"2145_CR361","doi-asserted-by":"publisher","first-page":"1523","DOI":"10.1007\/s11011-021-00760-1","volume":"36","author":"PBS Figueroa","year":"2021","unstructured":"Figueroa, P. B. S. et al. Association between thyroid function and Alzheimer\u2019s disease: A systematic review. Metab. Brain Dis. 36, 1523\u20131543 (2021).","journal-title":"Metab. Brain Dis."},{"key":"2145_CR362","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/bs.vh.2020.12.005","volume":"115","author":"M Mey","year":"2021","unstructured":"Mey, M., Bhatta, S. & Casadesus, G. Luteinizing hormone and the aging brain. Vitam. Horm. 115, 89\u2013104 (2021).","journal-title":"Vitam. Horm."},{"key":"2145_CR363","doi-asserted-by":"publisher","first-page":"135754","DOI":"10.1016\/j.neulet.2021.135754","volume":"749","author":"T Sharma","year":"2021","unstructured":"Sharma, T., Kaur, D., Grewal, A. K. & Singh, T. G. Therapies modulating insulin resistance in Parkinson\u2019s disease: A cross talk. Neurosci. Lett. 749, 135754 (2021).","journal-title":"Neurosci. Lett."},{"key":"2145_CR364","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.parkreldis.2020.08.018","volume":"79","author":"A S\u00e1nchez-G\u00f3mez","year":"2020","unstructured":"S\u00e1nchez-G\u00f3mez, A. et al. Peripheral insulin and amylin levels in Parkinson\u2019s disease. Parkinsonism Relat. Disord. 79, 91\u201396 (2020).","journal-title":"Parkinsonism Relat. Disord."},{"key":"2145_CR365","doi-asserted-by":"publisher","first-page":"105301","DOI":"10.1016\/j.nbd.2021.105301","volume":"152","author":"GE Choi","year":"2021","unstructured":"Choi, G. E. & Han, H. J. Glucocorticoid impairs mitochondrial quality control in neurons. Neurobiol. Dis. 152, 105301 (2021).","journal-title":"Neurobiol. Dis."},{"key":"2145_CR366","doi-asserted-by":"publisher","first-page":"32","DOI":"10.3389\/fnana.2015.00032","volume":"9","author":"MT Herrero","year":"2015","unstructured":"Herrero, M. T., Estrada, C., Maatouk, L. & Vyas, S. Inflammation in Parkinson\u2019s disease: role of glucocorticoids. Front. Neuroanat. 9, 32 (2015).","journal-title":"Front. Neuroanat."},{"key":"2145_CR367","doi-asserted-by":"publisher","first-page":"1713","DOI":"10.1093\/hmg\/ddl094","volume":"15","author":"M Bj\u00f6rkqvist","year":"2006","unstructured":"Bj\u00f6rkqvist, M. et al. Progressive alterations in the hypothalamic-pituitary-adrenal axis in the R6\/2 transgenic mouse model of Huntington\u2019s disease. Hum. Mol. Genet. 15, 1713\u20131721 (2006).","journal-title":"Hum. Mol. Genet."},{"key":"2145_CR368","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1111\/j.1399-0004.1985.tb00185.x","volume":"27","author":"LA Farrer","year":"1985","unstructured":"Farrer, L. A. Diabetes mellitus in Huntington disease. Clin. Genet. 27, 62\u201367 (1985).","journal-title":"Clin. Genet."},{"key":"2145_CR369","doi-asserted-by":"publisher","first-page":"407","DOI":"10.5694\/j.1326-5377.1981.tb135681.x","volume":"1","author":"PR Sanberg","year":"1981","unstructured":"Sanberg, P. R., Fibiger, H. C. & Mark, R. F. Body weight and dietary factors in Huntington\u2019s disease patients compared with matched controls. Med. J. Aust. 1, 407\u2013409 (1981).","journal-title":"Med. J. Aust."},{"key":"2145_CR370","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/s12929-019-0524-y","volume":"26","author":"MVF Silva","year":"2019","unstructured":"Silva, M. V. F. et al. Alzheimer\u2019s disease: risk factors and potentially protective measures. J. Biomed. Sci. 26, 33 (2019).","journal-title":"J. Biomed. Sci."},{"key":"2145_CR371","doi-asserted-by":"publisher","first-page":"101268","DOI":"10.1016\/j.arr.2021.101268","volume":"67","author":"AL Santos","year":"2021","unstructured":"Santos, A. L. & Sinha, S. Obesity and aging: Molecular mechanisms and therapeutic approaches. Ageing Res Rev. 67, 101268 (2021).","journal-title":"Ageing Res Rev."},{"key":"2145_CR372","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1212\/01.wnl.0000306313.89165.ef","volume":"71","author":"RA Whitmer","year":"2008","unstructured":"Whitmer, R. A. et al. Central obesity and increased risk of dementia more than three decades later. Neurology 71, 1057\u20131064 (2008).","journal-title":"Neurology"},{"key":"2145_CR373","doi-asserted-by":"publisher","first-page":"3396","DOI":"10.1038\/s41380-022-01600-z","volume":"27","author":"P Liu","year":"2022","unstructured":"Liu, P. et al. High-fat diet-induced diabetes couples to Alzheimer\u2019s disease through inflammation-activated C\/EBP\u03b2\/AEP pathway. Mol. Psychiatry 27, 3396\u20133409 (2022).","journal-title":"Mol. Psychiatry"},{"key":"2145_CR374","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-022-02466-2","volume":"19","author":"OJ Gannon","year":"2022","unstructured":"Gannon, O. J. et al. High-fat diet exacerbates cognitive decline in mouse models of Alzheimer\u2019s disease and mixed dementia in a sex-dependent manner. J. Neuroinflammation 19, 110 (2022).","journal-title":"J. Neuroinflammation"},{"key":"2145_CR375","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.arr.2016.10.005","volume":"39","author":"MP Mattson","year":"2017","unstructured":"Mattson, M. P., Longo, V. D. & Harvie, M. Impact of intermittent fasting on health and disease processes. Ageing Res. Rev. 39, 46\u201358 (2017).","journal-title":"Ageing Res. Rev."},{"key":"2145_CR376","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1001\/jama.2019.9879","volume":"322","author":"I Lourida","year":"2019","unstructured":"Lourida, I. et al. Association of Lifestyle and Genetic Risk With Incidence of Dementia. JAMA 322, 430\u2013437 (2019).","journal-title":"JAMA"},{"key":"2145_CR377","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1016\/S0140-6736(24)01296-0","volume":"404","author":"G Livingston","year":"2024","unstructured":"Livingston, G. et al. Dementia prevention, intervention, and care: 2024 report of the Lancet standing Commission. Lancet 404, 572\u2013628 (2024).","journal-title":"Lancet"},{"key":"2145_CR378","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1016\/S1474-4422(15)00177-5","volume":"14","author":"JB Carroll","year":"2015","unstructured":"Carroll, J. B. et al. Treating the whole body in Huntington\u2019s disease. Lancet Neurol. 14, 1135\u20131142 (2015).","journal-title":"Lancet Neurol."},{"key":"2145_CR379","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.1001\/jamaneurol.2015.1616","volume":"72","author":"JM Castellano","year":"2015","unstructured":"Castellano, J. M., Kirby, E. D. & Wyss-Coray, T. Blood-Borne Revitalization of the Aged Brain. JAMA Neurol. 72, 1191\u20131194 (2015).","journal-title":"JAMA Neurol."},{"key":"2145_CR380","doi-asserted-by":"publisher","first-page":"2859","DOI":"10.1084\/jem.20171320","volume":"214","author":"L Khrimian","year":"2017","unstructured":"Khrimian, L. et al. Gpr158 mediates osteocalcin\u2019s regulation of cognition. J. Exp. Med. 214, 2859\u20132873 (2017).","journal-title":"J. Exp. Med."},{"key":"2145_CR381","doi-asserted-by":"publisher","DOI":"10.1111\/acel.13038","volume":"19","author":"L Katsimpardi","year":"2020","unstructured":"Katsimpardi, L. et al. Systemic GDF11 stimulates the secretion of adiponectin and induces a calorie restriction-like phenotype in aged mice. Aging Cell 19, e13038 (2020).","journal-title":"Aging Cell"},{"key":"2145_CR382","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1016\/j.cmet.2013.09.008","volume":"18","author":"CD Wrann","year":"2013","unstructured":"Wrann, C. D. et al. Exercise induces hippocampal BDNF through a PGC-1\u03b1\/FNDC5 pathway. Cell Metab. 18, 649\u2013659 (2013).","journal-title":"Cell Metab."},{"key":"2145_CR383","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2204835119","volume":"119","author":"TI Kam","year":"2022","unstructured":"Kam, T. I. et al. Amelioration of pathologic \u03b1-synuclein-induced Parkinson\u2019s disease by irisin. Proc. Natl Acad. Sci. USA 119, e2204835119 (2022).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"2145_CR384","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1038\/s41586-021-04183-x","volume":"600","author":"Z De Miguel","year":"2021","unstructured":"De Miguel, Z. et al. Exercise plasma boosts memory and dampens brain inflammation via clusterin. Nature 600, 494\u2013499 (2021).","journal-title":"Nature"},{"key":"2145_CR385","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1038\/s41586-023-06436-3","volume":"620","author":"AB Schroer","year":"2023","unstructured":"Schroer, A. B. et al. Platelet factors attenuate inflammation and rescue cognition in ageing. Nature 620, 1071\u20131079 (2023).","journal-title":"Nature"},{"key":"2145_CR386","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1186\/s13024-023-00648-x","volume":"18","author":"MM Comerota","year":"2023","unstructured":"Comerota, M. M. et al. Oleoylethanolamide facilitates PPAR\u03b1 and TFEB signaling and attenuates A\u03b2 pathology in a mouse model of Alzheimer\u2019s disease. Mol. Neurodegener. 18, 56 (2023).","journal-title":"Mol. Neurodegener."},{"key":"2145_CR387","doi-asserted-by":"publisher","first-page":"12524","DOI":"10.1073\/pnas.1902672116","volume":"116","author":"KJ Gan","year":"2019","unstructured":"Gan, K. J. & S\u00fcdhof, T. C. Specific factors in blood from young but not old mice directly promote synapse formation and NMDA-receptor recruitment. Proc. Natl Acad. Sci. USA 116, 12524\u201312533 (2019).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"2145_CR388","doi-asserted-by":"publisher","first-page":"5628","DOI":"10.18632\/aging.102148","volume":"11","author":"M Mehdipour","year":"2019","unstructured":"Mehdipour, M. et al. Rejuvenation of brain, liver and muscle by simultaneous pharmacological modulation of two signaling determinants, that change in opposite directions with age. Aging 11, 5628\u20135645 (2019).","journal-title":"Aging"},{"key":"2145_CR389","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.lfs.2018.03.027","volume":"200","author":"HJ Zhou","year":"2018","unstructured":"Zhou, H. J. et al. Lentivirus-mediated klotho up-regulation improves aging-related memory deficits and oxidative stress in senescence-accelerated mouse prone-8 mice. Life Sci. 200, 56\u201362 (2018).","journal-title":"Life Sci."},{"key":"2145_CR390","doi-asserted-by":"publisher","first-page":"e2121499119","DOI":"10.1073\/pnas.2121499119","volume":"119","author":"DK Jaijyan","year":"2022","unstructured":"Jaijyan, D. K. et al. New intranasal and injectable gene therapy for healthy life extension. Proc. Natl Acad. Sci. USA 119, e2121499119 (2022).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"2145_CR391","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1038\/nature20411","volume":"539","author":"T Wyss-Coray","year":"2016","unstructured":"Wyss-Coray, T. Ageing, neurodegeneration and brain rejuvenation. Nature 539, 180\u2013186 (2016).","journal-title":"Nature"},{"key":"2145_CR392","doi-asserted-by":"publisher","first-page":"1026","DOI":"10.1016\/j.cell.2023.01.021","volume":"186","author":"Y Gao","year":"2023","unstructured":"Gao, Y. et al. beta2-microglobulin functions as an endogenous NMDAR antagonist to impair synaptic function. Cell 186, 1026\u20131038 e1020 (2023).","journal-title":"Cell"},{"key":"2145_CR393","doi-asserted-by":"publisher","first-page":"988","DOI":"10.1038\/s41591-019-0440-4","volume":"25","author":"H Yousef","year":"2019","unstructured":"Yousef, H. et al. Aged blood impairs hippocampal neural precursor activity and activates microglia via brain endothelial cell VCAM1. Nat. Med. 25, 988\u20131000 (2019).","journal-title":"Nat. Med."},{"key":"2145_CR394","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1038\/s12276-020-0399-8","volume":"52","author":"MH Park","year":"2020","unstructured":"Park, M. H., Jin, H. K. & Bae, J. S. Potential therapeutic target for aging and age-related neurodegenerative diseases: the role of acid sphingomyelinase. Exp. Mol. Med. 52, 380\u2013389 (2020).","journal-title":"Exp. Mol. Med."},{"key":"2145_CR395","doi-asserted-by":"publisher","DOI":"10.1111\/acel.13192","volume":"19","author":"LK Smith","year":"2020","unstructured":"Smith, L. K. et al. The aged hematopoietic system promotes hippocampal-dependent cognitive decline. Aging Cell 19, e13192 (2020).","journal-title":"Aging Cell"},{"key":"2145_CR396","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1038\/s41580-020-00313-x","volume":"22","author":"AJ Covarrubias","year":"2021","unstructured":"Covarrubias, A. J., Perrone, R., Grozio, A. & Verdin, E. NAD(+) metabolism and its roles in cellular processes during ageing. Nat. Rev. Mol. Cell Biol. 22, 119\u2013141 (2021).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"2145_CR397","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.arr.2016.04.003","volume":"28","author":"A Salminen","year":"2016","unstructured":"Salminen, A., Kaarniranta, K. & Kauppinen, A. Age-related changes in AMPK activation: Role for AMPK phosphatases and inhibitory phosphorylation by upstream signaling pathways. Ageing Res. Rev. 28, 15\u201326 (2016).","journal-title":"Ageing Res. Rev."},{"key":"2145_CR398","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.abj8658","volume":"8","author":"Y Xia","year":"2022","unstructured":"Xia, Y. et al. Neuronal C\/EBP\u03b2\/AEP pathway shortens life span via selective GABAnergic neuronal degeneration by FOXO repression. Sci. Adv. 8, eabj8658 (2022).","journal-title":"Sci. Adv."},{"key":"2145_CR399","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.1007\/s12264-023-01025-w","volume":"39","author":"J Xiong","year":"2023","unstructured":"Xiong, J., Zhang, Z. & Ye, K. C\/EBP\u03b2\/AEP Signaling Drives Alzheimer\u2019s Disease Pathogenesis. Neurosci. Bull. 39, 1173\u20131185 (2023).","journal-title":"Neurosci. Bull."},{"key":"2145_CR400","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1038\/s41380-020-0687-7","volume":"26","author":"Z Wu","year":"2021","unstructured":"Wu, Z. et al. C\/EBP\u03b2\/\u03b4-secretase signaling mediates Parkinson\u2019s disease pathogenesis via regulating transcription and proteolytic cleavage of \u03b1-synuclein and MAOB. Mol. Psychiatry 26, 568\u2013585 (2021).","journal-title":"Mol. Psychiatry"},{"key":"2145_CR401","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1038\/s41573-020-0067-7","volume":"19","author":"L Partridge","year":"2020","unstructured":"Partridge, L., Fuentealba, M. & Kennedy, B. K. The quest to slow ageing through drug discovery. Nat. Rev. Drug Discov. 19, 513\u2013532 (2020).","journal-title":"Nat. Rev. Drug Discov."},{"key":"2145_CR402","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1038\/s43587-022-00278-w","volume":"2","author":"P Juricic","year":"2022","unstructured":"Juricic, P. et al. Long-lasting geroprotection from brief rapamycin treatment in early adulthood by persistently increased intestinal autophagy. Nat. Aging 2, 824\u2013836 (2022).","journal-title":"Nat. Aging"},{"key":"2145_CR403","doi-asserted-by":"publisher","first-page":"101376","DOI":"10.1016\/j.arr.2021.101376","volume":"70","author":"Y Zhang","year":"2021","unstructured":"Zhang, Y., Zhang, J. & Wang, S. The Role of Rapamycin in Healthspan Extension via the Delay of Organ Aging. Ageing Res. Rev. 70, 101376 (2021).","journal-title":"Ageing Res. Rev."},{"key":"2145_CR404","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1016\/j.tem.2022.01.007","volume":"33","author":"A Moskalev","year":"2022","unstructured":"Moskalev, A. et al. Targeting aging mechanisms: pharmacological perspectives. Trends Endocrinol. Metab. 33, 266\u2013280 (2022).","journal-title":"Trends Endocrinol. Metab."},{"key":"2145_CR405","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.cmet.2020.04.001","volume":"32","author":"AS Kulkarni","year":"2020","unstructured":"Kulkarni, A. S., Gubbi, S. & Barzilai, N. Benefits of Metformin in Attenuating the Hallmarks of Aging. Cell Metab. 32, 15\u201330 (2020).","journal-title":"Cell Metab."},{"key":"2145_CR406","doi-asserted-by":"publisher","first-page":"468","DOI":"10.14336\/AD.2021.0928","volume":"13","author":"W Peng","year":"2022","unstructured":"Peng, W. et al. Novel Insights into the Roles and Mechanisms of GLP-1 Receptor Agonists against Aging-Related Diseases. Aging Dis. 13, 468\u2013490 (2022).","journal-title":"Aging Dis."},{"key":"2145_CR407","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1038\/s42003-021-02208-9","volume":"4","author":"Z Li","year":"2021","unstructured":"Li, Z. et al. Systemic GLP-1R agonist treatment reverses mouse glial and neurovascular cell transcriptomic aging signatures in a genome-wide manner. Commun. Biol. 4, 656 (2021).","journal-title":"Commun. Biol."},{"key":"2145_CR408","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-022-11229-1","volume":"12","author":"Z Jiang","year":"2022","unstructured":"Jiang, Z. et al. Short term treatment with a cocktail of rapamycin, acarbose and phenylbutyrate delays aging phenotypes in mice. Sci. Rep. 12, 7300 (2022).","journal-title":"Sci. Rep."},{"key":"2145_CR409","doi-asserted-by":"publisher","first-page":"4855","DOI":"10.1007\/s11357-024-01198-w","volume":"46","author":"Z Jiang","year":"2024","unstructured":"Jiang, Z. et al. A cocktail of rapamycin, acarbose, and phenylbutyrate prevents age-related cognitive decline in mice by targeting multiple aging pathways. Geroscience 46, 4855\u20134868 (2024).","journal-title":"Geroscience"},{"key":"2145_CR410","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-021-03926-y","volume":"12","author":"Y Yu","year":"2021","unstructured":"Yu, Y. et al. Parp mutations protect from mitochondrial toxicity in Alzheimer\u2019s disease. Cell Death Dis. 12, 651 (2021).","journal-title":"Cell Death Dis."},{"key":"2145_CR411","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2016.72","volume":"7","author":"S Lehmann","year":"2016","unstructured":"Lehmann, S. et al. Parp mutations protect against mitochondrial dysfunction and neurodegeneration in a PARKIN model of Parkinson\u2019s disease. Cell Death Dis. 7, e2166 (2016).","journal-title":"Cell Death Dis."},{"key":"2145_CR412","doi-asserted-by":"publisher","first-page":"2423","DOI":"10.1007\/s11064-019-02809-1","volume":"44","author":"A Lloret","year":"2019","unstructured":"Lloret, A. & Beal, M. F. PGC-1\u03b1, Sirtuins and PARPs in Huntington\u2019s Disease and Other Neurodegenerative Conditions: NAD+ to Rule Them All. Neurochem Res. 44, 2423\u20132434 (2019).","journal-title":"Neurochem Res."},{"key":"2145_CR413","doi-asserted-by":"publisher","first-page":"156","DOI":"10.3389\/fnmol.2017.00156","volume":"10","author":"E Buck","year":"2017","unstructured":"Buck, E. et al. Comparison of Sirtuin 3 Levels in ALS and Huntington\u2019s Disease-Differential Effects in Human Tissue Samples vs. Transgenic Mouse Models. Front. Mol. Neurosci. 10, 156 (2017).","journal-title":"Front. Mol. Neurosci."},{"key":"2145_CR414","doi-asserted-by":"publisher","first-page":"8152373","DOI":"10.1155\/2018\/8152373","volume":"2018","author":"BAQ Gomes","year":"2018","unstructured":"Gomes, B. A. Q. et al. Neuroprotective Mechanisms of Resveratrol in Alzheimer\u2019s Disease: Role of SIRT1. Oxid. Med. Cell Longev. 2018, 8152373 (2018).","journal-title":"Oxid. Med. Cell Longev."},{"key":"2145_CR415","doi-asserted-by":"publisher","first-page":"122537","DOI":"10.1016\/j.lfs.2024.122537","volume":"342","author":"S Dhiman","year":"2024","unstructured":"Dhiman, S. et al. Sirtuin dysregulation in Parkinson\u2019s disease: Implications of acetylation and deacetylation processes. Life Sci. 342, 122537 (2024).","journal-title":"Life Sci."},{"key":"2145_CR416","doi-asserted-by":"publisher","first-page":"2386","DOI":"10.1080\/15548627.2023.2175569","volume":"19","author":"JM Carosi","year":"2023","unstructured":"Carosi, J. M. & Sargeant, T. J. Rapamycin and Alzheimer disease: a hypothesis for the effective use of rapamycin for treatment of neurodegenerative disease. Autophagy 19, 2386\u20132390 (2023).","journal-title":"Autophagy"},{"key":"2145_CR417","doi-asserted-by":"publisher","first-page":"1460","DOI":"10.1080\/15548627.2019.1615823","volume":"15","author":"JM Carosi","year":"2019","unstructured":"Carosi, J. M. & Sargeant, T. J. Rapamycin and Alzheimer disease: a double-edged sword? Autophagy 15, 1460\u20131462 (2019).","journal-title":"Autophagy"},{"key":"2145_CR418","doi-asserted-by":"publisher","first-page":"2514","DOI":"10.4103\/1673-5374.371381","volume":"18","author":"T Liu","year":"2023","unstructured":"Liu, T. et al. Rapamycin reverses ferroptosis by increasing autophagy in MPTP\/MPP(+)-induced models of Parkinson\u2019s disease. Neural Regen. Res. 18, 2514\u20132519 (2023).","journal-title":"Neural Regen. Res."},{"key":"2145_CR419","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2023.1223911","volume":"15","author":"JR Roth","year":"2023","unstructured":"Roth, J. R. et al. Rapamycin reduces neuronal mutant huntingtin aggregation and ameliorates locomotor performance in Drosophila. Front. Aging Neurosci. 15, 1223911 (2023).","journal-title":"Front. Aging Neurosci."},{"key":"2145_CR420","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1186\/s13024-021-00428-5","volume":"16","author":"H Querfurth","year":"2021","unstructured":"Querfurth, H. & Lee, H. K. Mammalian\/mechanistic target of rapamycin (mTOR) complexes in neurodegeneration. Mol. Neurodegener. 16, 44 (2021).","journal-title":"Mol. Neurodegener."},{"key":"2145_CR421","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1038\/s41594-020-0442-4","volume":"27","author":"C R\u00f6der","year":"2020","unstructured":"R\u00f6der, C. et al. Cryo-EM structure of islet amyloid polypeptide fibrils reveals similarities with amyloid-\u03b2 fibrils. Nat. Struct. Mol. Biol. 27, 660\u2013667 (2020).","journal-title":"Nat. Struct. Mol. Biol."},{"key":"2145_CR422","doi-asserted-by":"publisher","first-page":"1420","DOI":"10.1002\/mds.28551","volume":"36","author":"H Chohan","year":"2021","unstructured":"Chohan, H. et al. Type 2 Diabetes as a Determinant of Parkinson\u2019s Disease Risk and Progression. Mov. Disord. 36, 1420\u20131429 (2021).","journal-title":"Mov. Disord."},{"key":"2145_CR423","doi-asserted-by":"publisher","first-page":"101979","DOI":"10.1016\/j.arr.2023.101979","volume":"89","author":"J Nowell","year":"2023","unstructured":"Nowell, J., Blunt, E., Gupta, D. & Edison, P. Antidiabetic agents as a novel treatment for Alzheimer\u2019s and Parkinson\u2019s disease. Ageing Res. Rev. 89, 101979 (2023).","journal-title":"Ageing Res. Rev."},{"key":"2145_CR424","doi-asserted-by":"publisher","first-page":"111670","DOI":"10.1016\/j.mad.2022.111670","volume":"204","author":"C Trujillo-Del R\u00edo","year":"2022","unstructured":"Trujillo-Del R\u00edo, C. et al. Metformin to treat Huntington disease: A pleiotropic drug against a multi-system disorder. Mech. Ageing Dev. 204, 111670 (2022).","journal-title":"Mech. Ageing Dev."},{"key":"2145_CR425","doi-asserted-by":"publisher","first-page":"18591","DOI":"10.1073\/pnas.2005748117","volume":"117","author":"T Zu","year":"2020","unstructured":"Zu, T. et al. Metformin inhibits RAN translation through PKR pathway and mitigates disease in C9orf72 ALS\/FTD mice. Proc. Natl Acad. Sci. USA 117, 18591\u201318599 (2020).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"2145_CR426","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1007\/s40263-015-0301-8","volume":"29","author":"V Calsolaro","year":"2015","unstructured":"Calsolaro, V. & Edison, P. Novel GLP-1 (Glucagon-Like Peptide-1) Analogues and Insulin in the Treatment for Alzheimer\u2019s Disease and Other Neurodegenerative Diseases. CNS Drugs 29, 1023\u20131039 (2015).","journal-title":"CNS Drugs"},{"key":"2145_CR427","doi-asserted-by":"publisher","first-page":"106550","DOI":"10.1016\/j.phrs.2022.106550","volume":"186","author":"KO Kopp","year":"2022","unstructured":"Kopp, K. O., Glotfelty, E. J., Li, Y. & Greig, N. H. Glucagon-like peptide-1 (GLP-1) receptor agonists and neuroinflammation: Implications for neurodegenerative disease treatment. Pharm. Res. 186, 106550 (2022).","journal-title":"Pharm. Res."},{"key":"2145_CR428","doi-asserted-by":"publisher","unstructured":"Wezeman, J. et al. A drug cocktail of rapamycin, acarbose, and phenylbutyrate enhances resilience to features of early-stage Alzheimer\u2019s disease in aging mice. Preprint at https:\/\/doi.org\/10.1101\/2024.01.26.577437 (2024).","DOI":"10.1101\/2024.01.26.577437"},{"key":"2145_CR429","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1038\/s42255-022-00609-6","volume":"4","author":"OH Jeon","year":"2022","unstructured":"Jeon, O. H. et al. Systemic induction of senescence in young mice after single heterochronic blood exchange. Nat. Metab. 4, 995\u20131006 (2022).","journal-title":"Nat. Metab."},{"key":"2145_CR430","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1038\/s41593-019-0372-9","volume":"22","author":"P Zhang","year":"2019","unstructured":"Zhang, P. et al. Senolytic therapy alleviates A\u03b2-associated oligodendrocyte progenitor cell senescence and cognitive deficits in an Alzheimer\u2019s disease model. Nat. Neurosci. 22, 719\u2013728 (2019).","journal-title":"Nat. Neurosci."},{"key":"2145_CR431","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2023.1271941","volume":"14","author":"SJ Miller","year":"2023","unstructured":"Miller, S. J. et al. Senolytic and senomorphic secondary metabolites as therapeutic agents in Drosophila melanogaster models of Parkinson\u2019s disease. Front. Neurol. 14, 1271941 (2023).","journal-title":"Front. Neurol."},{"key":"2145_CR432","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms1611","volume":"3","author":"M Lavasani","year":"2012","unstructured":"Lavasani, M. et al. Muscle-derived stem\/progenitor cell dysfunction limits healthspan and lifespan in a murine progeria model. Nat. Commun. 3, 608 (2012).","journal-title":"Nat. Commun."},{"key":"2145_CR433","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.stem.2011.11.019","volume":"10","author":"JM Ruckh","year":"2012","unstructured":"Ruckh, J. M. et al. Rejuvenation of regeneration in the aging central nervous system. Cell Stem Cell 10, 96\u2013103 (2012).","journal-title":"Cell Stem Cell"},{"key":"2145_CR434","doi-asserted-by":"publisher","first-page":"2399","DOI":"10.1093\/brain\/awv150","volume":"138","author":"Y Koronyo","year":"2015","unstructured":"Koronyo, Y. et al. Therapeutic effects of glatiramer acetate and grafted CD115+ monocytes in a mouse model of Alzheimer\u2019s disease. Brain 138, 2399\u20132422 (2015).","journal-title":"Brain"},{"key":"2145_CR435","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1038\/s41586-023-06300-4","volume":"619","author":"TY Park","year":"2023","unstructured":"Park, T. Y. et al. Co-transplantation of autologous T(reg) cells in a cell therapy for Parkinson\u2019s disease. Nature 619, 606\u2013615 (2023).","journal-title":"Nature"},{"key":"2145_CR436","doi-asserted-by":"publisher","first-page":"750","DOI":"10.4103\/1673-5374.295925","volume":"16","author":"Z Xiang","year":"2021","unstructured":"Xiang, Z. et al. Lineage tracing of direct astrocyte-to-neuron conversion in the mouse cortex. Neural Regen. Res. 16, 750\u2013756 (2021).","journal-title":"Neural Regen. Res."},{"key":"2145_CR437","doi-asserted-by":"publisher","first-page":"1284","DOI":"10.1016\/j.jcyt.2017.07.012","volume":"19","author":"G Sutrave","year":"2017","unstructured":"Sutrave, G., Blyth, E. & Gottlieb, D. J. Cellular therapy for multiple pathogen infections after hematopoietic stem cell transplant. Cytotherapy 19, 1284\u20131301 (2017).","journal-title":"Cytotherapy"},{"key":"2145_CR438","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jaad.2022.12.024","volume":"90","author":"E Baumrin","year":"2024","unstructured":"Baumrin, E. et al. Chronic graft-versus-host disease. Part I: Epidemiology, pathogenesis, and clinical manifestations. J. Am. Acad. Dermatol. 90, 1\u201316 (2024).","journal-title":"J. Am. Acad. Dermatol."},{"key":"2145_CR439","doi-asserted-by":"publisher","first-page":"3175","DOI":"10.2217\/fon.15.252","volume":"11","author":"J Adhikari","year":"2015","unstructured":"Adhikari, J., Sharma, P. & Bhatt, V. R. Risk of secondary solid malignancies after allogeneic hematopoietic stem cell transplantation and preventive strategies. Fut. Oncol. 11, 3175\u20133185 (2015).","journal-title":"Fut. Oncol."},{"key":"2145_CR440","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.abq2226","volume":"8","author":"J Sanz-Ros","year":"2022","unstructured":"Sanz-Ros, J. et al. Small extracellular vesicles from young adipose-derived stem cells prevent frailty, improve health span, and decrease epigenetic age in old mice. Sci. Adv. 8, eabq2226 (2022).","journal-title":"Sci. Adv."},{"key":"2145_CR441","doi-asserted-by":"crossref","unstructured":"Lei, Q. et al. Extracellular vesicles deposit PCNA to rejuvenate aged bone marrow-derived mesenchymal stem cells and slow age-related degeneration. Sci. Transl. Med. 13, eaaz8697 (2021).","DOI":"10.1126\/scitranslmed.aaz8697"},{"key":"2145_CR442","doi-asserted-by":"publisher","DOI":"10.1186\/s12951-024-02428-1","volume":"22","author":"X Liu","year":"2024","unstructured":"Liu, X. et al. Peripheral extracellular vesicles in neurodegeneration: pathogenic influencers and therapeutic vehicles. J. Nanobiotechnol. 22, 170 (2024).","journal-title":"J. Nanobiotechnol."},{"key":"2145_CR443","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1038\/nature23282","volume":"548","author":"Y Zhang","year":"2017","unstructured":"Zhang, Y. et al. Hypothalamic stem cells control ageing speed partly through exosomal miRNAs. Nature 548, 52\u201357 (2017).","journal-title":"Nature"},{"key":"2145_CR444","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1038\/s41392-023-01436-1","volume":"8","author":"G Gao","year":"2023","unstructured":"Gao, G. et al. Neural stem cell-derived extracellular vesicles mitigate Alzheimer\u2019s disease-like phenotypes in a preclinical mouse model. Signal Transduct. Target Ther. 8, 228 (2023).","journal-title":"Signal Transduct. Target Ther."},{"key":"2145_CR445","doi-asserted-by":"publisher","DOI":"10.1186\/s12951-022-01356-2","volume":"20","author":"EJ Lee","year":"2022","unstructured":"Lee, E. J. et al. Human neural stem cell-derived extracellular vesicles protect against Parkinson\u2019s disease pathologies. J. Nanobiotechnol. 20, 198 (2022).","journal-title":"J. Nanobiotechnol."},{"key":"2145_CR446","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1038\/s43587-024-00612-4","volume":"4","author":"X Chen","year":"2024","unstructured":"Chen, X. et al. Small extracellular vesicles from young plasma reverse age-related functional declines by improving mitochondrial energy metabolism. Nat. Aging 4, 814\u2013838 (2024).","journal-title":"Nat. Aging"},{"key":"2145_CR447","doi-asserted-by":"publisher","first-page":"948","DOI":"10.1038\/s43587-023-00451-9","volume":"3","author":"B Zhang","year":"2023","unstructured":"Zhang, B. et al. Multi-omic rejuvenation and life span extension on exposure to youthful circulation. Nat. Aging 3, 948\u2013964 (2023).","journal-title":"Nat. Aging"},{"key":"2145_CR448","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1038\/s42003-020-0797-4","volume":"3","author":"S Kang","year":"2020","unstructured":"Kang, S., Moser, V. A., Svendsen, C. N. & Goodridge, H. S. Rejuvenating the blood and bone marrow to slow aging-associated cognitive decline and Alzheimer\u2019s disease. Commun. Biol. 3, 69 (2020).","journal-title":"Commun. Biol."},{"key":"2145_CR449","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.neuroscience.2019.08.010","volume":"417","author":"E Xia","year":"2019","unstructured":"Xia, E. et al. Young Blood Rescues the Cognition of Alzheimer\u2019s Model Mice by Restoring the Hippocampal Cholinergic Circuit. Neuroscience 417, 57\u201369 (2019).","journal-title":"Neuroscience"},{"key":"2145_CR450","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1038\/nm.3569","volume":"20","author":"SA Villeda","year":"2014","unstructured":"Villeda, S. A. et al. Young blood reverses age-related impairments in cognitive function and synaptic plasticity in mice. Nat. Med. 20, 659\u2013663 (2014).","journal-title":"Nat. Med."},{"key":"2145_CR451","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1016\/j.exger.2018.06.019","volume":"110","author":"JC Dayoub","year":"2018","unstructured":"Dayoub, J. C. et al. The effects of donor age on organ transplants: A review and implications for aging research. Exp. Gerontol. 110, 230\u2013240 (2018).","journal-title":"Exp. Gerontol."},{"key":"2145_CR452","doi-asserted-by":"publisher","DOI":"10.1111\/acel.13696","volume":"21","author":"J Clement","year":"2022","unstructured":"Clement, J. et al. Umbilical cord plasma concentrate has beneficial effects on DNA methylation GrimAge and human clinical biomarkers. Aging Cell 21, e13696 (2022).","journal-title":"Aging Cell"},{"key":"2145_CR453","doi-asserted-by":"publisher","first-page":"4285","DOI":"10.1038\/s41380-022-01679-4","volume":"27","author":"A Urayama","year":"2022","unstructured":"Urayama, A. et al. Preventive and therapeutic reduction of amyloid deposition and behavioral impairments in a model of Alzheimer\u2019s disease by whole blood exchange. Mol. Psychiatry 27, 4285\u20134296 (2022).","journal-title":"Mol. Psychiatry"},{"key":"2145_CR454","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1038\/s42003-019-0298-5","volume":"2","author":"MM Das","year":"2019","unstructured":"Das, M. M. et al. Young bone marrow transplantation preserves learning and memory in old mice. Commun. Biol. 2, 73 (2019).","journal-title":"Commun. Biol."},{"key":"2145_CR455","doi-asserted-by":"publisher","first-page":"310","DOI":"10.3389\/fgene.2019.00310","volume":"10","author":"MV Kovina","year":"2019","unstructured":"Kovina, M. V. et al. Extension of Maximal Lifespan and High Bone Marrow Chimerism After Nonmyeloablative Syngeneic Transplantation of Bone Marrow From Young to Old Mice. Front. Genet. 10, 310 (2019).","journal-title":"Front. Genet."},{"key":"2145_CR456","doi-asserted-by":"publisher","first-page":"153331752092716","DOI":"10.1177\/1533317520927169","volume":"35","author":"C Li","year":"2020","unstructured":"Li, C., Chen, Y. H. & Zhang, K. Neuroprotective Properties and Therapeutic Potential of Bone Marrow-Derived Microglia in Alzheimer\u2019s Disease. Am. J. Alzheimers Dis. Other Demen 35, 1533317520927169 (2020).","journal-title":"Am. J. Alzheimers Dis. Other Demen"},{"key":"2145_CR457","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.adl1123","volume":"10","author":"PY Sun","year":"2024","unstructured":"Sun, P. Y. et al. Rejuvenation of peripheral immune cells attenuates Alzheimer\u2019s disease-like pathologies and behavioral deficits in a mouse model. Sci. Adv. 10, eadl1123 (2024).","journal-title":"Sci. Adv."},{"key":"2145_CR458","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1523\/JNEUROSCI.4846-11.2012","volume":"32","author":"W Kwan","year":"2012","unstructured":"Kwan, W. et al. Bone marrow transplantation confers modest benefits in mouse models of Huntington\u2019s disease. J. Neurosci. 32, 133\u2013142 (2012).","journal-title":"J. Neurosci."},{"key":"2145_CR459","doi-asserted-by":"publisher","DOI":"10.1186\/s40168-022-01243-w","volume":"10","author":"A Parker","year":"2022","unstructured":"Parker, A. et al. Fecal microbiota transfer between young and aged mice reverses hallmarks of the aging gut, eye, and brain. Microbiome 10, 68 (2022).","journal-title":"Microbiome"},{"key":"2145_CR460","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1136\/gutjnl-2018-317431","volume":"69","author":"MS Kim","year":"2020","unstructured":"Kim, M. S. et al. Transfer of a healthy microbiota reduces amyloid and tau pathology in an Alzheimer\u2019s disease animal model. Gut 69, 283\u2013294 (2020).","journal-title":"Gut"},{"key":"2145_CR461","doi-asserted-by":"publisher","first-page":"2193","DOI":"10.14336\/AD.2023.0309","volume":"14","author":"Z Xie","year":"2023","unstructured":"Xie, Z. et al. Healthy Human Fecal Microbiota Transplantation into Mice Attenuates MPTP-Induced Neurotoxicity via AMPK\/SOD2 Pathway. Aging Dis. 14, 2193\u20132214 (2023).","journal-title":"Aging Dis."},{"key":"2145_CR462","doi-asserted-by":"publisher","DOI":"10.1016\/j.clineuro.2021.106791","volume":"207","author":"A Segal","year":"2021","unstructured":"Segal, A. et al. Fecal microbiota transplant as a potential treatment for Parkinson\u2019s disease - A case series. Clin. Neurol. Neurosurg. 207, 106791 (2021).","journal-title":"Clin. Neurol. Neurosurg."},{"key":"2145_CR463","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1038\/nature12143","volume":"497","author":"G Zhang","year":"2013","unstructured":"Zhang, G. et al. Hypothalamic programming of systemic ageing involving IKK-\u03b2, NF-\u03baB and GnRH. Nature 497, 211\u2013216 (2013).","journal-title":"Nature"},{"key":"2145_CR464","first-page":"582","volume":"31","author":"J Cen","year":"2015","unstructured":"Cen, J. et al. Anti-aging effect of estrogen on telomerase activity in ovariectomised rats\u2013animal model for menopause. Gynecol. Endocrinol. 31, 582\u2013585 (2015).","journal-title":"Gynecol. Endocrinol."},{"key":"2145_CR465","doi-asserted-by":"publisher","first-page":"4907","DOI":"10.1007\/s00018-021-03830-w","volume":"78","author":"D Zhu","year":"2021","unstructured":"Zhu, D., Montagne, A. & Zhao, Z. Alzheimer\u2019s pathogenic mechanisms and underlying sex difference. Cell Mol. Life Sci. 78, 4907\u20134920 (2021).","journal-title":"Cell Mol. Life Sci."},{"key":"2145_CR466","doi-asserted-by":"publisher","first-page":"755","DOI":"10.18632\/aging.100504","volume":"4","author":"M Jaszberenyi","year":"2012","unstructured":"Jaszberenyi, M. et al. Beneficial effects of novel antagonists of GHRH in different models of Alzheimer\u2019s disease. Aging 4, 755\u2013767 (2012).","journal-title":"Aging"},{"key":"2145_CR467","doi-asserted-by":"publisher","first-page":"1449","DOI":"10.1111\/cns.14160","volume":"29","author":"GS Fitzgerald","year":"2023","unstructured":"Fitzgerald, G. S., Chuchta, T. G. & McNay, E. C. Insulin-like growth factor-2 is a promising candidate for the treatment and prevention of Alzheimer\u2019s disease. CNS Neurosci. Ther. 29, 1449\u20131469 (2023).","journal-title":"CNS Neurosci. Ther."},{"key":"2145_CR468","doi-asserted-by":"publisher","first-page":"2654","DOI":"10.1007\/s12035-020-01911-8","volume":"57","author":"MS Uddin","year":"2020","unstructured":"Uddin, M. S. et al. Estrogen Signaling in Alzheimer\u2019s Disease: Molecular Insights and Therapeutic Targets for Alzheimer\u2019s Dementia. Mol. Neurobiol. 57, 2654\u20132670 (2020).","journal-title":"Mol. Neurobiol."},{"key":"2145_CR469","doi-asserted-by":"publisher","first-page":"1515","DOI":"10.1007\/s12035-022-03152-3","volume":"60","author":"P Mishra","year":"2023","unstructured":"Mishra, P., Davies, D. A. & Albensi, B. C. The Interaction Between NF-\u03baB and Estrogen in Alzheimer\u2019s Disease. Mol. Neurobiol. 60, 1515\u20131526 (2023).","journal-title":"Mol. Neurobiol."},{"key":"2145_CR470","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1016\/j.neuroscience.2005.07.060","volume":"138","author":"MC Morale","year":"2006","unstructured":"Morale, M. C. et al. Estrogen, neuroinflammation and neuroprotection in Parkinson\u2019s disease: glia dictates resistance versus vulnerability to neurodegeneration. Neuroscience 138, 869\u2013878 (2006).","journal-title":"Neuroscience"},{"key":"2145_CR471","doi-asserted-by":"publisher","first-page":"21266","DOI":"10.1007\/s11356-020-11985-5","volume":"28","author":"M Makav","year":"2021","unstructured":"Makav, M. & Eroglu, H. A. Recuperative effect of estrogen on rotenone-induced experimental model of Parkinson\u2019s disease in rats. Environ. Sci. Pollut. Res. Int. 28, 21266\u201321275 (2021).","journal-title":"Environ. Sci. Pollut. Res. Int."},{"key":"2145_CR472","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/j.tem.2016.09.005","volume":"28","author":"C Franceschi","year":"2017","unstructured":"Franceschi, C. et al. Inflammaging and \u2018Garb-aging. Trends Endocrinol. Metab. 28, 199\u2013212 (2017).","journal-title":"Trends Endocrinol. Metab."},{"key":"2145_CR473","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1038\/s41586-019-1365-2","volume":"571","author":"J Campisi","year":"2019","unstructured":"Campisi, J. et al. From discoveries in ageing research to therapeutics for healthy ageing. Nature 571, 183\u2013192 (2019).","journal-title":"Nature"},{"key":"2145_CR474","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1007\/s00005-015-0377-3","volume":"64","author":"PL Minciullo","year":"2016","unstructured":"Minciullo, P. L. et al. Inflammaging and Anti-Inflammaging: The Role of Cytokines in Extreme Longevity. Arch. Immunol. Ther. Exp. 64, 111\u2013126 (2016).","journal-title":"Arch. Immunol. Ther. Exp."},{"key":"2145_CR475","doi-asserted-by":"publisher","first-page":"2311","DOI":"10.1101\/gad.197954.112","volume":"26","author":"FG Osorio","year":"2012","unstructured":"Osorio, F. G. et al. Nuclear lamina defects cause ATM-dependent NF-\u03baB activation and link accelerated aging to a systemic inflammatory response. Genes Dev. 26, 2311\u20132324 (2012).","journal-title":"Genes Dev."},{"key":"2145_CR476","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1038\/s41586-024-07701-9","volume":"632","author":"AA Widjaja","year":"2024","unstructured":"Widjaja, A. A. et al. Inhibition of IL-11 signalling extends mammalian healthspan and lifespan. Nature 632, 157\u2013165 (2024).","journal-title":"Nature"},{"key":"2145_CR477","doi-asserted-by":"publisher","DOI":"10.1111\/acel.13188","volume":"19","author":"E Fielder","year":"2020","unstructured":"Fielder, E. et al. Anti-inflammatory treatment rescues memory deficits during aging in nfkb1(-\/-) mice. Aging Cell 19, e13188 (2020).","journal-title":"Aging Cell"},{"key":"2145_CR478","doi-asserted-by":"publisher","first-page":"19428","DOI":"10.18632\/oncotarget.5118","volume":"6","author":"A Danilov","year":"2015","unstructured":"Danilov, A. et al. Influence of non-steroidal anti-inflammatory drugs on Drosophila melanogaster longevity. Oncotarget 6, 19428\u201319444 (2015).","journal-title":"Oncotarget"},{"key":"2145_CR479","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1111\/j.1474-9726.2008.00414.x","volume":"7","author":"R Strong","year":"2008","unstructured":"Strong, R. et al. Nordihydroguaiaretic acid and aspirin increase lifespan of genetically heterogeneous male mice. Aging Cell 7, 641\u2013650 (2008).","journal-title":"Aging Cell"},{"key":"2145_CR480","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1093\/gerona\/glad009","volume":"78","author":"H Zhu","year":"2023","unstructured":"Zhu, H. et al. Resveratrol Alleviates Inflammation and ER Stress Through SIRT1\/NRF2 to Delay Ovarian Aging in a Short-Lived Fish. J. Gerontol. A Biol. Sci. Med. Sci. 78, 596\u2013602 (2023).","journal-title":"J. Gerontol. A Biol. Sci. Med. Sci."},{"key":"2145_CR481","doi-asserted-by":"publisher","first-page":"4596","DOI":"10.1007\/s12011-023-04021-3","volume":"202","author":"X Chen","year":"2024","unstructured":"Chen, X. et al. Ginkgo Biloba Extract Can Antagonize Subchronic Arsenite Exposure-Induced Hepatocyte Senescence by Inhibiting Oxidative Damage and Inflammation in Rats. Biol. Trace Elem. Res. 202, 4596\u20134604 (2024).","journal-title":"Biol. Trace Elem. Res."},{"key":"2145_CR482","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1038\/s41586-023-06373-1","volume":"620","author":"MF Gulen","year":"2023","unstructured":"Gulen, M. F. et al. cGAS-STING drives ageing-related inflammation and neurodegeneration. Nature 620, 374\u2013380 (2023).","journal-title":"Nature"},{"key":"2145_CR483","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1523\/JNEUROSCI.20-02-00558.2000","volume":"20","author":"CK Combs","year":"2000","unstructured":"Combs, C. K. et al. Inflammatory mechanisms in Alzheimer\u2019s disease: inhibition of beta-amyloid-stimulated proinflammatory responses and neurotoxicity by PPARgamma agonists. J. Neurosci. 20, 558\u2013567 (2000).","journal-title":"J. Neurosci."},{"key":"2145_CR484","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1007\/s10787-023-01192-2","volume":"31","author":"M Alrouji","year":"2023","unstructured":"Alrouji, M. et al. A story of the potential effect of non-steroidal anti-inflammatory drugs (NSAIDs) in Parkinson\u2019s disease: beneficial or detrimental effects. Inflammopharmacology 31, 673\u2013688 (2023).","journal-title":"Inflammopharmacology"},{"key":"2145_CR485","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-71813-1","volume":"10","author":"MC Chang","year":"2020","unstructured":"Chang, M. C., Kwak, S. G., Park, J. S. & Park, D. The effectiveness of nonsteroidal anti-inflammatory drugs and acetaminophen in reduce the risk of amyotrophic lateral sclerosis? A meta-analysis. Sci. Rep. 10, 14759 (2020).","journal-title":"Sci. Rep."},{"key":"2145_CR486","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/s12877-016-0194-5","volume":"16","author":"T Li","year":"2016","unstructured":"Li, T. et al. Cognitive training can reduce the rate of cognitive aging: a neuroimaging cohort study. BMC Geriatr. 16, 12 (2016).","journal-title":"BMC Geriatr."},{"key":"2145_CR487","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1038\/s41586-021-03934-0","volume":"598","author":"M Ulgherait","year":"2021","unstructured":"Ulgherait, M. et al. Circadian autophagy drives iTRF-mediated longevity. Nature 598, 353\u2013358 (2021).","journal-title":"Nature"},{"key":"2145_CR488","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1038\/nrn3208","volume":"13","author":"AA Kondratova","year":"2012","unstructured":"Kondratova, A. A. & Kondratov, R. V. The circadian clock and pathology of the ageing brain. Nat. Rev. Neurosci. 13, 325\u2013335 (2012).","journal-title":"Nat. Rev. Neurosci."},{"key":"2145_CR489","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1038\/nature19329","volume":"537","author":"WP Vermeij","year":"2016","unstructured":"Vermeij, W. P. et al. Restricted diet delays accelerated ageing and genomic stress in DNA-repair-deficient mice. Nature 537, 427\u2013431 (2016).","journal-title":"Nature"},{"key":"2145_CR490","volume":"4","author":"S Sun","year":"2023","unstructured":"Sun, S. et al. A single-cell transcriptomic atlas of exercise-induced anti-inflammatory and geroprotective effects across the body. Innovation 4, 100380 (2023).","journal-title":"Innovation"},{"key":"2145_CR491","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1002\/alz.12001","volume":"16","author":"KB Casaletto","year":"2020","unstructured":"Casaletto, K. B. et al. Active lifestyles moderate clinical outcomes in autosomal dominant frontotemporal degeneration. Alzheimers Dement 16, 91\u2013105 (2020).","journal-title":"Alzheimers Dement"},{"key":"2145_CR492","doi-asserted-by":"publisher","first-page":"1704","DOI":"10.1016\/j.cmet.2023.07.014","volume":"35","author":"DS Whittaker","year":"2023","unstructured":"Whittaker, D. S. et al. Circadian modulation by time-restricted feeding rescues brain pathology and improves memory in mouse models of Alzheimer\u2019s disease. Cell Metab. 35, 1704\u20131721.e1706 (2023).","journal-title":"Cell Metab."},{"key":"2145_CR493","doi-asserted-by":"crossref","unstructured":"Kim, E. et al. Effects of the Clock Modulator Nobiletin on Circadian Rhythms and Pathophysiology in Female Mice of an Alzheimer\u2019s Disease Model. Biomolecules. 11, 1004 (2021).","DOI":"10.3390\/biom11071004"},{"key":"2145_CR494","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.brainres.2009.03.072","volume":"1279","author":"PN Pallier","year":"2009","unstructured":"Pallier, P. N. & Morton, A. J. Management of sleep\/wake cycles improves cognitive function in a transgenic mouse model of Huntington\u2019s disease. Brain Res. 1279, 90\u201398 (2009).","journal-title":"Brain Res."},{"key":"2145_CR495","doi-asserted-by":"publisher","DOI":"10.1007\/s11910-016-0680-3","volume":"16","author":"SJ McCarter","year":"2016","unstructured":"McCarter, S. J., St Louis, E. K. & Boeve, B. F. Sleep Disturbances in Frontotemporal Dementia. Curr. Neurol. Neurosci. Rep. 16, 85 (2016).","journal-title":"Curr. Neurol. Neurosci. Rep."},{"key":"2145_CR496","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.1039\/C9FO02611H","volume":"11","author":"Y Yang","year":"2020","unstructured":"Yang, Y. & Zhang, L. The effects of caloric restriction and its mimetics in Alzheimer\u2019s disease through autophagy pathways. Food Funct. 11, 1211\u20131224 (2020).","journal-title":"Food Funct."},{"key":"2145_CR497","doi-asserted-by":"publisher","first-page":"1640","DOI":"10.4103\/1673-5374.332126","volume":"17","author":"TS de Carvalho","year":"2022","unstructured":"de Carvalho, T. S. Calorie restriction or dietary restriction: how far they can protect the brain against neurodegenerative diseases? Neural Regen. Res. 17, 1640\u20131644 (2022).","journal-title":"Neural Regen. Res."},{"key":"2145_CR498","doi-asserted-by":"publisher","first-page":"1540","DOI":"10.1001\/jamaneurol.2014.1931","volume":"71","author":"RM Ahmed","year":"2014","unstructured":"Ahmed, R. M. et al. Quantifying the eating abnormalities in frontotemporal dementia. JAMA Neurol. 71, 1540\u20131546 (2014).","journal-title":"JAMA Neurol."},{"key":"2145_CR499","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1001\/jamaneurol.2015.4478","volume":"73","author":"RM Ahmed","year":"2016","unstructured":"Ahmed, R. M. et al. Assessment of Eating Behavior Disturbance and Associated Neural Networks in Frontotemporal Dementia. JAMA Neurol. 73, 282\u2013290 (2016).","journal-title":"JAMA Neurol."},{"key":"2145_CR500","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1038\/s41569-020-0354-3","volume":"17","author":"G Parry-Williams","year":"2020","unstructured":"Parry-Williams, G. & Sharma, S. The effects of endurance exercise on the heart: panacea or poison? Nat. Rev. Cardiol. 17, 402\u2013412 (2020).","journal-title":"Nat. Rev. Cardiol."},{"key":"2145_CR501","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.abl4988","volume":"7","author":"CE Xirouchaki","year":"2021","unstructured":"Xirouchaki, C. E. et al. Skeletal muscle NOX4 is required for adaptive responses that prevent insulin resistance. Sci. Adv. 7, eabl4988 (2021).","journal-title":"Sci. Adv."},{"key":"2145_CR502","doi-asserted-by":"crossref","unstructured":"Lee, B. et al. Physical Exercise-Induced Myokines in Neurodegenerative Diseases. Int. J. Mol. Sci. 22, 5795 (2021).","DOI":"10.3390\/ijms22115795"},{"key":"2145_CR503","doi-asserted-by":"publisher","first-page":"S42","DOI":"10.1016\/S1353-8020(09)70778-3","volume":"15","author":"MJ Zigmond","year":"2009","unstructured":"Zigmond, M. J. et al. Triggering endogenous neuroprotective processes through exercise in models of dopamine deficiency. Parkinsonism Relat. Disord. 15, S42\u2013S45 (2009).","journal-title":"Parkinsonism Relat. Disord."},{"key":"2145_CR504","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/bs.irn.2019.06.003","volume":"147","author":"X Xu","year":"2019","unstructured":"Xu, X., Fu, Z. & Le, W. Exercise and Parkinson\u2019s disease. Int. Rev. Neurobiol. 147, 45\u201374 (2019).","journal-title":"Int. Rev. Neurobiol."},{"key":"2145_CR505","doi-asserted-by":"crossref","unstructured":"Ortega-Hombrados, L. et al. Systematic Review of Therapeutic Physical Exercise in Patients with Amyotrophic Lateral Sclerosis over Time. Int. J. Environ. Res. Public Health. 18, 740 (2021).","DOI":"10.3390\/ijerph18031074"},{"key":"2145_CR506","doi-asserted-by":"publisher","first-page":"101108","DOI":"10.1016\/j.arr.2020.101108","volume":"62","author":"PL Valenzuela","year":"2020","unstructured":"Valenzuela, P. L. et al. Exercise benefits on Alzheimer\u2019s disease: State-of-the-science. Ageing Res. Rev. 62, 101108 (2020).","journal-title":"Ageing Res. Rev."},{"key":"2145_CR507","doi-asserted-by":"publisher","first-page":"601","DOI":"10.5334\/tohm.515","volume":"9","author":"SM Mueller","year":"2019","unstructured":"Mueller, S. M., Petersen, J. A. & Jung, H. H. Exercise in Huntington\u2019s Disease: Current State and Clinical Significance. Tremor. Other Hyperkinet. Mov. 9, 601 (2019).","journal-title":"Tremor. Other Hyperkinet. Mov."},{"key":"2145_CR508","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbr.2023.114810","volume":"460","author":"OK Fuller","year":"2024","unstructured":"Fuller, O. K. et al. Impact of voluntary exercise training on the metabolic and behavioral characteristics of the rTg4510 transgenic mouse model of frontotemporal dementia. Behav. Brain Res. 460, 114810 (2024).","journal-title":"Behav. Brain Res."},{"key":"2145_CR509","doi-asserted-by":"publisher","first-page":"1672","DOI":"10.1212\/01.wnl.0000311269.57716.63","volume":"70","author":"SC Vlad","year":"2008","unstructured":"Vlad, S. C., Miller, D. R., Kowall, N. W. & Felson, D. T. Protective effects of NSAIDs on the development of Alzheimer disease. Neurology 70, 1672\u20131677 (2008).","journal-title":"Neurology"},{"key":"2145_CR510","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1001\/archneur.2008.65.7.nct70006","volume":"65","author":"BK Martin","year":"2008","unstructured":"Martin, B. K. et al. Cognitive function over time in the Alzheimer\u2019s Disease Anti-inflammatory Prevention Trial (ADAPT): results of a randomized, controlled trial of naproxen and celecoxib. Arch. Neurol. 65, 896\u2013905 (2008).","journal-title":"Arch. Neurol."},{"key":"2145_CR511","first-page":"836","volume":"3","author":"TT Le","year":"2018","unstructured":"Le, T. T. et al. Effect of Ibuprofen on BrainAGE: A Randomized, Placebo-Controlled, Dose-Response Exploratory Study. Biol. Psychiatry Cogn. Neurosci. Neuroimaging 3, 836\u2013843 (2018).","journal-title":"Biol. Psychiatry Cogn. Neurosci. Neuroimaging"},{"key":"2145_CR512","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2019-032112","volume":"10","author":"DP Devanand","year":"2020","unstructured":"Devanand, D. P. et al. Antiviral therapy: Valacyclovir Treatment of Alzheimer\u2019s Disease (VALAD) Trial: protocol for a randomised, double-blind,placebo-controlled, treatment trial. BMJ Open 10, e032112 (2020).","journal-title":"BMJ Open"},{"key":"2145_CR513","doi-asserted-by":"crossref","unstructured":"Varesi, A. et al. The Role of Antioxidants in the Interplay between Oxidative Stress and Senescence. Antioxidants. 11, 5795 (2022).","DOI":"10.3390\/antiox11071224"},{"key":"2145_CR514","doi-asserted-by":"publisher","first-page":"104413","DOI":"10.1016\/j.archger.2021.104413","volume":"95","author":"MM Mehdi","year":"2021","unstructured":"Mehdi, M. M., Solanki, P. & Singh, P. Oxidative stress, antioxidants, hormesis and calorie restriction: The current perspective in the biology of aging. Arch. Gerontol. Geriatr. 95, 104413 (2021).","journal-title":"Arch. Gerontol. Geriatr."},{"key":"2145_CR515","doi-asserted-by":"crossref","unstructured":"Miwa, S., Kashyap, S., Chini, E. & von Zglinicki, T. Mitochondrial dysfunction in cell senescence and aging. J. Clin. Invest. 132, e158447 (2022).","DOI":"10.1172\/JCI158447"},{"key":"2145_CR516","first-page":"503","volume":"15","author":"QH Phua","year":"2024","unstructured":"Phua, Q. H., Ng, S. Y. & Soh, B. S. Mitochondria: A Potential Rejuvenation Tool against Aging. Aging Dis. 15, 503\u2013516 (2024).","journal-title":"Aging Dis."},{"key":"2145_CR517","doi-asserted-by":"publisher","first-page":"441","DOI":"10.14336\/AD.2020.0910","volume":"12","author":"A Adlimoghaddam","year":"2021","unstructured":"Adlimoghaddam, A. et al. Nilotinib Improves Bioenergetic Profiling in Brain Astroglia in the 3xTg Mouse Model of Alzheimer\u2019s Disease. Aging Dis. 12, 441\u2013465 (2021).","journal-title":"Aging Dis."},{"key":"2145_CR518","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1001\/jamaneurol.2020.4725","volume":"78","author":"T Simuni","year":"2021","unstructured":"Simuni, T. et al. Efficacy of Nilotinib in Patients With Moderately Advanced Parkinson Disease: A Randomized Clinical Trial. JAMA Neurol. 78, 312\u2013320 (2021).","journal-title":"JAMA Neurol."},{"key":"2145_CR519","doi-asserted-by":"publisher","first-page":"503","DOI":"10.3233\/JPD-160867","volume":"6","author":"F Pagan","year":"2016","unstructured":"Pagan, F. et al. Nilotinib Effects in Parkinson\u2019s disease and Dementia with Lewy bodies. J. Parkinsons Dis. 6, 503\u2013517 (2016).","journal-title":"J. Parkinsons Dis."},{"key":"2145_CR520","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1007\/s40266-021-00845-7","volume":"38","author":"M Rosenbloom","year":"2021","unstructured":"Rosenbloom, M. et al. A Phase II, Single-Center, Randomized, Double-Blind, Placebo-Controlled Study of the Safety and Therapeutic Efficacy of Intranasal Glulisine in Amnestic Mild Cognitive Impairment and Probable Mild Alzheimer\u2019s Disease. Drugs Aging 38, 407\u2013415 (2021).","journal-title":"Drugs Aging"},{"key":"2145_CR521","doi-asserted-by":"crossref","unstructured":"Kaeberlein, M. & Galvan, V. Rapamycin and Alzheimer\u2019s disease: Time for a clinical trial? Sci. Transl Med. 11, eaar4289 (2019).","DOI":"10.1126\/scitranslmed.aar4289"},{"key":"2145_CR522","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-17718-y","volume":"7","author":"M Gejl","year":"2017","unstructured":"Gejl, M. et al. Blood-Brain Glucose Transfer in Alzheimer\u2019s disease: Effect of GLP-1 Analog Treatment. Sci. Rep. 7, 17490 (2017).","journal-title":"Sci. Rep."},{"key":"2145_CR523","doi-asserted-by":"publisher","first-page":"2730","DOI":"10.1172\/JCI68295","volume":"123","author":"I Aviles-Olmos","year":"2013","unstructured":"Aviles-Olmos, I. et al. Exenatide and the treatment of patients with Parkinson\u2019s disease. J. Clin. Invest. 123, 2730\u20132736 (2013).","journal-title":"J. Clin. Invest."},{"key":"2145_CR524","doi-asserted-by":"publisher","first-page":"e024954","DOI":"10.1136\/bmjopen-2018-024954","volume":"9","author":"Q Shi","year":"2019","unstructured":"Shi, Q. et al. Effect of metformin on neurodegenerative disease among elderly adult US veterans with type 2 diabetes mellitus. BMJ Open 9, e024954 (2019).","journal-title":"BMJ Open"},{"key":"2145_CR525","doi-asserted-by":"crossref","unstructured":"Sluggett, J. K. et al. Metformin and Risk of Alzheimer\u2019s Disease Among Community-Dwelling People With Diabetes: A National Case-Control Study. J Clin Endocrinol Metab. 105, dgz234 (2020).","DOI":"10.1210\/clinem\/dgz234"},{"key":"2145_CR526","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/s40035-023-00336-2","volume":"12","author":"B Yulug","year":"2023","unstructured":"Yulug, B. et al. Combined metabolic activators improve cognitive functions in Alzheimer\u2019s disease patients: a randomised, double-blinded, placebo-controlled phase-II trial. Transl. Neurodegener. 12, 4 (2023).","journal-title":"Transl. Neurodegener."},{"key":"2145_CR527","doi-asserted-by":"publisher","first-page":"989","DOI":"10.3233\/JAD-200896","volume":"78","author":"GE Gibson","year":"2020","unstructured":"Gibson, G. E. et al. Benfotiamine and Cognitive Decline in Alzheimer\u2019s Disease: Results of a Randomized Placebo-Controlled Phase IIa Clinical Trial. J. Alzheimers Dis. 78, 989\u20131010 (2020).","journal-title":"J. Alzheimers Dis."},{"key":"2145_CR528","doi-asserted-by":"publisher","first-page":"111","DOI":"10.3233\/JAD-130722","volume":"38","author":"L Shinto","year":"2014","unstructured":"Shinto, L. et al. A randomized placebo-controlled pilot trial of omega-3 fatty acids and alpha lipoic acid in Alzheimer\u2019s disease. J. Alzheimers Dis. 38, 111\u2013120 (2014).","journal-title":"J. Alzheimers Dis."},{"key":"2145_CR529","volume":"8","author":"AC Raikes","year":"2022","unstructured":"Raikes, A. C. et al. Exploratory imaging outcomes of a phase 1b\/2a clinical trial of allopregnanolone as a regenerative therapeutic for Alzheimer\u2019s disease: Structural effects and functional connectivity outcomes. Alzheimers Dement. 8, e12258 (2022).","journal-title":"Alzheimers Dement."},{"key":"2145_CR530","volume":"6","author":"GD Hernandez","year":"2020","unstructured":"Hernandez, G. D. et al. Safety, tolerability, and pharmacokinetics of allopregnanolone as a regenerative therapeutic for Alzheimer\u2019s disease: A single and multiple ascending dose phase 1b\/2a clinical trial. Alzheimers Dement. 6, e12107 (2020).","journal-title":"Alzheimers Dement."},{"key":"2145_CR531","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.3233\/JAD-142958","volume":"47","author":"CE Gleason","year":"2015","unstructured":"Gleason, C. E. et al. Cognitive Effects of Soy Isoflavones in Patients with Alzheimer\u2019s Disease. J. Alzheimers Dis. 47, 1009\u20131019 (2015).","journal-title":"J. Alzheimers Dis."},{"key":"2145_CR532","doi-asserted-by":"publisher","first-page":"1420","DOI":"10.1001\/archneurol.2012.1970","volume":"69","author":"LD Baker","year":"2012","unstructured":"Baker, L. D. et al. Effects of growth hormone\u2013releasing hormone on cognitive function in adults with mild cognitive impairment and healthy older adults: results of a controlled trial. Arch. Neurol. 69, 1420\u20131429 (2012).","journal-title":"Arch. Neurol."},{"key":"2145_CR533","doi-asserted-by":"publisher","DOI":"10.1111\/acel.13028","volume":"18","author":"GM Fahy","year":"2019","unstructured":"Fahy, G. M. et al. Reversal of epigenetic aging and immunosenescent trends in humans. Aging Cell 18, e13028 (2019).","journal-title":"Aging Cell"},{"key":"2145_CR534","doi-asserted-by":"publisher","first-page":"129","DOI":"10.3233\/JAD-160565","volume":"56","author":"M Boada","year":"2017","unstructured":"Boada, M. et al. Efficacy and Safety of Plasma Exchange with 5% Albumin to Modify Cerebrospinal Fluid and Plasma Amyloid-\u03b2 Concentrations and Cognition Outcomes in Alzheimer\u2019s Disease Patients: A Multicenter, Randomized, Controlled Clinical Trial. J. Alzheimers Dis. 56, 129\u2013143 (2017).","journal-title":"J. Alzheimers Dis."},{"key":"2145_CR535","doi-asserted-by":"publisher","first-page":"1412","DOI":"10.1002\/alz.12137","volume":"16","author":"M Boada","year":"2020","unstructured":"Boada, M. et al. A randomized, controlled clinical trial of plasma exchange with albumin replacement for Alzheimer\u2019s disease: Primary results of the AMBAR Study. Alzheimers Dement. 16, 1412\u20131425 (2020).","journal-title":"Alzheimers Dement."},{"key":"2145_CR536","doi-asserted-by":"publisher","first-page":"1428244","DOI":"10.3389\/fnagi.2024.1428244","volume":"16","author":"S Navakkode","year":"2024","unstructured":"Navakkode, S. & Kennedy, B. K. Neural ageing and synaptic plasticity: prioritizing brain health in healthy longevity. Front. Aging Neurosci. 16, 1428244 (2024).","journal-title":"Front. Aging Neurosci."},{"key":"2145_CR537","doi-asserted-by":"publisher","first-page":"1556","DOI":"10.1038\/s41591-022-01923-y","volume":"28","author":"S Chaib","year":"2022","unstructured":"Chaib, S., Tchkonia, T. & Kirkland, J. L. Cellular senescence and senolytics: the path to the clinic. Nat. Med. 28, 1556\u20131568 (2022).","journal-title":"Nat. Med."},{"key":"2145_CR538","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.jshs.2022.10.003","volume":"12","author":"Y Qiu","year":"2023","unstructured":"Qiu, Y. et al. Exercise sustains the hallmarks of health. J. Sport Health Sci. 12, 8\u201335 (2023).","journal-title":"J. Sport Health Sci."},{"key":"2145_CR539","doi-asserted-by":"publisher","first-page":"3017","DOI":"10.1073\/pnas.1015950108","volume":"108","author":"KI Erickson","year":"2011","unstructured":"Erickson, K. I. et al. Exercise training increases size of hippocampus and improves memory. Proc. Natl Acad. Sci. USA 108, 3017\u20133022 (2011).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"2145_CR540","doi-asserted-by":"publisher","first-page":"E92","DOI":"10.1152\/ajpendo.00366.2003","volume":"286","author":"KR Short","year":"2004","unstructured":"Short, K. R. et al. Age and aerobic exercise training effects on whole body and muscle protein metabolism. Am. J. Physiol. Endocrinol. Metab. 286, E92\u2013101 (2004).","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"2145_CR541","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1007\/s11357-016-9897-y","volume":"38","author":"Y Mej\u00edas-Pe\u00f1a","year":"2016","unstructured":"Mej\u00edas-Pe\u00f1a, Y. et al. Effects of aerobic training on markers of autophagy in the elderly. Age 38, 33 (2016).","journal-title":"Age"},{"key":"2145_CR542","doi-asserted-by":"publisher","first-page":"101479","DOI":"10.1016\/j.arr.2021.101479","volume":"72","author":"S L\u00f3pez-Ortiz","year":"2021","unstructured":"L\u00f3pez-Ortiz, S. et al. Exercise interventions in Alzheimer\u2019s disease: A systematic review and meta-analysis of randomized controlled trials. Ageing Res. Rev. 72, 101479 (2021).","journal-title":"Ageing Res. Rev."},{"key":"2145_CR543","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1016\/S1474-4422(19)30285-6","volume":"18","author":"NM van der Kolk","year":"2019","unstructured":"van der Kolk, N. M. et al. Effectiveness of home-based and remotely supervised aerobic exercise in Parkinson\u2019s disease: a double-blind, randomised controlled trial. Lancet Neurol. 18, 998\u20131008 (2019).","journal-title":"Lancet Neurol."},{"key":"2145_CR544","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1001\/jamaneurol.2017.3517","volume":"75","author":"M Schenkman","year":"2018","unstructured":"Schenkman, M. et al. Effect of High-Intensity Treadmill Exercise on Motor Symptoms in Patients With De Novo Parkinson Disease: A Phase 2 Randomized Clinical Trial. JAMA Neurol. 75, 219\u2013226 (2018).","journal-title":"JAMA Neurol."},{"key":"2145_CR545","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1212\/WNL.0000000000000644","volume":"83","author":"EY Uc","year":"2014","unstructured":"Uc, E. Y. et al. Phase I\/II randomized trial of aerobic exercise in Parkinson disease in a community setting. Neurology 83, 413\u2013425 (2014).","journal-title":"Neurology"},{"key":"2145_CR546","doi-asserted-by":"publisher","DOI":"10.1186\/s13104-019-4633-1","volume":"12","author":"MA Carskadon","year":"2019","unstructured":"Carskadon, M. A. et al. A pilot prospective study of sleep patterns and DNA methylation-characterized epigenetic aging in young adults. BMC Res. Notes 12, 583 (2019).","journal-title":"BMC Res. Notes"},{"key":"2145_CR547","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1038\/s43587-023-00432-y","volume":"3","author":"R Waziry","year":"2023","unstructured":"Waziry, R. et al. Effect of long-term caloric restriction on DNA methylation measures of biological aging in healthy adults from the CALERIE trial. Nat. Aging 3, 248\u2013257 (2023).","journal-title":"Nat. Aging"},{"key":"2145_CR548","doi-asserted-by":"publisher","first-page":"2795","DOI":"10.1007\/s11357-021-00480-5","volume":"43","author":"D Kwon","year":"2021","unstructured":"Kwon, D. & Belsky, D. W. A toolkit for quantification of biological age from blood chemistry and organ function test data: BioAge. Geroscience 43, 2795\u20132808 (2021).","journal-title":"Geroscience"},{"key":"2145_CR549","doi-asserted-by":"publisher","DOI":"10.1111\/acel.13439","volume":"20","author":"G Fiorito","year":"2021","unstructured":"Fiorito, G. et al. DNA methylation-based biomarkers of aging were slowed down in a two-year diet and physical activity intervention trial: the DAMA study. Aging Cell 20, e13439 (2021).","journal-title":"Aging Cell"},{"key":"2145_CR550","doi-asserted-by":"publisher","first-page":"e2259","DOI":"10.1212\/WNL.0000000000207176","volume":"100","author":"P Agarwal","year":"2023","unstructured":"Agarwal, P. et al. Association of Mediterranean-DASH Intervention for Neurodegenerative Delay and Mediterranean Diets With Alzheimer Disease Pathology. Neurology 100, e2259\u2013e2268 (2023).","journal-title":"Neurology"},{"key":"2145_CR551","doi-asserted-by":"publisher","first-page":"9419","DOI":"10.18632\/aging.202913","volume":"13","author":"KN Fitzgerald","year":"2021","unstructured":"Fitzgerald, K. N. et al. Potential reversal of epigenetic age using a diet and lifestyle intervention: a pilot randomized clinical trial. Aging 13, 9419\u20139432 (2021).","journal-title":"Aging"}],"container-title":["Signal Transduction and Targeted Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41392-025-02145-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41392-025-02145-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41392-025-02145-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,9]],"date-time":"2025-03-09T20:02:34Z","timestamp":1741550554000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41392-025-02145-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,10]]},"references-count":551,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["2145"],"URL":"https:\/\/doi.org\/10.1038\/s41392-025-02145-7","relation":{},"ISSN":["2059-3635"],"issn-type":[{"value":"2059-3635","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,10]]},"assertion":[{"value":"1 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 November 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 January 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 March 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"76"}}